SEC Info - Organovo Holdings, Inc. - ‘S-1’ on 4/12/24

SEC Info℠

Home

My Interests

Help

Please Sign In

Organovo Holdings, Inc. – ‘S-1’ on 4/12/24 – ‘JSON’

On: Friday, 4/12/24, at 5:16pm ET · Accession #: 950170-24-44137 · File #: 333-278668

Previous ‘S-1’: ‘S-1/A’ on 7/5/12 · Next & Latest: ‘S-1/A’ on 4/30/24 · 30 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/12/24  Organovo Holdings, Inc.           S-1                   76:11M                                    Donnelley … Solutions/FA

Registration Statement (General Form) — Form S-1 — SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   3.89M 
 2: EX-23.1     Consent of Expert or Counsel                        HTML     23K 
 3: EX-FILING FEES  Filing Fees                                     HTML     44K 
 5: R1          Document and Entity Information                     HTML     56K 
 6: R2          Condensed Consolidated Balance Sheets               HTML    115K 
 7: R3          Condensed Consolidated Balance Sheets               HTML     35K 
                (Parenthetical)                                                  
 8: R4          Condensed Consolidated Statements of Operations     HTML     99K 
                and Other Comprehensive Loss                                     
 9: R5          Condensed Consolidated Statements of Stockholders'  HTML    106K 
                Equity                                                           
10: R6          Condensed Consolidated Statements of Cash Flows     HTML    116K 
11: R7          Description of Business                             HTML     33K 
12: R8          Description of Business and Summary of Significant  HTML     69K 
                Accounting Policies                                              
13: R9          Summary of Significant Accounting Policies          HTML     46K 
14: R10         Investments and Fair Value Measurement              HTML     81K 
15: R11         Fixed Assets                                        HTML     43K 
16: R12         Accrued Expenses                                    HTML     53K 
17: R13         Collaborative Research, Development, and License    HTML     73K 
                Agreements                                                       
18: R14         Stockholders' Equity                                HTML    308K 
19: R15         Leases                                              HTML    105K 
20: R16         Commitments and Contingencies                       HTML     32K 
21: R17         Income Taxes                                        HTML    102K 
22: R18         Concentrations                                      HTML     28K 
23: R19         Related Parties                                     HTML     37K 
24: R20         Defined Contribution Plan                           HTML     27K 
25: R21         Recent Accounting Pronouncements                    HTML     35K 
26: R22         Restructuring                                       HTML     46K 
27: R23         Subsequent Events                                   HTML     26K 
28: R24         Summary of Significant Accounting Policies          HTML    134K 
                (Policies)                                                       
29: R25         Investments and Fair Value Measurement (Tables)     HTML     77K 
30: R26         Fixed Assets (Tables)                               HTML     41K 
31: R27         Accrued Expenses (Tables)                           HTML     52K 
32: R28         Collaborative Research, Development, and License    HTML     34K 
                Agreements (Tables)                                              
33: R29         Stockholders' Equity (Tables)                       HTML    261K 
34: R30         Leases (Tables)                                     HTML     87K 
35: R31         Income Taxes (Tables)                               HTML     91K 
36: R32         Restructuring (Tables)                              HTML     45K 
37: R33         Description of Business - Additional Information    HTML     30K 
                (Details)                                                        
38: R34         Description of Business and Summary of Significant  HTML     79K 
                Accounting Policies - Additional Information                     
                (Details)                                                        
39: R35         Summary of Significant Accounting Policies -        HTML     46K 
                Additional Information (Details)                                 
40: R36         Investments and Fair Value Measurement -            HTML     51K 
                Additional Information (Details)                                 
41: R37         Investments and Fair Value Measurement - Summary    HTML     37K 
                of Investments in Debt Securities that are                       
                Measured at Fair Value (Details)                                 
42: R38         Investments and Fair Value Measurement - Schedule   HTML     40K 
                of Activity for Investments in Equity Securities                 
                Measured at Fair Value (Details)                                 
43: R39         Fixed Assets - Schedule of Fixed Assets (Details)   HTML     38K 
44: R40         Fixed Assets - Additional Information (Details)     HTML     25K 
45: R41         Accrued Expenses - Summary of Accrued Expenses      HTML     34K 
                (Details)                                                        
46: R42         Collaborative Research, Development, and License    HTML    115K 
                Agreements - Additional Information (Details)                    
47: R43         Collaborative Research, Development, and License    HTML     31K 
                Agreements - Schedule of Capitalized License Fees                
                (Details)                                                        
48: R44         Stockholders' Equity - Preferred Stock -            HTML     28K 
                Additional Information (Details)                                 
49: R45         Stockholders' Equity - Common Stock - Additional    HTML    113K 
                Information (Details)                                            
50: R46         Stockholders' Equity - Summary of Company's RSUs    HTML     50K 
                Activity (Details)                                               
51: R47         Stockholders' Equity - Stock Options and Employee   HTML    127K 
                Stock Purchase Plan - Additional Information                     
                (Details)                                                        
52: R48         Stockholders' Equity - Summary of Stock Option      HTML     65K 
                Activity (Details)                                               
53: R49         Stockholders' Equity - Common Stock Reserved for    HTML     57K 
                Future Issuance (Details)                                        
54: R50         Stockholders' Equity - Stock-based Compensation     HTML     43K 
                Expense and Valuation Information - Additional                   
                Information (Details)                                            
55: R51         Stockholders' Equity - Schedule of Stock-based      HTML     32K 
                Compensation Expense (Details)                                   
56: R52         Stockholders' Equity - Fair Value of Employee       HTML     36K 
                Stock Options (Details)                                          
57: R53         Stockholders' Equity - Fair Value of ESPP Shares    HTML     51K 
                (Details)                                                        
58: R54         Stockholders' Equity - Fair Value of Employee       HTML     35K 
                Stock Purchase Plan (Parenthetical) (Details)                    
59: R55         Leases - Additional Information (Details)           HTML     62K 
60: R56         Leases - Schedule of Lease Liabilities and          HTML     41K 
                Corresponding Right-of-use Assets (Details)                      
61: R57         Leases - Schedule of Future Lease Payments          HTML     43K 
                Quarterly (Details)                                              
62: R58         Leases - Schedule of Future Lease Payments          HTML     45K 
                (Details)                                                        
63: R59         Income Taxes - Summary of Reconciliation of         HTML     66K 
                Statutory Federal Rate and Effective Rate for                    
                Operations (Details)                                             
64: R60         Income Taxes - Summary of Net Deferred Tax Assets   HTML     56K 
                (Details)                                                        
65: R61         Income Taxes - Additional Information (Details)     HTML     54K 
66: R62         Related Parties - Additional Information (Details)  HTML     29K 
67: R63         Defined Contribution Plan - Additional Information  HTML     26K 
                (Details)                                                        
68: R64         Restructuring - Additional Information (Details)    HTML     38K 
69: R65         Restructuring - Summary of Restructuring Charges    HTML     30K 
                Recorded in Selling, General and Administrative                  
                Expenses (Details)                                               
70: R66         Restructuring - Summary of Activity and Balances    HTML     35K 
                of Restructuring Reserve (Details)                               
71: R67         Subsequent Events - Additional Information          HTML     35K 
                (Details)                                                        
73: XML         IDEA XML File -- Filing Summary                      XML    149K 
76: XML         XBRL Instance -- onvo-20240412_htm                   XML   2.52M 
72: EXCEL       IDEA Workbook of Financial Report Info              XLSX    168K 
 4: EX-101.SCH  XBRL Taxonomy Extension Schema With Embedded         XSD   3.33M 
                Linkbases Document -- onvo-20240412                              
74: JSON        XBRL Instance as JSON Data -- MetaLinks              466±   751K 
75: ZIP         XBRL Zipped Folder -- 0000950170-24-044137-xbrl      Zip    601K

‘JSON’ — XBRL Instance as JSON Data — MetaLinks

This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.

{
"version":  "2.2",
"instance":  {
    "onvo-20240412.htm":  {
        "nsprefix":  "onvo",
        "nsuri":  "http://www.organovo.com/20240412",
        "dts":  {
            "inline":  {
                "local":  [
                    "onvo-20240412.htm"
                    ]
                },
            "schema":  {
                "local":  [
                    "onvo-20240412.xsd"
                    ],
                "remote":  [
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
                    "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
                    "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
                    "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
                    "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
                    "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
                    "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
                    "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
                    "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
                    "https://xbrl.sec.gov/country/2023/country-2023.xsd",
                    "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
                    ]
                }
            },
        "keyStandard":  287,
        "keyCustom":  62,
        "axisStandard":  23,
        "axisCustom":  0,
        "memberStandard":  21,
        "memberCustom":  35,
        "hidden":  {
            "total":  15,
            "http://xbrl.sec.gov/dei/2023":  2,
            "http://fasb.org/us-gaap/2023":  13
            },
        "contextCount":  269,
        "entityCount":  1,
        "segmentCount":  56,
        "elementCount":  564,
        "unitCount":  9,
        "baseTaxonomies":  {
            "http://fasb.org/us-gaap/2023":  1083,
            "http://xbrl.sec.gov/dei/2023":  24
            },
        "report":  {
            "R1":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
                "longName":  "100000 - Document - Document and Entity Information",
                "shortName":  "Document and Entity Information",
                "isDefault":  "true",
                "groupType":  "document",
                "subGroupType":  "",
                "menuCat":  "Cover",
                "order":  "1",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "dei:DocumentType",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "dei:DocumentType",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R2":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets",
                "longName":  "100010 - Statement - Condensed Consolidated Balance Sheets",
                "shortName":  "Condensed Consolidated Balance Sheets",
                "isDefault":  "false",
                "groupType":  "statement",
                "subGroupType":  "",
                "menuCat":  "Statements",
                "order":  "2",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:AccountsReceivableNetCurrent",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R3":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
                "longName":  "100030 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
                "shortName":  "Condensed Consolidated Balance Sheets (Parenthetical)",
                "isDefault":  "false",
                "groupType":  "statement",
                "subGroupType":  "parenthetical",
                "menuCat":  "Statements",
                "order":  "3",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:CommonStockParOrStatedValuePerShare",
                    "unitRef":  "U_UnitedStatesOfAmericaDollarsShare",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:CommonStockParOrStatedValuePerShare",
                    "unitRef":  "U_UnitedStatesOfAmericaDollarsShare",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R4":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss",
                "longName":  "100040 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Loss",
                "shortName":  "Condensed Consolidated Statements of Operations and Other Comprehensive Loss",
                "isDefault":  "false",
                "groupType":  "statement",
                "subGroupType":  "",
                "menuCat":  "Statements",
                "order":  "4",
                "firstAnchor":  {
                    "contextRef":  "C_fc61a264-ad38-4c63-bd4c-4e4cfa25ecb3",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_fc61a264-ad38-4c63-bd4c-4e4cfa25ecb3",
                    "name":  "us-gaap:ResearchAndDevelopmentExpense",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R5":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity",
                "longName":  "100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
                "shortName":  "Condensed Consolidated Statements of Stockholders' Equity",
                "isDefault":  "false",
                "groupType":  "statement",
                "subGroupType":  "",
                "menuCat":  "Statements",
                "order":  "5",
                "firstAnchor":  {
                    "contextRef":  "C_7571104d-29b5-41f4-9123-232896c31d54",
                    "name":  "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_7571104d-29b5-41f4-9123-232896c31d54",
                    "name":  "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R6":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows",
                "longName":  "100060 - Statement - Condensed Consolidated Statements of Cash Flows",
                "shortName":  "Condensed Consolidated Statements of Cash Flows",
                "isDefault":  "false",
                "groupType":  "statement",
                "subGroupType":  "",
                "menuCat":  "Statements",
                "order":  "6",
                "firstAnchor":  {
                    "contextRef":  "C_fc61a264-ad38-4c63-bd4c-4e4cfa25ecb3",
                    "name":  "us-gaap:ProfitLoss",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:GainLossOnSaleOfPropertyPlantEquipment",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R7":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusiness",
                "longName":  "100070 - Disclosure - Description of Business",
                "shortName":  "Description of Business",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "7",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:NatureOfOperations",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:NatureOfOperations",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R8":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies",
                "longName":  "100080 - Disclosure - Description of Business and Summary of Significant Accounting Policies",
                "shortName":  "Description of Business and Summary of Significant Accounting Policies",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "8",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R9":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies",
                "longName":  "100090 - Disclosure - Summary of Significant Accounting Policies",
                "shortName":  "Summary of Significant Accounting Policies",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "9",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R10":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurement",
                "longName":  "100100 - Disclosure - Investments and Fair Value Measurement",
                "shortName":  "Investments and Fair Value Measurement",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "10",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:InvestmentTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:InvestmentTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R11":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureFixedAssets",
                "longName":  "100110 - Disclosure - Fixed Assets",
                "shortName":  "Fixed Assets",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "11",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R12":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureAccruedExpenses",
                "longName":  "100120 - Disclosure - Accrued Expenses",
                "shortName":  "Accrued Expenses",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "12",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R13":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements",
                "longName":  "100130 - Disclosure - Collaborative Research, Development, and License Agreements",
                "shortName":  "Collaborative Research, Development, and License Agreements",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "13",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:CollaborativeArrangementDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:CollaborativeArrangementDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R14":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquity",
                "longName":  "100140 - Disclosure - Stockholders' Equity",
                "shortName":  "Stockholders' Equity",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "14",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R15":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeases",
                "longName":  "100150 - Disclosure - Leases",
                "shortName":  "Leases",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "15",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R16":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
                "longName":  "100160 - Disclosure - Commitments and Contingencies",
                "shortName":  "Commitments and Contingencies",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "16",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:CommitmentsDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:CommitmentsDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R17":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureIncomeTaxes",
                "longName":  "100170 - Disclosure - Income Taxes",
                "shortName":  "Income Taxes",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "17",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R18":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureConcentrations",
                "longName":  "100180 - Disclosure - Concentrations",
                "shortName":  "Concentrations",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "18",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ConcentrationRiskDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ConcentrationRiskDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R19":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRelatedParties",
                "longName":  "100190 - Disclosure - Related Parties",
                "shortName":  "Related Parties",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "19",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R20":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureDefinedContributionPlan",
                "longName":  "100200 - Disclosure - Defined Contribution Plan",
                "shortName":  "Defined Contribution Plan",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "20",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R21":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRecentAccountingPronouncements",
                "longName":  "100210 - Disclosure - Recent Accounting Pronouncements",
                "shortName":  "Recent Accounting Pronouncements",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "21",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R22":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuring",
                "longName":  "100220 - Disclosure - Restructuring",
                "shortName":  "Restructuring",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "22",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R23":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureSubsequentEvents",
                "longName":  "100230 - Disclosure - Subsequent Events",
                "shortName":  "Subsequent Events",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "",
                "menuCat":  "Notes",
                "order":  "23",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R24":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
                "longName":  "100240 - Disclosure - Summary of Significant Accounting Policies (Policies)",
                "shortName":  "Summary of Significant Accounting Policies (Policies)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "policies",
                "menuCat":  "Policies",
                "order":  "24",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R25":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementTables",
                "longName":  "100250 - Disclosure - Investments and Fair Value Measurement (Tables)",
                "shortName":  "Investments and Fair Value Measurement (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "25",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:InvestmentTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:InvestmentTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R26":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureFixedAssetsTables",
                "longName":  "100260 - Disclosure - Fixed Assets (Tables)",
                "shortName":  "Fixed Assets (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "26",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R27":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureAccruedExpensesTables",
                "longName":  "100270 - Disclosure - Accrued Expenses (Tables)",
                "shortName":  "Accrued Expenses (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "27",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R28":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsTables",
                "longName":  "100280 - Disclosure - Collaborative Research, Development, and License Agreements (Tables)",
                "shortName":  "Collaborative Research, Development, and License Agreements (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "28",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "onvo:ScheduleOfCapitalizedLicenseFeesTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:CollaborativeArrangementDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "onvo:ScheduleOfCapitalizedLicenseFeesTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:CollaborativeArrangementDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R29":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables",
                "longName":  "100290 - Disclosure - Stockholders' Equity (Tables)",
                "shortName":  "Stockholders' Equity (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "29",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R30":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesTables",
                "longName":  "100300 - Disclosure - Leases (Tables)",
                "shortName":  "Leases (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "30",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:LeaseCostTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:LeaseCostTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R31":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureIncomeTaxesTables",
                "longName":  "100310 - Disclosure - Income Taxes (Tables)",
                "shortName":  "Income Taxes (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "31",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R32":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringTables",
                "longName":  "100320 - Disclosure - Restructuring (Tables)",
                "shortName":  "Restructuring (Tables)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "tables",
                "menuCat":  "Tables",
                "order":  "32",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "div",
                        "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R33":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails",
                "longName":  "100330 - Disclosure - Description of Business - Additional Information (Details)",
                "shortName":  "Description of Business - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "33",
                "firstAnchor":  {
                    "contextRef":  "C_77353c16-32df-497d-bbe6-9aa727505037",
                    "name":  "onvo:NumberOfClinicallyTestedCompounds",
                    "unitRef":  "U_Compounds",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:NatureOfOperations",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  null
                },
            "R34":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                "longName":  "100340 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)",
                "shortName":  "Description of Business and Summary of Significant Accounting Policies - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "34",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "us-gaap:RestrictedCashAndCashEquivalentsNoncurrent",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-5",
                    "ancestors":  [
                        "us-gaap:RestrictedCashAndCashEquivalentsNoncurrent",
                        "span",
                        "ix:continuation",
                        "span",
                        "p",
                        "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R35":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                "longName":  "100350 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
                "shortName":  "Summary of Significant Accounting Policies - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "35",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  null
                },
            "R36":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails",
                "longName":  "100360 - Disclosure - Investments and Fair Value Measurement - Additional Information (Details)",
                "shortName":  "Investments and Fair Value Measurement - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "36",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:Investments",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-5",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:InvestmentTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "us-gaap:Investments",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-5",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:InvestmentTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R37":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails",
                "longName":  "100370 - Disclosure - Investments and Fair Value Measurement - Summary of Investments in Debt Securities that are Measured at Fair Value (Details)",
                "shortName":  "Investments and Fair Value Measurement - Summary of Investments in Debt Securities that are Measured at Fair Value (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "37",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
                        "div",
                        "us-gaap:InvestmentTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
                        "div",
                        "us-gaap:InvestmentTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R38":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails",
                "longName":  "100380 - Disclosure - Investments and Fair Value Measurement - Schedule of Activity for Investments in Equity Securities Measured at Fair Value (Details)",
                "shortName":  "Investments and Fair Value Measurement - Schedule of Activity for Investments in Equity Securities Measured at Fair Value (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "38",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:PaymentsToAcquireEquitySecuritiesFvNi",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_149aa667-a4c3-4e01-83ab-adf1b46da6e5",
                    "name":  "us-gaap:PaymentsToAcquireEquitySecuritiesFvNi",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "onvo:ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueTableTextBlock",
                        "div",
                        "us-gaap:InvestmentTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R39":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails",
                "longName":  "100390 - Disclosure - Fixed Assets - Schedule of Fixed Assets (Details)",
                "shortName":  "Fixed Assets - Schedule of Fixed Assets (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "39",
                "firstAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "us-gaap:MachineryAndEquipmentGross",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:PropertyPlantAndEquipmentTextBlock",
                        "div",
                        "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "us-gaap:MachineryAndEquipmentGross",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:PropertyPlantAndEquipmentTextBlock",
                        "div",
                        "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R40":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsAdditionalInformationDetails",
                "longName":  "100400 - Disclosure - Fixed Assets - Additional Information (Details)",
                "shortName":  "Fixed Assets - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "40",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:Depreciation",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "ix:continuation",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:Depreciation",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "ix:continuation",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R41":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails",
                "longName":  "100410 - Disclosure - Accrued Expenses - Summary of Accrued Expenses (Details)",
                "shortName":  "Accrued Expenses - Summary of Accrued Expenses (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "41",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:EmployeeRelatedLiabilitiesCurrent",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "div",
                        "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:EmployeeRelatedLiabilitiesCurrent",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "div",
                        "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R42":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails",
                "longName":  "100420 - Disclosure - Collaborative Research, Development, and License Agreements - Additional Information (Details)",
                "shortName":  "Collaborative Research, Development, and License Agreements - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "42",
                "firstAnchor":  {
                    "contextRef":  "C_4bd2a77d-c672-4d8d-811d-69682d16b84a",
                    "name":  "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-5",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_b395a853-0a52-4802-8cc3-e68103bc8bd9",
                    "name":  "us-gaap:AmortizationOfIntangibleAssets",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:CollaborativeArrangementDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R43":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails",
                "longName":  "100430 - Disclosure - Collaborative Research, Development, and License Agreements - Schedule of Capitalized License Fees (Details)",
                "shortName":  "Collaborative Research, Development, and License Agreements - Schedule of Capitalized License Fees (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "43",
                "firstAnchor":  {
                    "contextRef":  "C_d642f6b9-7aa4-4970-99ec-ab72d0a2e3af",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsGross",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "onvo:ScheduleOfCapitalizedLicenseFeesTableTextBlock",
                        "div",
                        "us-gaap:CollaborativeArrangementDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_d642f6b9-7aa4-4970-99ec-ab72d0a2e3af",
                    "name":  "us-gaap:FiniteLivedIntangibleAssetsGross",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "onvo:ScheduleOfCapitalizedLicenseFeesTableTextBlock",
                        "div",
                        "us-gaap:CollaborativeArrangementDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R44":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityPreferredStockAdditionalInformationDetails",
                "longName":  "100440 - Disclosure - Stockholders' Equity - Preferred Stock - Additional Information (Details)",
                "shortName":  "Stockholders' Equity - Preferred Stock - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "44",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:PreferredStockSharesAuthorized",
                    "unitRef":  "U_shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:PreferredStockSharesAuthorized",
                    "unitRef":  "U_shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R45":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                "longName":  "100450 - Disclosure - Stockholders' Equity - Common Stock - Additional Information (Details)",
                "shortName":  "Stockholders' Equity - Common Stock - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "45",
                "firstAnchor":  {
                    "contextRef":  "C_606eaf66-0b97-40d9-8117-8a1b26efd619",
                    "name":  "onvo:CombinationOfSecuritiesAuthorizedForOfferAndSale",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_606eaf66-0b97-40d9-8117-8a1b26efd619",
                    "name":  "onvo:CombinationOfSecuritiesAuthorizedForOfferAndSale",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R46":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails",
                "longName":  "100460 - Disclosure - Stockholders' Equity - Summary of Company's RSUs Activity (Details)",
                "shortName":  "Stockholders' Equity - Summary of Company's RSUs Activity (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "46",
                "firstAnchor":  {
                    "contextRef":  "C_6a9a5b4d-3bc9-4505-b6c7-2d77e14f080a",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                    "unitRef":  "U_shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_002035ae-16ba-4e0f-9e06-923622316fea",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                    "unitRef":  "U_shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R47":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                "longName":  "100470 - Disclosure - Stockholders' Equity - Stock Options and Employee Stock Purchase Plan - Additional Information (Details)",
                "shortName":  "Stockholders' Equity - Stock Options and Employee Stock Purchase Plan - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "47",
                "firstAnchor":  {
                    "contextRef":  "C_0487827d-be5f-4bc5-a260-30ec3655a63b",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
                    "unitRef":  "U_shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "onvo:VestingCriteriaProbabilityOfAchievementPercentage",
                    "unitRef":  "U_pure",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "2",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R48":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails",
                "longName":  "100480 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity (Details)",
                "shortName":  "Stockholders' Equity - Summary of Stock Option Activity (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "48",
                "firstAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "unitRef":  "U_shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_dc6e85f2-6d06-4e2f-8c9a-7166659b60ba",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "unitRef":  "U_shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R49":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                "longName":  "100490 - Disclosure - Stockholders' Equity - Common Stock Reserved for Future Issuance (Details)",
                "shortName":  "Stockholders' Equity - Common Stock Reserved for Future Issuance (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "49",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
                    "unitRef":  "U_shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "onvo:CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_9ef40ea8-7e52-4f7a-886d-d34ab1813b66",
                    "name":  "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
                    "unitRef":  "U_shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "onvo:CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R50":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails",
                "longName":  "100500 - Disclosure - Stockholders' Equity - Stock-based Compensation Expense and Valuation Information - Additional Information (Details)",
                "shortName":  "Stockholders' Equity - Stock-based Compensation Expense and Valuation Information - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "50",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-5",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-5",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R51":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockbasedCompensationExpenseDetails",
                "longName":  "100520 - Disclosure - Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details)",
                "shortName":  "Stockholders' Equity - Schedule of Stock-based Compensation Expense (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "51",
                "firstAnchor":  {
                    "contextRef":  "C_fc61a264-ad38-4c63-bd4c-4e4cfa25ecb3",
                    "name":  "us-gaap:AllocatedShareBasedCompensationExpense",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5af2b11c-198c-46b2-a586-b849618df9c5",
                    "name":  "us-gaap:AllocatedShareBasedCompensationExpense",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R52":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetails",
                "longName":  "100530 - Disclosure - Stockholders' Equity - Fair Value of Employee Stock Options (Details)",
                "shortName":  "Stockholders' Equity - Fair Value of Employee Stock Options (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "52",
                "firstAnchor":  {
                    "contextRef":  "C_fc61a264-ad38-4c63-bd4c-4e4cfa25ecb3",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                    "unitRef":  "U_pure",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "2",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  null
                },
            "R53":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails",
                "longName":  "100540 - Disclosure - Stockholders' Equity - Fair Value of ESPP Shares (Details)",
                "shortName":  "Stockholders' Equity - Fair Value of ESPP Shares (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "53",
                "firstAnchor":  {
                    "contextRef":  "C_fc61a264-ad38-4c63-bd4c-4e4cfa25ecb3",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                    "unitRef":  "U_pure",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "2",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_15e7e7c3-8405-40b9-9e9c-462553dd8f39",
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                    "unitRef":  "U_pure",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "2",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R54":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockPurchasePlanParentheticalDetails",
                "longName":  "100550 - Disclosure - Stockholders' Equity - Fair Value of Employee Stock Purchase Plan (Parenthetical) (Details)",
                "shortName":  "Stockholders' Equity - Fair Value of Employee Stock Purchase Plan (Parenthetical) (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "parenthetical",
                "menuCat":  "Details",
                "order":  "54",
                "firstAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "onvo:NumberOfParticipantsEnrolledInEmployeeStockPurchasePlan",
                    "unitRef":  "U_Participant",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_0d3d70ef-19e7-4a79-9d6b-a184372281d5",
                    "name":  "onvo:NumberOfParticipantsEnrolledInEmployeeStockPurchasePlan",
                    "unitRef":  "U_Participant",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R55":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails",
                "longName":  "100560 - Disclosure - Leases - Additional Information (Details)",
                "shortName":  "Leases - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "55",
                "firstAnchor":  {
                    "contextRef":  "C_8b7f0b01-78b6-45d6-8f99-55ec72b1297b",
                    "name":  "onvo:MonthlyRentPayments",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_8b7f0b01-78b6-45d6-8f99-55ec72b1297b",
                    "name":  "onvo:MonthlyRentPayments",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R56":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                "longName":  "100570 - Disclosure - Leases - Schedule of Lease Liabilities and Corresponding Right-of-use Assets (Details)",
                "shortName":  "Leases - Schedule of Lease Liabilities and Corresponding Right-of-use Assets (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "56",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "onvo:OperatingLeaseRightOfUseAssetNonCurrent",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LeaseCostTableTextBlock",
                        "div",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "onvo:OperatingLeaseRightOfUseAssetNonCurrent",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LeaseCostTableTextBlock",
                        "div",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R57":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails",
                "longName":  "100580 - Disclosure - Leases - Schedule of Future Lease Payments Quarterly (Details)",
                "shortName":  "Leases - Schedule of Future Lease Payments Quarterly (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "57",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "div",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "div",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R58":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails",
                "longName":  "100590 - Disclosure - Leases - Schedule of Future Lease Payments (Details)",
                "shortName":  "Leases - Schedule of Future Lease Payments (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "58",
                "firstAnchor":  {
                    "contextRef":  "C_47512af4-cf39-4ab1-8965-52d3c968d046",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "div",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                        "div",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R59":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails",
                "longName":  "100610 - Disclosure - Income Taxes - Summary of Reconciliation of Statutory Federal Rate and Effective Rate for Operations (Details)",
                "shortName":  "Income Taxes - Summary of Reconciliation of Statutory Federal Rate and Effective Rate for Operations (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "59",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                        "div",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                        "div",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R60":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails",
                "longName":  "100620 - Disclosure - Income Taxes - Summary of Net Deferred Tax Assets (Details)",
                "shortName":  "Income Taxes - Summary of Net Deferred Tax Assets (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "60",
                "firstAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "div",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R61":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
                "longName":  "100630 - Disclosure - Income Taxes - Additional Information (Details)",
                "shortName":  "Income Taxes - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "61",
                "firstAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "us-gaap:UnrecognizedTaxBenefits",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_6ea5874c-5584-47eb-8af9-8546fac9ad78",
                    "name":  "us-gaap:UnrecognizedTaxBenefits",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R62":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails",
                "longName":  "100640 - Disclosure - Related Parties - Additional Information (Details)",
                "shortName":  "Related Parties - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "62",
                "firstAnchor":  {
                    "contextRef":  "C_6cdd2b1b-a664-430c-b330-19db16e943e6",
                    "name":  "onvo:ConsultingExpenses",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "ix:continuation",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_6cdd2b1b-a664-430c-b330-19db16e943e6",
                    "name":  "onvo:ConsultingExpenses",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "0",
                    "ancestors":  [
                        "span",
                        "ix:continuation",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R63":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureDefinedContributionPlanAdditionalInformationDetails",
                "longName":  "100650 - Disclosure - Defined Contribution Plan - Additional Information (Details)",
                "shortName":  "Defined Contribution Plan - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "63",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
                    "unitRef":  "U_pure",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
                    "unitRef":  "U_pure",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R64":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails",
                "longName":  "100660 - Disclosure - Restructuring - Additional Information (Details)",
                "shortName":  "Restructuring - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "64",
                "firstAnchor":  {
                    "contextRef":  "C_fc61a264-ad38-4c63-bd4c-4e4cfa25ecb3",
                    "name":  "us-gaap:RestructuringCharges",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_2c75b9db-853e-4d5e-b315-d84460a70e60",
                    "name":  "us-gaap:RestructuringAndRelatedActivitiesInitiationDate",
                    "unitRef":  null,
                    "xsiNil":  "false",
                    "lang":  "en-US",
                    "decimals":  null,
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                },
            "R65":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfRestructuringChargesRecordedInSellingGeneralAndAdministrativeExpensesDetails",
                "longName":  "100670 - Disclosure - Restructuring - Summary of Restructuring Charges Recorded in Selling, General and Administrative Expenses (Details)",
                "shortName":  "Restructuring - Summary of Restructuring Charges Recorded in Selling, General and Administrative Expenses (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "65",
                "firstAnchor":  {
                    "contextRef":  "C_2c75b9db-853e-4d5e-b315-d84460a70e60",
                    "name":  "us-gaap:SeveranceCosts1",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-5",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  null
                },
            "R66":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfActivityAndBalancesOfRestructuringReserveDetails",
                "longName":  "100680 - Disclosure - Restructuring - Summary of Activity and Balances of Restructuring Reserve (Details)",
                "shortName":  "Restructuring - Summary of Activity and Balances of Restructuring Reserve (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "66",
                "firstAnchor":  {
                    "contextRef":  "C_fec1f9c2-63a9-4c7d-8357-cc0611de50e0",
                    "name":  "us-gaap:RestructuringReserve",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
                        "div",
                        "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_fec1f9c2-63a9-4c7d-8357-cc0611de50e0",
                    "name":  "us-gaap:RestructuringReserve",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-3",
                    "ancestors":  [
                        "span",
                        "p",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
                        "div",
                        "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true,
                    "unique":  true
                    }
                },
            "R67":  {
                "role":  "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
                "longName":  "100690 - Disclosure - Subsequent Events - Additional Information (Details)",
                "shortName":  "Subsequent Events - Additional Information (Details)",
                "isDefault":  "false",
                "groupType":  "disclosure",
                "subGroupType":  "details",
                "menuCat":  "Details",
                "order":  "67",
                "firstAnchor":  {
                    "contextRef":  "C_5da672a5-2ccd-4919-aa76-a080656838f3",
                    "name":  "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
                    "unitRef":  "U_shares",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "INF",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "first":  true
                    },
                "uniqueAnchor":  {
                    "contextRef":  "C_e908c7b2-f6b1-481c-963a-27b164ca492b",
                    "name":  "us-gaap:ProceedsFromIssuanceOfCommonStock",
                    "unitRef":  "U_USD",
                    "xsiNil":  "false",
                    "lang":  null,
                    "decimals":  "-5",
                    "ancestors":  [
                        "span",
                        "p",
                        "us-gaap:SubsequentEventsTextBlock",
                        "div",
                        "body",
                        "html"
                        ],
                    "reportCount":  1,
                    "baseRef":  "onvo-20240412.htm",
                    "unique":  true
                    }
                }
            },
        "tag":  {
            "us-gaap_AccountingChangesAndErrorCorrectionsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccountingChangesAndErrorCorrectionsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Changes and Error Corrections [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccountingPoliciesAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureAccruedExpenses"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
                            "terseLabel":  "Accrued Expenses",
                            "documentation":  "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r18"
                    ]
                },
            "us-gaap_AccountsPayableCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccountsPayableCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounts Payable, Current",
                            "terseLabel":  "Accounts payable",
                            "totalLabel":  "Accounts Payable, Current, Total",
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r17",
                    "r638"
                    ]
                },
            "us-gaap_AccountsReceivableNetCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccountsReceivableNetCurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Accounts Receivable, after Allowance for Credit Loss, Current, Total",
                            "label":  "Accounts Receivable, after Allowance for Credit Loss, Current",
                            "terseLabel":  "Accounts receivable",
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
                            }
                        }
                    },
                "auth_ref":  [
                    "r242",
                    "r243"
                    ]
                },
            "onvo_AccretionOnInvestments":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "AccretionOnInvestments",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accretion on Investments.",
                            "label":  "Accretion On Investments",
                            "negatedLabel":  "Accretion on investments"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AccruedLiabilitiesCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccruedLiabilitiesCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  1.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accrued Liabilities, Current",
                            "terseLabel":  "Accrued expenses",
                            "totalLabel":  "Accrued expenses",
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r20"
                    ]
                },
            "us-gaap_AccruedProfessionalFeesCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccruedProfessionalFeesCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails":  {
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accrued Professional Fees, Current",
                            "terseLabel":  "Accrued legal and professional fees",
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r20"
                    ]
                },
            "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails":  {
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentNet",
                        "weight":  -1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
                            "negatedLabel":  "Less accumulated depreciation",
                            "totalLabel":  "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total",
                            "periodStartLabel":  "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
                            "periodEndLabel":  "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
                            "documentation":  "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
                            }
                        }
                    },
                "auth_ref":  [
                    "r50",
                    "r164",
                    "r501"
                    ]
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total",
                            "label":  "Accumulated Other Comprehensive Income (Loss), Net of Tax",
                            "terseLabel":  "Accumulated other comprehensive income",
                            "documentation":  "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
                            }
                        }
                    },
                "auth_ref":  [
                    "r27",
                    "r28",
                    "r95",
                    "r171",
                    "r497",
                    "r523",
                    "r527"
                    ]
                },
            "us-gaap_AccumulatedOtherComprehensiveIncomeMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AccumulatedOtherComprehensiveIncomeMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "AOCI Attributable to Parent [Member]",
                            "terseLabel":  "Accumulated Other Comprehensive Income [Member]",
                            "documentation":  "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent.  Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
                            }
                        }
                    },
                "auth_ref":  [
                    "r2",
                    "r9",
                    "r28",
                    "r410",
                    "r413",
                    "r453",
                    "r518",
                    "r519",
                    "r675",
                    "r676",
                    "r677",
                    "r686",
                    "r687",
                    "r688"
                    ]
                },
            "onvo_AcquiredInProcessResearchAndDevelopmentAccruedExpenses":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "AcquiredInProcessResearchAndDevelopmentAccruedExpenses",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails":  {
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Acquired in-process research and development accrued expenses",
                            "label":  "Acquired in-process research and development accrued expenses",
                            "terseLabel":  "Acquired in-process research and development accrued expenses",
                            "verboseLabel":  "Acquired in-process research and development"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AdditionalPaidInCapitalCommonStock":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AdditionalPaidInCapitalCommonStock",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional Paid in Capital, Common Stock",
                            "terseLabel":  "Additional paid-in capital",
                            "documentation":  "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions.  Includes only common stock transactions (excludes preferred stock transactions).  May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
                            }
                        }
                    },
                "auth_ref":  [
                    "r90"
                    ]
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AdditionalPaidInCapitalMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional Paid-in Capital [Member]",
                            "terseLabel":  "Additional Paid-in Capital [Member]",
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
                            }
                        }
                    },
                "auth_ref":  [
                    "r360",
                    "r361",
                    "r362",
                    "r545",
                    "r686",
                    "r687",
                    "r688",
                    "r755",
                    "r777"
                    ]
                },
            "onvo_AdditionalUpfrontFeePayment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "AdditionalUpfrontFeePayment",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Additional upfront fee payment.",
                            "label":  "Additional Upfront Fee Payment",
                            "terseLabel":  "Additional upfront payment"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_AddressTypeDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "AddressTypeDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Address Type [Domain]",
                            "documentation":  "An entity may have several addresses for different purposes and this domain represents all such types."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShare":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionShare",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Stock-based compensation expense, shares",
                            "label":  "Adjustments To Additional Paid In Capital Share based Compensation Requisite Service Period Recognition Share",
                            "documentation":  "Adjustments To Additional Paid In Capital Share based Compensation Requisite Service Period Recognition Share"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
                            "terseLabel":  "Stock-based compensation expense",
                            "totalLabel":  "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total",
                            "documentation":  "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r70",
                    "r71",
                    "r327"
                    ]
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Adjustments to reconcile net loss to net cash used in operating activities:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_AforementionedOfficerOneMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "AforementionedOfficerOneMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aforementioned officer one.",
                            "label":  "Aforementioned Officer One [Member]",
                            "terseLabel":  "Aforementioned Officer One [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_AforementionedOfficerTwoMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "AforementionedOfficerTwoMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aforementioned officer two.",
                            "label":  "Aforementioned Officer Two [Member]",
                            "terseLabel":  "Aforementioned Officer Two [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AllocatedShareBasedCompensationExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AllocatedShareBasedCompensationExpense",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  5.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockbasedCompensationExpenseDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Expense",
                            "terseLabel":  "Stock-based compensation",
                            "verboseLabel":  "Total stock-based compensation expense",
                            "documentation":  "Amount of expense for award under share-based payment arrangement.  Excludes amount capitalized."
                            }
                        }
                    },
                "auth_ref":  [
                    "r358",
                    "r367"
                    ]
                },
            "dei_AmendmentFlag":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "AmendmentFlag",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Amendment Flag",
                            "terseLabel":  "Amendment Flag",
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AmortizationOfIntangibleAssets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AmortizationOfIntangibleAssets",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Amortization of Intangible Assets",
                            "terseLabel":  "Amortization expense of licenses",
                            "documentation":  "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.  As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5",
                    "r44",
                    "r47"
                    ]
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
                            "terseLabel":  "Common stock equivalents excluded from computing diluted net loss per share",
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
                            }
                        }
                    },
                "auth_ref":  [
                    "r221"
                    ]
                },
            "us-gaap_ArrangementsAndNonarrangementTransactionsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ArrangementsAndNonarrangementTransactionsMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
                            "documentation":  "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
                            }
                        }
                    },
                "auth_ref":  [
                    "r401"
                    ]
                },
            "us-gaap_AssetAcquisitionAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AssetAcquisitionAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Asset Acquisition [Axis]",
                            "documentation":  "Information by asset acquisition."
                            }
                        }
                    },
                "auth_ref":  [
                    "r754"
                    ]
                },
            "us-gaap_AssetAcquisitionDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AssetAcquisitionDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Asset Acquisition [Domain]",
                            "documentation":  "Asset acquisition."
                            }
                        }
                    },
                "auth_ref":  [
                    "r754"
                    ]
                },
            "us-gaap_AssetAcquisitionPriceOfAcquisitionExpected":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AssetAcquisitionPriceOfAcquisitionExpected",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Asset Acquisition, Price of Acquisition, Expected",
                            "terseLabel":  "Consideration of cash payments",
                            "documentation":  "Purchase price of expected asset acquisition prior to consideration being transferred.  Excludes business acquisition."
                            }
                        }
                    },
                "auth_ref":  [
                    "r754"
                    ]
                },
            "us-gaap_Assets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "Assets",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets",
                            "totalLabel":  "Total assets",
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
                            }
                        }
                    },
                "auth_ref":  [
                    "r132",
                    "r166",
                    "r191",
                    "r225",
                    "r233",
                    "r237",
                    "r258",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r295",
                    "r296",
                    "r403",
                    "r407",
                    "r426",
                    "r494",
                    "r569",
                    "r638",
                    "r651",
                    "r718",
                    "r719",
                    "r766"
                    ]
                },
            "us-gaap_AssetsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AssetsAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets [Abstract]",
                            "terseLabel":  "Assets"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_AssetsCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AssetsCurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets, Current",
                            "totalLabel":  "Total current assets",
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
                            }
                        }
                    },
                "auth_ref":  [
                    "r160",
                    "r172",
                    "r191",
                    "r258",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r295",
                    "r296",
                    "r403",
                    "r407",
                    "r426",
                    "r638",
                    "r718",
                    "r719",
                    "r766"
                    ]
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AssetsCurrentAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets, Current [Abstract]",
                            "terseLabel":  "Current Assets"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_AtTheMarketFacilityMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "AtTheMarketFacilityMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "At-the-market facility.",
                            "label":  "At The Market Facility [Member]",
                            "terseLabel":  "At The Market Facility [Member]",
                            "verboseLabel":  "At-The-Market Facility [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_AuditorFirmId":  {
                "xbrltype":  "nonemptySequenceNumberItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "AuditorFirmId",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Auditor Firm ID",
                            "terseLabel":  "Auditor Firm ID",
                            "documentation":  "PCAOB issued Audit Firm Identifier"
                            }
                        }
                    },
                "auth_ref":  [
                    "r656",
                    "r657",
                    "r658"
                    ]
                },
            "dei_AuditorLocation":  {
                "xbrltype":  "internationalNameItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "AuditorLocation",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Auditor Location",
                            "terseLabel":  "Auditor Location"
                            }
                        }
                    },
                "auth_ref":  [
                    "r656",
                    "r657",
                    "r658"
                    ]
                },
            "dei_AuditorName":  {
                "xbrltype":  "internationalNameItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "AuditorName",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Auditor Name",
                            "terseLabel":  "Auditor Name"
                            }
                        }
                    },
                "auth_ref":  [
                    "r656",
                    "r657",
                    "r658"
                    ]
                },
            "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails":  {
                        "parentTag":  "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
                        "weight":  -1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
                            "terseLabel":  "Investment in debt securities, Gross unrealized gains",
                            "documentation":  "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r248"
                    ]
                },
            "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails":  {
                        "parentTag":  "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
                            "terseLabel":  "Investment in debt securities, Gross unrealized losses",
                            "documentation":  "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r249"
                    ]
                },
            "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails":  {
                        "parentTag":  "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Debt Securities, Available-for-Sale, Amortized Cost, Total",
                            "label":  "Debt Securities, Available-for-Sale, Amortized Cost",
                            "terseLabel":  "Investment in debt securities, Amortized costs basis",
                            "documentation":  "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r245",
                    "r265",
                    "r493"
                    ]
                },
            "us-gaap_AvailableForSaleSecuritiesDebtSecurities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AvailableForSaleSecuritiesDebtSecurities",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Securities, Available-for-Sale",
                            "terseLabel":  "Fair value",
                            "totalLabel":  "Investment in debt securities, Fair value",
                            "documentation":  "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r246",
                    "r265",
                    "r487",
                    "r692"
                    ]
                },
            "us-gaap_AwardTypeAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "AwardTypeAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Award Type [Axis]",
                            "terseLabel":  "Award Type",
                            "documentation":  "Information by type of award under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r329",
                    "r330",
                    "r331",
                    "r333",
                    "r334",
                    "r335",
                    "r336",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r342",
                    "r343",
                    "r344",
                    "r345",
                    "r346",
                    "r347",
                    "r348",
                    "r349",
                    "r350",
                    "r353",
                    "r354",
                    "r355",
                    "r356",
                    "r357"
                    ]
                },
            "onvo_BICOGroupABMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "BICOGroupABMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "BICO Group AB Member",
                            "documentation":  "BICO Group AB.",
                            "label":  "B I C O Group A B [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "BasisOfPresentationAndPrinciplesOfConsolidationPolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Basis of presentation and principles of consolidation.",
                            "label":  "Basis Of Presentation And Principles Of Consolidation Policy [Text Block]",
                            "terseLabel":  "Basis of Presentation and Principles of Consolidation"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_BusinessContactMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "BusinessContactMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Business Contact",
                            "label":  "Business Contact [Member]",
                            "documentation":  "Business contact for the entity"
                            }
                        }
                    },
                "auth_ref":  [
                    "r657",
                    "r658"
                    ]
                },
            "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "BusinessDescriptionAndBasisOfPresentationTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Business Description and Basis of Presentation [Text Block]",
                            "terseLabel":  "Nature of operations and basis of presentation",
                            "documentation":  "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r85",
                    "r107",
                    "r109"
                    ]
                },
            "us-gaap_CapitalExpendituresIncurredButNotYetPaid":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CapitalExpendituresIncurredButNotYetPaid",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Capital Expenditures Incurred but Not yet Paid",
                            "terseLabel":  "Purchases of fixed assets in accounts payable",
                            "documentation":  "Future cash outflow to pay for purchases of fixed assets that have occurred."
                            }
                        }
                    },
                "auth_ref":  [
                    "r35",
                    "r36",
                    "r37"
                    ]
                },
            "us-gaap_CapitalizedComputerSoftwareGross":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CapitalizedComputerSoftwareGross",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails":  {
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentGross",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Capitalized Computer Software, Gross",
                            "terseLabel":  "Computer software and equipment",
                            "documentation":  "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software."
                            }
                        }
                    },
                "auth_ref":  [
                    "r779"
                    ]
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash and Cash Equivalents, at Carrying Value",
                            "periodEndLabel":  "Cash and cash equivalents",
                            "terseLabel":  "Cash and cash equivalents",
                            "totalLabel":  "Cash and Cash Equivalents, at Carrying Value, Total",
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r32",
                    "r162",
                    "r618"
                    ]
                },
            "onvo_CashAndCashEquivalentsMaturityPeriod":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "CashAndCashEquivalentsMaturityPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cash and cash equivalents maturity period.",
                            "label":  "Cash And Cash Equivalents Maturity Period",
                            "terseLabel":  "Maturity of highly liquid investment"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
                            "terseLabel":  "Restricted cash",
                            "documentation":  "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
                            }
                        }
                    },
                "auth_ref":  [
                    "r33",
                    "r130"
                    ]
                },
            "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]",
                            "terseLabel":  "Cash and cash equivalents",
                            "documentation":  "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances."
                            }
                        }
                    },
                "auth_ref":  [
                    "r33"
                    ]
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
                            "terseLabel":  "Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
                            "periodEndLabel":  "Cash, cash equivalents, and restricted cash at end of period",
                            "periodStartLabel":  "Cash, cash equivalents, and restricted cash at beginning of period",
                            "totalLabel":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total",
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
                            }
                        }
                    },
                "auth_ref":  [
                    "r32",
                    "r104",
                    "r189"
                    ]
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
                            "totalLabel":  "Net Decrease in Cash, Cash Equivalents, and Restricted Cash",
                            "documentation":  "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
                            }
                        }
                    },
                "auth_ref":  [
                    "r1",
                    "r104"
                    ]
                },
            "onvo_ChiefScientificOfficerMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ChiefScientificOfficerMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Chief scientific officer.",
                            "label":  "Chief Scientific Officer [Member]",
                            "terseLabel":  "Chief Scientific Officer [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_CityAreaCode":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "CityAreaCode",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "City Area Code",
                            "terseLabel":  "City Area Code",
                            "documentation":  "Area code of city"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ClassOfStockLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ClassOfStockLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Class of Stock [Line Items]",
                            "terseLabel":  "Class Of Stock [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    "r168",
                    "r169",
                    "r170",
                    "r224",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r302",
                    "r303",
                    "r304",
                    "r534",
                    "r535",
                    "r536",
                    "r537",
                    "r626",
                    "r663",
                    "r684"
                    ]
                },
            "onvo_ClemsonUniversityMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ClemsonUniversityMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Clemson University Member",
                            "documentation":  "Clemson University.",
                            "label":  "Clemson University [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_CollaborativeArrangementDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CollaborativeArrangementDisclosureTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Collaborative Arrangement Disclosure [Text Block]",
                            "terseLabel":  "Collaborative Research, Development, and License Agreements",
                            "documentation":  "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
                            }
                        }
                    },
                "auth_ref":  [
                    "r140",
                    "r142",
                    "r155"
                    ]
                },
            "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
                            "terseLabel":  "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    "r401"
                    ]
                },
            "onvo_CombinationOfSecuritiesAuthorizedForOfferAndSale":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "CombinationOfSecuritiesAuthorizedForOfferAndSale",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Combination of securities authorized for offer and sale.",
                            "label":  "Combination Of Securities Authorized For Offer And Sale",
                            "terseLabel":  "Securities authorized for offer and sale, amount"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommitmentsAndContingencies",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Commitments and Contingencies",
                            "label":  "Commitments and Contingencies",
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
                            }
                        }
                    },
                "auth_ref":  [
                    "r23",
                    "r83",
                    "r495",
                    "r556"
                    ]
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_CommitmentsDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommitmentsDisclosureTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments Disclosure [Text Block]",
                            "terseLabel":  "Commitments and Contingencies",
                            "documentation":  "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements.  Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights."
                            }
                        }
                    },
                "auth_ref":  [
                    "r116"
                    ]
                },
            "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockCapitalSharesReservedForFutureIssuance",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common Stock, Capital Shares Reserved for Future Issuance",
                            "terseLabel":  "Common stock reserved for future issuance",
                            "verboseLabel":  "Number of common stock shares approved under ESPP",
                            "documentation":  "Aggregate number of common shares reserved for future issuance."
                            }
                        }
                    },
                "auth_ref":  [
                    "r24"
                    ]
                },
            "onvo_CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "CommonStockCapitalSharesReservedForFutureIssuanceTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common stock capital shares reserved for future issuance.",
                            "label":  "Common Stock Capital Shares Reserved For Future Issuance Table [Text Block]",
                            "terseLabel":  "Common Stock Reserved for Future Issuance"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_CommonStockCapitalValueReservedForFutureIssuance":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "CommonStockCapitalValueReservedForFutureIssuance",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common stock capital value reserved for future issuance.",
                            "label":  "Common Stock Capital Value Reserved For Future Issuance",
                            "terseLabel":  "Common stock value reserved for future issuance"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_CommonStockMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common Stock [Member]",
                            "terseLabel":  "Common Stock [Member]",
                            "documentation":  "Stock that is subordinate to all other stock of the issuer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r641",
                    "r642",
                    "r643",
                    "r645",
                    "r646",
                    "r647",
                    "r648",
                    "r686",
                    "r687",
                    "r755",
                    "r776",
                    "r777"
                    ]
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockParOrStatedValuePerShare",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Common stock, par value",
                            "documentation":  "Face amount or stated value per share of common stock."
                            }
                        }
                    },
                "auth_ref":  [
                    "r89"
                    ]
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockSharesAuthorized",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common Stock, Shares Authorized",
                            "terseLabel":  "Common stock, shares authorized",
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
                            }
                        }
                    },
                "auth_ref":  [
                    "r89",
                    "r557"
                    ]
                },
            "us-gaap_CommonStockSharesIssued":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockSharesIssued",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common Stock, Shares, Issued",
                            "terseLabel":  "Common stock, shares issued",
                            "verboseLabel":  "Issuance of common stock",
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury."
                            }
                        }
                    },
                "auth_ref":  [
                    "r89"
                    ]
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockSharesOutstanding",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common Stock, Shares, Outstanding",
                            "terseLabel":  "Common stock, shares outstanding",
                            "periodStartLabel":  "Common Stock, Shares, Outstanding, Beginning Balance",
                            "periodEndLabel":  "Common Stock, Shares, Outstanding, Ending Balance",
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r89",
                    "r557",
                    "r575",
                    "r777",
                    "r778"
                    ]
                },
            "us-gaap_CommonStockValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CommonStockValue",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Common stock",
                            "label":  "Common Stock, Value, Issued",
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r89",
                    "r496",
                    "r638"
                    ]
                },
            "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CompensationAndEmployeeBenefitPlansTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureDefinedContributionPlan"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Compensation and Employee Benefit Plans [Text Block]",
                            "terseLabel":  "Defined Contribution Plan",
                            "documentation":  "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans."
                            }
                        }
                    },
                "auth_ref":  [
                    "r121",
                    "r122",
                    "r123",
                    "r124"
                    ]
                },
            "us-gaap_CompensationAndRetirementDisclosureAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CompensationAndRetirementDisclosureAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Retirement Benefits [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ComprehensiveIncomeNetOfTax":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ComprehensiveIncomeNetOfTax",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
                            "totalLabel":  "Comprehensive Loss",
                            "documentation":  "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity.  Excludes changes in equity resulting from investments by owners and distributions to owners."
                            }
                        }
                    },
                "auth_ref":  [
                    "r29",
                    "r176",
                    "r178",
                    "r183",
                    "r488",
                    "r505"
                    ]
                },
            "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ComprehensiveIncomePolicyPolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Comprehensive Income, Policy [Policy Text Block]",
                            "terseLabel":  "Comprehensive income (loss)",
                            "documentation":  "Disclosure of accounting policy for comprehensive income."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ConcentrationRiskDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ConcentrationRiskDisclosureTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureConcentrations"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Concentration Risk Disclosure [Text Block]",
                            "terseLabel":  "Concentrations",
                            "documentation":  "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact.  This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
                            }
                        }
                    },
                "auth_ref":  [
                    "r109"
                    ]
                },
            "onvo_ConsultingExpenses":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ConsultingExpenses",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Consulting expenses.",
                            "label":  "Consulting Expenses",
                            "terseLabel":  "Consulting expenses"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_ContactPersonnelName":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "ContactPersonnelName",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Contact Personnel Name",
                            "label":  "Contact Personnel Name",
                            "documentation":  "Name of contact personnel"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_CostsAndExpenses":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "CostsAndExpenses",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Costs and Expenses",
                            "totalLabel":  "Total costs and expenses",
                            "documentation":  "Total costs of sales and operating expenses for the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r98"
                    ]
                },
            "dei_CoverAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "CoverAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cover [Abstract]",
                            "documentation":  "Cover page."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_CurrentFiscalYearEndDate":  {
                "xbrltype":  "gMonthDayItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "CurrentFiscalYearEndDate",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current Fiscal Year End Date",
                            "terseLabel":  "Current Fiscal Year End Date",
                            "documentation":  "End date of current fiscal year in the format --MM-DD."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_DaysOfFdaApprovalOfFirstLicensedProductMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "DaysOfFdaApprovalOfFirstLicensedProductMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "45 days of FDA Approval of First Licensed Product Member",
                            "documentation":  "45 Days of FDA approval of first licensed product.",
                            "label":  "45 Days of FDA Approval of First Licensed Product [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_DaysOfFirstCommercialSaleOfALicensedProductInTerritoryMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "DaysOfFirstCommercialSaleOfALicensedProductInTerritoryMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "45 Days of First Commercial Sale of Licensed Product in Territory Member",
                            "documentation":  "45 days of first commercial sale of a licensed product in territory.",
                            "label":  "45 days of first commercial sale of a Licensed Product in Territory [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_DaysOfTheDosingOfTheFirstPatientInAPhaseIiiClinicalTrialMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "DaysOfTheDosingOfTheFirstPatientInAPhaseIiiClinicalTrialMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "45 days of Dosing of First Patient in a Phase III Clinical Trial Member",
                            "documentation":  "45 days of the dosing of the first patient in a phase III clinical trial.",
                            "label":  "45 days of the dosing of the first patient in a phase III clinical trial [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_DebtSecuritiesAvailableForSaleTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DebtSecuritiesAvailableForSaleTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Securities, Available-for-Sale [Table]",
                            "documentation":  "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r244",
                    "r245",
                    "r246",
                    "r247",
                    "r248",
                    "r249",
                    "r250",
                    "r251",
                    "r252",
                    "r253",
                    "r254",
                    "r255"
                    ]
                },
            "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DebtSecuritiesAvailableForSaleTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Securities, Available-for-Sale [Table Text Block]",
                            "terseLabel":  "Summary of Investments in Debt Securities that are Measured at Fair Value",
                            "documentation":  "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r693",
                    "r694",
                    "r695",
                    "r696",
                    "r697",
                    "r698",
                    "r699",
                    "r700",
                    "r701",
                    "r702",
                    "r703",
                    "r704"
                    ]
                },
            "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Unrealized gain (loss) on available-for-sale debt securities",
                            "totalLabel":  "Debt Securities, Available-for-Sale, Unrealized Gain (Loss), Total",
                            "label":  "Debt Securities, Available-for-Sale, Unrealized Gain (Loss)",
                            "documentation":  "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r696",
                    "r697"
                    ]
                },
            "us-gaap_DebtSecuritiesUnrealizedGainLoss":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DebtSecuritiesUnrealizedGainLoss",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Debt Securities, Unrealized Gain (Loss), Total",
                            "label":  "Debt Securities, Unrealized Gain (Loss)",
                            "terseLabel":  "Unrealized gains on short-term investments",
                            "verboseLabel":  "Unrealized gains on investments in debt securities",
                            "documentation":  "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r508",
                    "r678",
                    "r679"
                    ]
                },
            "us-gaap_DeferredIncomeTaxLiabilities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredIncomeTaxLiabilities",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsLiabilitiesNet",
                        "weight":  -1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Liabilities, Gross",
                            "negatedTotalLabel":  "Total deferred tax liabilities",
                            "totalLabel":  "Deferred Tax Liabilities, Gross, Total",
                            "documentation":  "Amount of deferred tax liability attributable to taxable temporary differences."
                            }
                        }
                    },
                "auth_ref":  [
                    "r86",
                    "r87",
                    "r133",
                    "r384"
                    ]
                },
            "onvo_DeferredTaxAssetLiabilityPropertyPlantAndEquipment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "DeferredTaxAssetLiabilityPropertyPlantAndEquipment",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredIncomeTaxLiabilities",
                        "weight":  -1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset or (liability) attributable to deductible temporary differences from property, plant, and equipment.",
                            "label":  "Deferred Tax Asset Liability Property Plant And Equipment",
                            "negatedLabel":  "Depreciation"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsGoodwillAndIntangibleAssets",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Goodwill and Intangible Assets",
                            "terseLabel":  "Amortization",
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_DeferredTaxAssetsGross":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsGross",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsNet",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Gross",
                            "totalLabel":  "Total deferred tax assets",
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
                            }
                        }
                    },
                "auth_ref":  [
                    "r385"
                    ]
                },
            "us-gaap_DeferredTaxAssetsInventory":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsInventory",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0,
                        "order":  6.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Inventory",
                            "terseLabel":  "Inventory",
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
                            }
                        }
                    },
                "auth_ref":  [
                    "r76",
                    "r752"
                    ]
                },
            "us-gaap_DeferredTaxAssetsLiabilitiesNet":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsLiabilitiesNet",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Net",
                            "totalLabel":  "Deferred tax assets net",
                            "documentation":  "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
                            }
                        }
                    },
                "auth_ref":  [
                    "r751"
                    ]
                },
            "us-gaap_DeferredTaxAssetsNet":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsNet",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsLiabilitiesNet",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Net of Valuation Allowance",
                            "totalLabel":  "Net deferred tax assets",
                            "documentation":  "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
                            }
                        }
                    },
                "auth_ref":  [
                    "r751"
                    ]
                },
            "us-gaap_DeferredTaxAssetsNetAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsNetAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Net [Abstract]",
                            "terseLabel":  "Deferred tax assets:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_DeferredTaxAssetsOperatingLeaseLiability":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "DeferredTaxAssetsOperatingLeaseLiability",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0,
                        "order":  5.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Deferred tax assets operating lease liability.",
                            "label":  "Deferred Tax Assets Operating Lease Liability",
                            "terseLabel":  "Operating lease liability"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
                            "terseLabel":  "Federal net operating loss carryforwards",
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards.  Excludes state and local operating loss carryforwards."
                            }
                        }
                    },
                "auth_ref":  [
                    "r76",
                    "r752"
                    ]
                },
            "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
                            "terseLabel":  "State net operating loss carryforwards",
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
                            }
                        }
                    },
                "auth_ref":  [
                    "r76",
                    "r752"
                    ]
                },
            "onvo_DeferredTaxAssetsResearchAndDevelopmentCapitalization":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "DeferredTaxAssetsResearchAndDevelopmentCapitalization",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Deferred tax assets research and development capitalization.",
                            "label":  "Deferred tax assets research and development capitalization",
                            "terseLabel":  "Section 174 R&D capitalization"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Tax Credit Carryforwards, Research",
                            "terseLabel":  "Research tax credit carryforwards",
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
                            }
                        }
                    },
                "auth_ref":  [
                    "r75",
                    "r76",
                    "r752"
                    ]
                },
            "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0,
                        "order":  7.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
                            "terseLabel":  "Stock-based compensation",
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r76",
                    "r752"
                    ]
                },
            "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
                            "terseLabel":  "Accrued expenses and reserves",
                            "totalLabel":  "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total",
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
                            }
                        }
                    },
                "auth_ref":  [
                    "r76",
                    "r752"
                    ]
                },
            "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0,
                        "order":  8.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
                            "terseLabel":  "Other, net",
                            "documentation":  "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other."
                            }
                        }
                    },
                "auth_ref":  [
                    "r76",
                    "r752"
                    ]
                },
            "us-gaap_DeferredTaxAssetsValuationAllowance":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxAssetsValuationAllowance",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredTaxAssetsNet",
                        "weight":  -1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets, Valuation Allowance",
                            "negatedLabel":  "Valuation allowance",
                            "documentation":  "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
                            }
                        }
                    },
                "auth_ref":  [
                    "r386"
                    ]
                },
            "onvo_DeferredTaxLiabilitiesInvestmentInEquitySecurities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "DeferredTaxLiabilitiesInvestmentInEquitySecurities",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredIncomeTaxLiabilities",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Deferred tax liabilities investment in equity securities.",
                            "label":  "Deferred tax liabilities investment in equity securities",
                            "terseLabel":  "Investment in equity securities"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_DeferredTaxLiabilitiesNetAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DeferredTaxLiabilitiesNetAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Liabilities, Net [Abstract]",
                            "terseLabel":  "Deferred tax liabilities:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails":  {
                        "parentTag":  "us-gaap_DeferredIncomeTaxLiabilities",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfNetDeferredTaxAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Deferred tax liability operating lease right-of-use assets.",
                            "label":  "Deferred Tax Liabilities Operating Lease Right Of Use Assets",
                            "terseLabel":  "Operating lease right-of-use assets"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_DefinedBenefitPlanAdministrationExpenses":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DefinedBenefitPlanAdministrationExpenses",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureDefinedContributionPlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Defined Benefit Plan, Plan Assets, Administration Expense",
                            "terseLabel":  "Administration expenses",
                            "documentation":  "Amount of administration expense of defined benefit plan which decreases plan assets.  Excludes plan administration expense paid by employer."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureDefinedContributionPlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
                            "terseLabel":  "Percentage of employees contribution",
                            "documentation":  "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_Depreciation":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "Depreciation",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Depreciation",
                            "terseLabel":  "Depreciation expense",
                            "totalLabel":  "Depreciation, Total",
                            "documentation":  "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives.  Includes production and non-production related depreciation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5",
                    "r49"
                    ]
                },
            "us-gaap_DepreciationDepletionAndAmortization":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DepreciationDepletionAndAmortization",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Depreciation, Depletion and Amortization",
                            "terseLabel":  "Depreciation and amortization",
                            "totalLabel":  "Depreciation, Depletion and Amortization, Total",
                            "documentation":  "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5",
                    "r229"
                    ]
                },
            "onvo_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of business and summary of significant accounting policies.",
                            "label":  "Description Of Business And Summary Of Significant Accounting Policies [Line Items]",
                            "terseLabel":  "Description Of Business And Summary Of Significant Accounting Policies [Line Items]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "DescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of business and summary of significant accounting policies.",
                            "label":  "Description Of Business And Summary Of Significant Accounting Policies [Table]",
                            "terseLabel":  "Description Of Business And Summary Of Significant Accounting Policies [Table]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_DilutiveSecurities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DilutiveSecurities",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Dilutive Securities, Effect on Basic Earnings Per Share",
                            "terseLabel":  "Dilutive effect",
                            "totalLabel":  "Dilutive Securities, Effect on Basic Earnings Per Share, Total",
                            "documentation":  "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities."
                            }
                        }
                    },
                "auth_ref":  [
                    "r38"
                    ]
                },
            "us-gaap_DisaggregationOfRevenueAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DisaggregationOfRevenueAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Disaggregation of Revenue [Abstract]",
                            "terseLabel":  "Revenues"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentAnnualReport":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentAnnualReport",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Annual Report",
                            "terseLabel":  "Document Annual Report",
                            "documentation":  "Boolean flag that is true only for a form used as an annual report."
                            }
                        }
                    },
                "auth_ref":  [
                    "r656",
                    "r657",
                    "r658"
                    ]
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "xbrltype":  "fiscalPeriodItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentFiscalPeriodFocus",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Fiscal Period Focus",
                            "terseLabel":  "Document Fiscal Period Focus",
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.   1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentFiscalYearFocus":  {
                "xbrltype":  "gYearItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentFiscalYearFocus",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Fiscal Year Focus",
                            "terseLabel":  "Document Fiscal Year Focus",
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentInformationLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentInformationLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Information [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentInformationTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentInformationTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Information [Table]",
                            "documentation":  "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentPeriodEndDate":  {
                "xbrltype":  "dateItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentPeriodEndDate",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Period End Date",
                            "terseLabel":  "Document Period End Date",
                            "documentation":  "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentTransitionReport":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentTransitionReport",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Transition Report",
                            "terseLabel":  "Document Transition Report",
                            "documentation":  "Boolean flag that is true only for a form used as a transition report."
                            }
                        }
                    },
                "auth_ref":  [
                    "r659"
                    ]
                },
            "dei_DocumentType":  {
                "xbrltype":  "submissionTypeItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentType",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Document Type",
                            "terseLabel":  "Document Type",
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_DocumentsIncorporatedByReferenceTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "DocumentsIncorporatedByReferenceTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Documents Incorporated by Reference [Text Block]",
                            "terseLabel":  "Documents Incorporated by Reference",
                            "documentation":  "Documents incorporated by reference."
                            }
                        }
                    },
                "auth_ref":  [
                    "r654"
                    ]
                },
            "us-gaap_DomesticCountryMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "DomesticCountryMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Domestic Tax Authority [Member]",
                            "terseLabel":  "Federal [Member]",
                            "documentation":  "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_ESPPSharesMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ESPPSharesMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "ESPP Shares [Member]",
                            "label":  "E S P P Shares [Member]",
                            "documentation":  "ESPP shares."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EarningsPerShareBasic":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EarningsPerShareBasic",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Earnings Per Share, Basic, Total",
                            "label":  "Earnings Per Share, Basic",
                            "terseLabel":  "Net loss per common share basic",
                            "documentation":  "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r184",
                    "r202",
                    "r203",
                    "r205",
                    "r206",
                    "r208",
                    "r214",
                    "r216",
                    "r218",
                    "r219",
                    "r220",
                    "r222",
                    "r419",
                    "r420",
                    "r489",
                    "r506",
                    "r620"
                    ]
                },
            "us-gaap_EarningsPerShareDiluted":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EarningsPerShareDiluted",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Earnings Per Share, Diluted, Total",
                            "label":  "Earnings Per Share, Diluted",
                            "terseLabel":  "Net loss per common share diluted",
                            "documentation":  "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r184",
                    "r202",
                    "r203",
                    "r205",
                    "r206",
                    "r208",
                    "r216",
                    "r218",
                    "r219",
                    "r220",
                    "r222",
                    "r419",
                    "r420",
                    "r489",
                    "r506",
                    "r620"
                    ]
                },
            "us-gaap_EarningsPerSharePolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EarningsPerSharePolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Earnings Per Share, Policy [Policy Text Block]",
                            "terseLabel":  "Net loss per share",
                            "documentation":  "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security.  Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
                            }
                        }
                    },
                "auth_ref":  [
                    "r39",
                    "r40"
                    ]
                },
            "us-gaap_EffectiveIncomeTaxRateContinuingOperations":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectiveIncomeTaxRateContinuingOperations",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Percent",
                            "totalLabel":  "Provision (benefit) for income taxes",
                            "documentation":  "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
                            }
                        }
                    },
                "auth_ref":  [
                    "r377"
                    ]
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
                            "terseLabel":  "Tax computed at federal statutory rate",
                            "documentation":  "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r192",
                    "r377",
                    "r397"
                    ]
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0,
                        "order":  9.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
                            "terseLabel":  "Valuation allowance",
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r750",
                    "r753"
                    ]
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0,
                        "order":  5.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
                            "terseLabel":  "Change in tax rate",
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates."
                            }
                        }
                    },
                "auth_ref":  [
                    "r397",
                    "r750"
                    ]
                },
            "onvo_EffectiveIncomeTaxRateReconciliationExecutiveCompensationAmount":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "EffectiveIncomeTaxRateReconciliationExecutiveCompensationAmount",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "onvo_ProvisionBenefitForIncomeTaxes",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effective income tax rate reconciliation, executive compensation, amount.",
                            "label":  "Effective Income Tax Rate Reconciliation Executive Compensation Amount",
                            "terseLabel":  "Executive compensation"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0,
                        "order":  6.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent",
                            "terseLabel":  "Removal of net operating losses and research development credits",
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense."
                            }
                        }
                    },
                "auth_ref":  [
                    "r750",
                    "r753"
                    ]
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0,
                        "order":  8.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
                            "terseLabel":  "Other",
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
                            }
                        }
                    },
                "auth_ref":  [
                    "r750",
                    "r753"
                    ]
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "onvo_ProvisionBenefitForIncomeTaxes",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
                            "terseLabel":  "Stock-based compensation",
                            "documentation":  "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement.  Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r664",
                    "r750"
                    ]
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent",
                            "terseLabel":  "Stock-based compensation",
                            "documentation":  "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement.  Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r664",
                    "r750"
                    ]
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
                            "terseLabel":  "State income tax, net of federal benefit",
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r750",
                    "r753"
                    ]
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
                            "terseLabel":  "Research credits",
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
                            }
                        }
                    },
                "auth_ref":  [
                    "r750",
                    "r753"
                    ]
                },
            "onvo_EffectiveIncomeTaxRateReconciliationUncertainTaxPositions":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "EffectiveIncomeTaxRateReconciliationUncertainTaxPositions",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0,
                        "order":  7.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effective income tax rate reconciliation uncertain tax positions.",
                            "label":  "Effective income tax rate reconciliation uncertain tax positions",
                            "terseLabel":  "Uncertain tax positions"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_EffectiveIncomeTaxReconciliationEmployeeCompensationPercentage":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "EffectiveIncomeTaxReconciliationEmployeeCompensationPercentage",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Effective income tax reconciliation, employee compensation, percentage.",
                            "label":  "Effective Income Tax Reconciliation Employee Compensation Percentage",
                            "terseLabel":  "Executive compensation"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EmployeeRelatedLiabilitiesCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeRelatedLiabilitiesCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails":  {
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Employee-related Liabilities, Current",
                            "terseLabel":  "Accrued compensation",
                            "totalLabel":  "Employee-related Liabilities, Current, Total",
                            "documentation":  "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r20"
                    ]
                },
            "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockbasedCompensationExpenseDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
                            "terseLabel":  "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
                            "terseLabel":  "Total unrecognized compensation cost related, weighted average period",
                            "documentation":  "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
                            }
                        }
                    },
                "auth_ref":  [
                    "r359"
                    ]
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
                            "terseLabel":  "Unrecognized stock-based compensation expense",
                            "documentation":  "Amount of cost to be recognized for nonvested award under share-based payment arrangement.  Excludes share and unit options."
                            }
                        }
                    },
                "auth_ref":  [
                    "r748"
                    ]
                },
            "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
                            "terseLabel":  "Total unrecognized compensation cost related to unvested stock option grants",
                            "documentation":  "Amount of cost to be recognized for option under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r748"
                    ]
                },
            "onvo_EmployeeSeveranceAndBenefitsCostsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "EmployeeSeveranceAndBenefitsCostsMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Employee severance and benefits costs.",
                            "label":  "Employee Severance And Benefits Costs [Member]",
                            "terseLabel":  "Employee Severance And Benefits Costs"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EmployeeSeveranceMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeSeveranceMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfActivityAndBalancesOfRestructuringReserveDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Employee Severance [Member]",
                            "terseLabel":  "Severance for Involuntary Employee Terminations [Member]",
                            "documentation":  "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EmployeeStockOptionMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeStockOptionMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Option [Member]",
                            "terseLabel":  "Stock options [Member]",
                            "documentation":  "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Employee Stock Ownership Plan (ESOP) Name [Axis]",
                            "documentation":  "Information by name of employee stock ownership plan."
                            }
                        }
                    },
                "auth_ref":  [
                    "r72"
                    ]
                },
            "us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EmployeeStockOwnershipPlanESOPPlanDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Employee Stock Ownership Plan (ESOP), Plan [Domain]",
                            "documentation":  "Entities identify multiple employee stock ownership plans by unique name."
                            }
                        }
                    },
                "auth_ref":  [
                    "r73"
                    ]
                },
            "onvo_EmployeeStockPurchasePlanMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "EmployeeStockPurchasePlanMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Employee Stock Purchase Plan.",
                            "label":  "Employee Stock Purchase Plan [Member]",
                            "terseLabel":  "ESPP [Member]",
                            "verboseLabel":  "2016 Employee Stock Purchase Plan [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_EmployeeStockPurchasePlanTwoThousandSixteenMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "EmployeeStockPurchasePlanTwoThousandSixteenMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockPurchasePlanParentheticalDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Employee stock purchase plan two thousand sixteen.",
                            "label":  "Employee Stock Purchase Plan Two Thousand Sixteen [Member]",
                            "terseLabel":  "2016 Employee Stock Purchase Plan [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressAddressLine1":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressAddressLine1",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, Address Line One",
                            "terseLabel":  "Entity Address, Address Line One",
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressAddressLine2":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressAddressLine2",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, Address Line Two",
                            "terseLabel":  "Entity Address, Address Line Two",
                            "documentation":  "Address Line 2 such as Street or Suite number"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressCityOrTown":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressCityOrTown",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, City or Town",
                            "terseLabel":  "Entity Address, City or Town",
                            "documentation":  "Name of the City or Town"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressPostalZipCode":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressPostalZipCode",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, Postal Zip Code",
                            "terseLabel":  "Entity Address, Postal Zip Code",
                            "documentation":  "Code for the postal or zip code"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressStateOrProvince":  {
                "xbrltype":  "stateOrProvinceItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressStateOrProvince",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Address, State or Province",
                            "terseLabel":  "Entity Address, State or Province",
                            "documentation":  "Name of the state or province."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityAddressesAddressTypeAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityAddressesAddressTypeAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Addresses, Address Type [Axis]",
                            "documentation":  "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityCentralIndexKey":  {
                "xbrltype":  "centralIndexKeyItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityCentralIndexKey",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Central Index Key",
                            "terseLabel":  "Entity Central Index Key",
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK."
                            }
                        }
                    },
                "auth_ref":  [
                    "r653"
                    ]
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityCommonStockSharesOutstanding",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Common Stock, Shares Outstanding",
                            "terseLabel":  "Entity Common Stock, Shares Outstanding",
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityCurrentReportingStatus":  {
                "xbrltype":  "yesNoItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityCurrentReportingStatus",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Current Reporting Status",
                            "terseLabel":  "Entity Current Reporting Status",
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityEmergingGrowthCompany":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityEmergingGrowthCompany",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Emerging Growth Company",
                            "terseLabel":  "Entity Emerging Growth Company",
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria."
                            }
                        }
                    },
                "auth_ref":  [
                    "r653"
                    ]
                },
            "dei_EntityExTransitionPeriod":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityExTransitionPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Entity Ex Transition Period",
                            "label":  "Entity Ex Transition Period",
                            "documentation":  "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
                            }
                        }
                    },
                "auth_ref":  [
                    "r662"
                    ]
                },
            "dei_EntityFileNumber":  {
                "xbrltype":  "fileNumberItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityFileNumber",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity File Number",
                            "terseLabel":  "Entity File Number",
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityFilerCategory":  {
                "xbrltype":  "filerCategoryItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityFilerCategory",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Filer Category",
                            "terseLabel":  "Entity Filer Category",
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure."
                            }
                        }
                    },
                "auth_ref":  [
                    "r653"
                    ]
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "xbrltype":  "edgarStateCountryItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityIncorporationStateCountryCode",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Incorporation, State or Country Code",
                            "terseLabel":  "Entity Incorporation, State or Country Code",
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityInteractiveDataCurrent":  {
                "xbrltype":  "yesNoItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityInteractiveDataCurrent",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Interactive Data Current",
                            "terseLabel":  "Entity Interactive Data Current",
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r660"
                    ]
                },
            "dei_EntityPublicFloat":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityPublicFloat",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Public Float",
                            "terseLabel":  "Entity Public Float",
                            "documentation":  "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityRegistrantName":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityRegistrantName",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Registrant Name",
                            "terseLabel":  "Entity Registrant Name",
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
                            }
                        }
                    },
                "auth_ref":  [
                    "r653"
                    ]
                },
            "dei_EntityShellCompany":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityShellCompany",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Shell Company",
                            "terseLabel":  "Entity Shell Company",
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
                            }
                        }
                    },
                "auth_ref":  [
                    "r653"
                    ]
                },
            "dei_EntitySmallBusiness":  {
                "xbrltype":  "booleanItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntitySmallBusiness",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Small Business",
                            "terseLabel":  "Entity Small Business",
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r653"
                    ]
                },
            "dei_EntityTaxIdentificationNumber":  {
                "xbrltype":  "employerIdItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityTaxIdentificationNumber",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Tax Identification Number",
                            "terseLabel":  "Entity Tax Identification Number",
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
                            }
                        }
                    },
                "auth_ref":  [
                    "r653"
                    ]
                },
            "dei_EntityVoluntaryFilers":  {
                "xbrltype":  "yesNoItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityVoluntaryFilers",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Voluntary Filers",
                            "terseLabel":  "Entity Voluntary Filers",
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_EntityWellKnownSeasonedIssuer":  {
                "xbrltype":  "yesNoItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "EntityWellKnownSeasonedIssuer",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Entity Well-known Seasoned Issuer",
                            "terseLabel":  "Entity Well-known Seasoned Issuer",
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
                            }
                        }
                    },
                "auth_ref":  [
                    "r661"
                    ]
                },
            "us-gaap_EquityAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquityAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EquityComponentDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquityComponentDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity Component [Domain]",
                            "terseLabel":  "Equity Component",
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r156",
                    "r180",
                    "r181",
                    "r182",
                    "r193",
                    "r194",
                    "r195",
                    "r199",
                    "r209",
                    "r211",
                    "r223",
                    "r259",
                    "r264",
                    "r305",
                    "r360",
                    "r361",
                    "r362",
                    "r390",
                    "r391",
                    "r409",
                    "r410",
                    "r411",
                    "r412",
                    "r413",
                    "r415",
                    "r418",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r453",
                    "r518",
                    "r519",
                    "r520",
                    "r545",
                    "r599"
                    ]
                },
            "onvo_EquityIncentivePlanTwoThousandTwelveMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "EquityIncentivePlanTwoThousandTwelveMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity incentive plan two thousand twelve.",
                            "label":  "Equity Incentive Plan Two Thousand Twelve [Member]",
                            "terseLabel":  "Equity Incentive Plan 2012 [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_EquityIncentivePlanTwoThousandTwentyTwoMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "EquityIncentivePlanTwoThousandTwentyTwoMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity Incentive Plan Two Thousand Twenty Two [Member]",
                            "label":  "Equity Incentive Plan Two Thousand Twenty Two [Member]",
                            "terseLabel":  "Equity Incentive Plan 2022 [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_EquitySalesAgreementExpirationDate":  {
                "xbrltype":  "dateItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "EquitySalesAgreementExpirationDate",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity sales agreement expiration date.",
                            "label":  "Equity Sales Agreement Expiration Date",
                            "terseLabel":  "Equity sales agreement expiration date"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_EquitySecuritiesCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "EquitySecuritiesCurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Investment in equity securities",
                            "label":  "Equity Securities Current",
                            "documentation":  "Equity securities current."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EquitySecuritiesFVNIAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquitySecuritiesFVNIAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity Securities, FV-NI [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_EquitySecuritiesFVNINoncurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquitySecuritiesFVNINoncurrent",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance",
                            "label":  "Equity Securities, FV-NI, Noncurrent",
                            "documentation":  "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as noncurrent."
                            }
                        }
                    },
                "auth_ref":  [
                    "r425"
                    ]
                },
            "us-gaap_EquitySecuritiesFvNi":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquitySecuritiesFvNi",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity Securities, FV-NI, Current",
                            "terseLabel":  "Fair value of investment in equity securities",
                            "documentation":  "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current."
                            }
                        }
                    },
                "auth_ref":  [
                    "r167",
                    "r425",
                    "r619"
                    ]
                },
            "us-gaap_EquitySecuritiesFvNiGainLoss":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquitySecuritiesFvNiGainLoss",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0,
                        "order":  1.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "(Gain) loss on investment in equity securities",
                            "terseLabel":  "(Loss) gain on investment in equity securities",
                            "totalLabel":  "Equity Securities, FV-NI, Gain (Loss), Total",
                            "label":  "Equity Securities, FV-NI, Gain (Loss)",
                            "verboseLabel":  "Gain on investment in equity securities",
                            "documentation":  "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r509",
                    "r705"
                    ]
                },
            "us-gaap_EquitySecuritiesFvNiUnrealizedGain":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquitySecuritiesFvNiUnrealizedGain",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity Securities, FV-NI, Unrealized Gain",
                            "terseLabel":  "Unrealized gain on investment in equity securities",
                            "documentation":  "Amount of unrealized gain on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r257"
                    ]
                },
            "us-gaap_EquitySecuritiesFvNiUnrealizedLoss":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "EquitySecuritiesFvNiUnrealizedLoss",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity Securities, FV-NI, Unrealized Loss",
                            "terseLabel":  "Unrealized loss on investment in equity securities",
                            "documentation":  "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r257"
                    ]
                },
            "onvo_ExcessOfMinimumAnnualRoyaltiesPayment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ExcessOfMinimumAnnualRoyaltiesPayment",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of minimum annual royalties payment.",
                            "label":  "Excess Of Minimum Annual Royalties Payment",
                            "terseLabel":  "Excess of minimum annual royalties payment"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_ExecutiveChairmanMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ExecutiveChairmanMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Executive chairman.",
                            "label":  "Executive Chairman [Member]",
                            "terseLabel":  "Executive Chairman [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_FairValueByFairValueHierarchyLevelAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FairValueByFairValueHierarchyLevelAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Fair Value Hierarchy and NAV [Axis]",
                            "documentation":  "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
                            }
                        }
                    },
                "auth_ref":  [
                    "r297",
                    "r317",
                    "r318",
                    "r319",
                    "r320",
                    "r321",
                    "r322",
                    "r424",
                    "r464",
                    "r465",
                    "r466",
                    "r624",
                    "r625",
                    "r628",
                    "r629",
                    "r630"
                    ]
                },
            "us-gaap_FairValueInputsLevel1Member":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FairValueInputsLevel1Member",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Fair Value, Inputs, Level 1 [Member]",
                            "terseLabel":  "Level 1 [Member]",
                            "documentation":  "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
                            }
                        }
                    },
                "auth_ref":  [
                    "r297",
                    "r317",
                    "r322",
                    "r424",
                    "r464",
                    "r628",
                    "r629",
                    "r630"
                    ]
                },
            "us-gaap_FairValueMeasurementPolicyPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FairValueMeasurementPolicyPolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Fair Value Measurement, Policy [Policy Text Block]",
                            "terseLabel":  "Fair value measurement",
                            "documentation":  "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity.  Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_FairValueMeasurementsFairValueHierarchyDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FairValueMeasurementsFairValueHierarchyDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Fair Value Hierarchy and NAV [Domain]",
                            "documentation":  "Categories used to prioritize the inputs to valuation techniques to measure fair value."
                            }
                        }
                    },
                "auth_ref":  [
                    "r297",
                    "r317",
                    "r318",
                    "r319",
                    "r320",
                    "r321",
                    "r322",
                    "r464",
                    "r465",
                    "r466",
                    "r624",
                    "r625",
                    "r628",
                    "r629",
                    "r630"
                    ]
                },
            "us-gaap_FairValueOfFinancialInstrumentsPolicy":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FairValueOfFinancialInstrumentsPolicy",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Fair Value of Financial Instruments, Policy [Policy Text Block]",
                            "terseLabel":  "Financial instruments",
                            "documentation":  "Disclosure of accounting policy for determining the fair value of financial instruments."
                            }
                        }
                    },
                "auth_ref":  [
                    "r7",
                    "r16"
                    ]
                },
            "onvo_FederalNetOperatingLossCarryForwardsExpirationYearStart":  {
                "xbrltype":  "gYearItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "FederalNetOperatingLossCarryForwardsExpirationYearStart",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Federal net operating loss carry forwards expiration year start.",
                            "label":  "Federal Net Operating Loss Carry Forwards Expiration Year Start",
                            "verboseLabel":  "Federal net operating loss carryforwards (\u201cNOLs\u201d) expiring year"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_FederalResearchTaxCreditCarryForwardsExpirationYearStart":  {
                "xbrltype":  "gYearItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "FederalResearchTaxCreditCarryForwardsExpirationYearStart",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Federal research tax credit carry forwards expiration year start.",
                            "label":  "Federal Research Tax Credit Carry Forwards Expiration Year Start",
                            "terseLabel":  "Federal research tax credit carryforwards expiration period"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Asset, Weighted Average Period before Next Renewal or Extension",
                            "terseLabel":  "Weighted average remaining amortization period for all licenses",
                            "documentation":  "Weighted average period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
                            }
                        }
                    },
                "auth_ref":  [
                    "r13"
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsAccumulatedAmortization",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails":  {
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  -1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Accumulated Amortization",
                            "negatedLabel":  "Less accumulated amortization",
                            "documentation":  "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
                            }
                        }
                    },
                "auth_ref":  [
                    "r165",
                    "r268"
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Amortization Expense, Next Rolling 12 Months",
                            "terseLabel":  "Annual amortization expense of licenses year 1",
                            "documentation":  "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet.  For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five",
                            "terseLabel":  "Annual amortization expense of licenses year 5",
                            "documentation":  "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fifth rolling twelve months following the latest balance sheet.  For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four",
                            "terseLabel":  "Annual amortization expense of licenses year 4",
                            "documentation":  "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fourth rolling twelve months following the latest balance sheet.  For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three",
                            "terseLabel":  "Annual amortization expense of licenses year 3",
                            "documentation":  "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the third rolling twelve months following the latest balance sheet.  For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two",
                            "terseLabel":  "Annual amortization expense of licenses year 2",
                            "documentation":  "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet.  For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsByMajorClassAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets by Major Class [Axis]",
                            "terseLabel":  "Finite-Lived Intangible Assets by Major Class",
                            "documentation":  "Information by major type or class of finite-lived intangible assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r266",
                    "r267",
                    "r268",
                    "r269",
                    "r470",
                    "r474"
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsGross":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsGross",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails":  {
                        "parentTag":  "us-gaap_FiniteLivedIntangibleAssetsNet",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Gross",
                            "terseLabel":  "License fees",
                            "totalLabel":  "Finite-Lived Intangible Assets, Gross, Total",
                            "documentation":  "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
                            }
                        }
                    },
                "auth_ref":  [
                    "r111",
                    "r474"
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets [Line Items]",
                            "terseLabel":  "Finite-Lived Intangible Assets [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    "r470"
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsMajorClassNameDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Major Class Name [Domain]",
                            "terseLabel":  "Finite-Lived Intangible Assets, Major Class Name",
                            "documentation":  "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
                            }
                        }
                    },
                "auth_ref":  [
                    "r45",
                    "r46"
                    ]
                },
            "us-gaap_FiniteLivedIntangibleAssetsNet":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FiniteLivedIntangibleAssetsNet",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finite-Lived Intangible Assets, Net",
                            "totalLabel":  "License fees, net",
                            "periodStartLabel":  "Finite-Lived Intangible Assets, Net, Beginning Balance",
                            "periodEndLabel":  "Finite-Lived Intangible Assets, Net, Ending Balance",
                            "documentation":  "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
                            }
                        }
                    },
                "auth_ref":  [
                    "r111",
                    "r470"
                    ]
                },
            "us-gaap_FurnitureAndFixturesGross":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "FurnitureAndFixturesGross",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails":  {
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentGross",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Furniture and Fixtures, Gross",
                            "terseLabel":  "Furniture and fixtures",
                            "documentation":  "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities.  Examples include, but are not limited to, desks, chairs, tables, and bookcases."
                            }
                        }
                    },
                "auth_ref":  [
                    "r113"
                    ]
                },
            "us-gaap_GainLossOnDispositionOfAssets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "GainLossOnDispositionOfAssets",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
                            "terseLabel":  "Loss on fixed asset disposals",
                            "documentation":  "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property."
                            }
                        }
                    },
                "auth_ref":  [
                    "r682",
                    "r710",
                    "r711"
                    ]
                },
            "us-gaap_GainLossOnSaleOfPropertyPlantEquipment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "GainLossOnSaleOfPropertyPlantEquipment",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Gain (Loss) on Disposition of Property Plant Equipment",
                            "negatedLabel":  "Loss on disposal of fixed assets",
                            "totalLabel":  "Gain (Loss) on Disposition of Property Plant Equipment, Total",
                            "documentation":  "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5"
                    ]
                },
            "us-gaap_GeneralAndAdministrativeExpenseMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "GeneralAndAdministrativeExpenseMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockbasedCompensationExpenseDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "General and Administrative Expense [Member]",
                            "terseLabel":  "General and administrative",
                            "documentation":  "Primary financial statement caption encompassing general and administrative expense."
                            }
                        }
                    },
                "auth_ref":  [
                    "r97"
                    ]
                },
            "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "GoodwillAndIntangibleAssetsDisclosureAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Goodwill and Intangible Assets Disclosure [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_HistologyServicesToRelatedParties":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "HistologyServicesToRelatedParties",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Histology services to related parties.",
                            "label":  "Histology Services To Related Parties",
                            "terseLabel":  "Histology services to related parties"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_IPOMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IPOMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "IPO [Member]",
                            "terseLabel":  "IPO [Member]",
                            "documentation":  "First sale of stock by a private company to the public."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ImpairmentOfLongLivedAssetsHeldForUse",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Impairment, Long-Lived Asset, Held-for-Use",
                            "terseLabel":  "Impairment of long-lived assets",
                            "totalLabel":  "Impairment, Long-Lived Asset, Held-for-Use, Total",
                            "documentation":  "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5",
                    "r48",
                    "r114"
                    ]
                },
            "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
                            "terseLabel":  "Impairment of long-lived assets",
                            "documentation":  "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets.  An entity also may disclose its accounting policy for long-lived assets to be sold.  This policy excludes goodwill and intangible assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r0",
                    "r115"
                    ]
                },
            "us-gaap_InProcessResearchAndDevelopmentPolicy":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InProcessResearchAndDevelopmentPolicy",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "In Process Research and Development, Policy [Policy Text Block]",
                            "terseLabel":  "Acquired in-process research and development",
                            "documentation":  "Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise.  An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_IncentiveAwardPlanMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "IncentiveAwardPlanMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incentive award plan.",
                            "label":  "Incentive Award Plan [Member]",
                            "terseLabel":  "Incentive Award Plan [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_IncomeStatementAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeStatementAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_IncomeStatementLocationAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeStatementLocationAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockbasedCompensationExpenseDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfRestructuringChargesRecordedInSellingGeneralAndAdministrativeExpensesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement Location [Axis]",
                            "terseLabel":  "Income Statement Location",
                            "documentation":  "Information by location in the income statement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r270",
                    "r275",
                    "r584"
                    ]
                },
            "us-gaap_IncomeStatementLocationDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeStatementLocationDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockbasedCompensationExpenseDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfRestructuringChargesRecordedInSellingGeneralAndAdministrativeExpensesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement Location [Domain]",
                            "terseLabel":  "Income Statement Location",
                            "documentation":  "Location in the income statement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r275",
                    "r584"
                    ]
                },
            "us-gaap_IncomeTaxAuthorityAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxAuthorityAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Authority [Axis]",
                            "terseLabel":  "Income Tax Authority",
                            "documentation":  "Information by tax jurisdiction."
                            }
                        }
                    },
                "auth_ref":  [
                    "r8"
                    ]
                },
            "us-gaap_IncomeTaxAuthorityDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxAuthorityDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Authority [Domain]",
                            "terseLabel":  "Income Tax Authority",
                            "documentation":  "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_IncomeTaxDisclosureAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxDisclosureAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Disclosure [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_IncomeTaxDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxDisclosureTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureIncomeTaxes"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Disclosure [Text Block]",
                            "terseLabel":  "Income Taxes",
                            "documentation":  "The entire disclosure for income taxes.  Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
                            }
                        }
                    },
                "auth_ref":  [
                    "r192",
                    "r371",
                    "r378",
                    "r381",
                    "r388",
                    "r395",
                    "r398",
                    "r399",
                    "r400",
                    "r539"
                    ]
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxExpenseBenefit",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  -1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Expense (Benefit)",
                            "negatedLabel":  "Income Tax Expense",
                            "totalLabel":  "Income Tax Expense (Benefit), Total",
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
                            }
                        }
                    },
                "auth_ref":  [
                    "r137",
                    "r151",
                    "r210",
                    "r211",
                    "r230",
                    "r376",
                    "r396",
                    "r510"
                    ]
                },
            "us-gaap_IncomeTaxPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxPolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax, Policy [Policy Text Block]",
                            "terseLabel":  "Income taxes",
                            "documentation":  "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
                            }
                        }
                    },
                "auth_ref":  [
                    "r179",
                    "r374",
                    "r375",
                    "r381",
                    "r382",
                    "r387",
                    "r389",
                    "r533"
                    ]
                },
            "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "onvo_ProvisionBenefitForIncomeTaxes",
                        "weight":  1.0,
                        "order":  10.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
                            "terseLabel":  "Valuation allowance",
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r750"
                    ]
                },
            "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxReconciliationChangeInEnactedTaxRate",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "onvo_ProvisionBenefitForIncomeTaxes",
                        "weight":  1.0,
                        "order":  5.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
                            "terseLabel":  "Change in tax rate",
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
                            }
                        }
                    },
                "auth_ref":  [
                    "r373",
                    "r377"
                    ]
                },
            "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "onvo_ProvisionBenefitForIncomeTaxes",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
                            "terseLabel":  "Tax computed at federal statutory rate",
                            "documentation":  "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
                            }
                        }
                    },
                "auth_ref":  [
                    "r377"
                    ]
                },
            "onvo_IncomeTaxReconciliationNondeductibleExpenseIncomeResearchAndDevelopment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "IncomeTaxReconciliationNondeductibleExpenseIncomeResearchAndDevelopment",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "onvo_ProvisionBenefitForIncomeTaxes",
                        "weight":  1.0,
                        "order":  8.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Income tax reconciliation nondeductible expense (income) research and development.",
                            "label":  "Income Tax Reconciliation Nondeductible Expense (Income) Research and Development",
                            "terseLabel":  "Removal of net operating losses and research development credits"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_IncomeTaxReconciliationOtherAdjustments":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxReconciliationOtherAdjustments",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "onvo_ProvisionBenefitForIncomeTaxes",
                        "weight":  1.0,
                        "order":  9.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
                            "terseLabel":  "Other",
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
                            }
                        }
                    },
                "auth_ref":  [
                    "r750"
                    ]
                },
            "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "onvo_ProvisionBenefitForIncomeTaxes",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
                            "terseLabel":  "State income tax, net of federal benefit",
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r750"
                    ]
                },
            "us-gaap_IncomeTaxReconciliationTaxCreditsResearch":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxReconciliationTaxCreditsResearch",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "onvo_ProvisionBenefitForIncomeTaxes",
                        "weight":  -1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
                            "negatedLabel":  "Research credits",
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
                            }
                        }
                    },
                "auth_ref":  [
                    "r750"
                    ]
                },
            "onvo_IncomeTaxReconciliationUncertainTaxPositions":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "IncomeTaxReconciliationUncertainTaxPositions",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  "onvo_ProvisionBenefitForIncomeTaxes",
                        "weight":  1.0,
                        "order":  7.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Income tax reconciliation uncertain tax positions.",
                            "label":  "Income Tax Reconciliation Uncertain tax positions",
                            "terseLabel":  "Uncertain tax positions"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_IncomeTaxesPaid":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncomeTaxesPaid",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Taxes Paid",
                            "terseLabel":  "Income taxes paid",
                            "documentation":  "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income."
                            }
                        }
                    },
                "auth_ref":  [
                    "r31",
                    "r34"
                    ]
                },
            "us-gaap_IncreaseDecreaseInAccountsPayable":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInAccountsPayable",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  8.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Accounts Payable",
                            "terseLabel":  "Accounts payable",
                            "totalLabel":  "Increase (Decrease) in Accounts Payable, Total",
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
                            }
                        }
                    },
                "auth_ref":  [
                    "r4"
                    ]
                },
            "us-gaap_IncreaseDecreaseInAccountsReceivable":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInAccountsReceivable",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0,
                        "order":  6.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Accounts Receivable",
                            "negatedLabel":  "Accounts receivable",
                            "documentation":  "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
                            }
                        }
                    },
                "auth_ref":  [
                    "r4"
                    ]
                },
            "us-gaap_IncreaseDecreaseInAccruedLiabilities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInAccruedLiabilities",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  9.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Accrued Liabilities",
                            "terseLabel":  "Accrued expenses",
                            "totalLabel":  "Increase (Decrease) in Accrued Liabilities, Total",
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
                            }
                        }
                    },
                "auth_ref":  [
                    "r4"
                    ]
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Operating Capital [Abstract]",
                            "terseLabel":  "Increase (decrease) in cash resulting from changes in:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  10.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Increase decrease in operating lease right-of-use assets and liabilities, net.",
                            "label":  "Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net",
                            "terseLabel":  "Operating right-of-use asset and lease liability, net"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0,
                        "order":  7.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Prepaid Expense and Other Assets",
                            "negatedLabel":  "Prepaid expenses and other assets",
                            "documentation":  "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
                            }
                        }
                    },
                "auth_ref":  [
                    "r4"
                    ]
                },
            "us-gaap_IncreaseDecreaseInRestructuringReserve":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "IncreaseDecreaseInRestructuringReserve",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfActivityAndBalancesOfRestructuringReserveDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Restructuring Reserve",
                            "terseLabel":  "Increase to reserve",
                            "documentation":  "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations."
                            }
                        }
                    },
                "auth_ref":  [
                    "r681"
                    ]
                },
            "onvo_InducementAwardAgreementsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "InducementAwardAgreementsMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Inducement award agreements.",
                            "label":  "Inducement Award Agreements [Member]",
                            "terseLabel":  "Inducement Award Agreements [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_InterestIncomeOnInvestmentsInDebtSecurities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "InterestIncomeOnInvestmentsInDebtSecurities",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Interest income on investments in debt securities.",
                            "label":  "Interest Income On Investments in debt securities",
                            "terseLabel":  "Interest income on investments in debt securities"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_InvestmentIncomeInterest":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InvestmentIncomeInterest",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investment Income, Interest",
                            "terseLabel":  "Interest income",
                            "documentation":  "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
                            }
                        }
                    },
                "auth_ref":  [
                    "r100",
                    "r228"
                    ]
                },
            "us-gaap_InvestmentPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InvestmentPolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investment, Policy [Policy Text Block]",
                            "terseLabel":  "Investments",
                            "documentation":  "Disclosure of accounting policy for investment in financial asset."
                            }
                        }
                    },
                "auth_ref":  [
                    "r507",
                    "r529",
                    "r530",
                    "r531",
                    "r532",
                    "r606",
                    "r607"
                    ]
                },
            "us-gaap_InvestmentTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InvestmentTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurement"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investment [Text Block]",
                            "terseLabel":  "Investments and Fair Value Measurement",
                            "documentation":  "The entire disclosure for investment."
                            }
                        }
                    },
                "auth_ref":  [
                    "r670",
                    "r671",
                    "r691"
                    ]
                },
            "us-gaap_Investments":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "Investments",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Investments, Total",
                            "label":  "Investments",
                            "terseLabel":  "Investments in debt securities",
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all investments."
                            }
                        }
                    },
                "auth_ref":  [
                    "r492"
                    ]
                },
            "us-gaap_InvestmentsAllOtherInvestmentsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "InvestmentsAllOtherInvestmentsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investments, All Other Investments [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_InvestmentsLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "InvestmentsLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Investments [Line Items]",
                            "label":  "Investments [Line Items]",
                            "documentation":  "Investments."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_InvestmentsTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "InvestmentsTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Investments [Table]",
                            "label":  "Investments [Table]",
                            "documentation":  "Investments."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_LabAndOfficeSpaceAreaUnderLeaseAgreement":  {
                "xbrltype":  "areaItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "LabAndOfficeSpaceAreaUnderLeaseAgreement",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lab and office space area under lease agreement.",
                            "label":  "Lab And Office Space Area Under Lease Agreement",
                            "terseLabel":  "Lab and Office space under lease agreement"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_LeaseCostTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LeaseCostTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lease, Cost [Table Text Block]",
                            "terseLabel":  "Schedule of Lease Liabilities and Corresponding Right-of-use Assets",
                            "documentation":  "Tabular disclosure of lessee's lease cost.  Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
                            }
                        }
                    },
                "auth_ref":  [
                    "r760"
                    ]
                },
            "us-gaap_LeasesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LeasesAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Leases [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_LesseeOperatingLeaseDiscountRate":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseDiscountRate",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lessee, Operating Lease, Discount Rate",
                            "terseLabel":  "Base rent escalators",
                            "documentation":  "Discount rate used by lessee to determine present value of operating lease payments."
                            }
                        }
                    },
                "auth_ref":  [
                    "r636"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
                            "terseLabel":  "Schedule of Future Lease Payments",
                            "documentation":  "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability.  Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
                            }
                        }
                    },
                "auth_ref":  [
                    "r761"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDue",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails2":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails2":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lessee, Operating Lease, Liability, to be Paid",
                            "totalLabel":  "Total future lease payments",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r451"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  5.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
                            "terseLabel":  "Thereafter",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r451"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  0.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Fiscal year ending March 31, 2025",
                            "terseLabel":  "Fiscal year ending March 31, 2024",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year One",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r451"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Four",
                            "terseLabel":  "Fiscal year ending March 31, 2027",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r451"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  2.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Fiscal year ending March 31, 2027",
                            "terseLabel":  "Fiscal year ending March 31, 2026",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Three",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r451"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  1.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Fiscal year ending March 31, 2026",
                            "terseLabel":  "Fiscal year ending March 31, 2025",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Two",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r451"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Fiscal year ending March 31, 2024",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
                            }
                        }
                    },
                "auth_ref":  [
                    "r761"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails2":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  0.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails2":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
                            "negatedLabel":  "Less:  Imputed Interest",
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r451"
                    ]
                },
            "us-gaap_LesseeOperatingLeaseTermOfContract":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeaseTermOfContract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lessee, Operating Lease, Term of Contract",
                            "terseLabel":  "Lease term",
                            "documentation":  "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
                            }
                        }
                    },
                "auth_ref":  [
                    "r759"
                    ]
                },
            "us-gaap_LesseeOperatingLeasesTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LesseeOperatingLeasesTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeases"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lessee, Operating Leases [Text Block]",
                            "terseLabel":  "Leases",
                            "documentation":  "The entire disclosure for operating leases of lessee.  Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
                            }
                        }
                    },
                "auth_ref":  [
                    "r440"
                    ]
                },
            "us-gaap_Liabilities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "Liabilities",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities",
                            "totalLabel":  "Total liabilities",
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized.  Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
                            }
                        }
                    },
                "auth_ref":  [
                    "r19",
                    "r191",
                    "r258",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r295",
                    "r296",
                    "r404",
                    "r407",
                    "r408",
                    "r426",
                    "r555",
                    "r621",
                    "r651",
                    "r718",
                    "r766",
                    "r767"
                    ]
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LiabilitiesAndStockholdersEquity",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities and Equity",
                            "totalLabel":  "Total Liabilities and Stockholders' Equity",
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
                            }
                        }
                    },
                "auth_ref":  [
                    "r94",
                    "r134",
                    "r499",
                    "r638",
                    "r685",
                    "r706",
                    "r757"
                    ]
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities and Equity [Abstract]",
                            "terseLabel":  "Liabilities and Stockholders' Equity"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_LiabilitiesCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LiabilitiesCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities, Current",
                            "totalLabel":  "Total current liabilities",
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r21",
                    "r161",
                    "r191",
                    "r258",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r295",
                    "r296",
                    "r404",
                    "r407",
                    "r408",
                    "r426",
                    "r638",
                    "r718",
                    "r766",
                    "r767"
                    ]
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LiabilitiesCurrentAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities, Current [Abstract]",
                            "terseLabel":  "Current Liabilities"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_LiabilitiesNoncurrentAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LiabilitiesNoncurrentAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities, Noncurrent [Abstract]",
                            "terseLabel":  "Noncurrent"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LiabilityForUncertainTaxPositionsNoncurrent",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liability for Uncertainty in Income Taxes, Noncurrent",
                            "terseLabel":  "Uncertain tax position netted against deferred tax asset",
                            "documentation":  "Amount recognized for uncertainty in income taxes classified as noncurrent."
                            }
                        }
                    },
                "auth_ref":  [
                    "r22"
                    ]
                },
            "onvo_LicenseAgreementExpirationMonth":  {
                "xbrltype":  "gYearMonthItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "LicenseAgreementExpirationMonth",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "License agreement expiration month.",
                            "label":  "License Agreement Expiration Month",
                            "terseLabel":  "Expected expiration year of license agreement"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_LicenseAgreementExpirationYearStart":  {
                "xbrltype":  "gYearItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "LicenseAgreementExpirationYearStart",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "License agreement expiration year start.",
                            "label":  "License Agreement Expiration Year Start",
                            "terseLabel":  "Expected expiration year of license agreement"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_LicensingAgreementsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "LicensingAgreementsMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Licensing Agreements Member",
                            "label":  "Licensing Agreements [Member]",
                            "documentation":  "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r77",
                    "r370",
                    "r749"
                    ]
                },
            "onvo_LiquidationOfEquitySecuritiesFvni":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "LiquidationOfEquitySecuritiesFvni",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Liquidation of equity securities",
                            "label":  "Liquidation of Equity Securities FVNi",
                            "documentation":  "Liquidation of equity securities fvni."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_LiquidityAndGoingConcernPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "LiquidityAndGoingConcernPolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Liquidity and going concern.",
                            "label":  "Liquidity And Going Concern [Policy Text Block]",
                            "terseLabel":  "Liquidity and Going Concern"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_LocalPhoneNumber":  {
                "xbrltype":  "normalizedStringItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "LocalPhoneNumber",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Local Phone Number",
                            "terseLabel":  "Local Phone Number",
                            "documentation":  "Local phone number for entity."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_MachineryAndEquipmentGross":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "MachineryAndEquipmentGross",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails":  {
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentGross",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Machinery and Equipment, Gross",
                            "terseLabel":  "Laboratory equipment",
                            "documentation":  "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
                            }
                        }
                    },
                "auth_ref":  [
                    "r113"
                    ]
                },
            "srt_MaximumMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "MaximumMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maximum [Member]",
                            "terseLabel":  "Maximum [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r284",
                    "r285",
                    "r286",
                    "r287",
                    "r324",
                    "r468",
                    "r517",
                    "r547",
                    "r548",
                    "r605",
                    "r608",
                    "r609",
                    "r610",
                    "r611",
                    "r614",
                    "r615",
                    "r623",
                    "r626",
                    "r631",
                    "r640",
                    "r720",
                    "r768",
                    "r769",
                    "r770",
                    "r771",
                    "r772",
                    "r773"
                    ]
                },
            "onvo_MetacrineIncMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "MetacrineIncMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Metacrine, Inc. member.",
                            "label":  "Metacrine, Inc. [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_MetacrinesFxrProgramMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "MetacrinesFxrProgramMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Metacrine's FXR program member.",
                            "label":  "Metacrine's FXR Program [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_MilestonePayments":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "MilestonePayments",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Milestone payments.",
                            "label":  "Milestone payments"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_MinimumAnnualRoyaltyPayment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "MinimumAnnualRoyaltyPayment",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Minimum annual royalty payment.",
                            "label":  "Minimum Annual Royalty Payment",
                            "terseLabel":  "Minimum annual royalty paid"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "srt_MinimumMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "MinimumMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Minimum [Member]",
                            "terseLabel":  "Minimum [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r284",
                    "r285",
                    "r286",
                    "r287",
                    "r324",
                    "r468",
                    "r517",
                    "r547",
                    "r548",
                    "r605",
                    "r608",
                    "r609",
                    "r610",
                    "r611",
                    "r614",
                    "r615",
                    "r623",
                    "r626",
                    "r631",
                    "r640",
                    "r720",
                    "r768",
                    "r769",
                    "r770",
                    "r771",
                    "r772",
                    "r773"
                    ]
                },
            "onvo_MonthlyRentPayments":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "MonthlyRentPayments",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Monthly rent payments.",
                            "label":  "Monthly Rent Payments",
                            "terseLabel":  "Monthly rental payments"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_NatureOfOperations":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NatureOfOperations",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusiness"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Description of Business",
                            "label":  "Nature of Operations [Text Block]",
                            "documentation":  "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings.  For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
                            }
                        }
                    },
                "auth_ref":  [
                    "r139",
                    "r153"
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net cash provided by financing activities",
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
                            }
                        }
                    },
                "auth_ref":  [
                    "r188"
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Financing Activities [Abstract]",
                            "terseLabel":  "Cash Flows From Financing Activities"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Investing Activities",
                            "totalLabel":  "Net cash used in investing activities",
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r188"
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Investing Activities [Abstract]",
                            "terseLabel":  "Cash Flows From Investing Activities"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "totalLabel":  "Net cash used in operating activities",
                            "negatedLabel":  "Cash flow from operations",
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
                            }
                        }
                    },
                "auth_ref":  [
                    "r104",
                    "r105",
                    "r106"
                    ]
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Cash Flows From Operating Activities"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_NetIncomeLoss":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NetIncomeLoss",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Income (Loss) Attributable to Parent",
                            "terseLabel":  "Net Loss",
                            "totalLabel":  "Net Loss",
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
                            }
                        }
                    },
                "auth_ref":  [
                    "r96",
                    "r106",
                    "r135",
                    "r159",
                    "r175",
                    "r177",
                    "r182",
                    "r191",
                    "r198",
                    "r202",
                    "r203",
                    "r205",
                    "r206",
                    "r210",
                    "r211",
                    "r217",
                    "r225",
                    "r232",
                    "r236",
                    "r238",
                    "r258",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r295",
                    "r296",
                    "r420",
                    "r426",
                    "r504",
                    "r577",
                    "r597",
                    "r598",
                    "r622",
                    "r649",
                    "r718"
                    ]
                },
            "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRecentAccountingPronouncements"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Standards Update and Change in Accounting Principle [Text Block]",
                            "terseLabel":  "Recent Accounting Pronouncements",
                            "documentation":  "The entire disclosure for change in accounting principle.  Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle."
                            }
                        }
                    },
                "auth_ref":  [
                    "r149",
                    "r150",
                    "r152",
                    "r158",
                    "r196",
                    "r197",
                    "r200",
                    "r201",
                    "r212",
                    "r213",
                    "r260",
                    "r261",
                    "r392",
                    "r393",
                    "r394",
                    "r414",
                    "r417",
                    "r421",
                    "r422",
                    "r423",
                    "r427",
                    "r428",
                    "r429",
                    "r438",
                    "r439",
                    "r454",
                    "r471",
                    "r472",
                    "r473",
                    "r522",
                    "r523",
                    "r524",
                    "r525",
                    "r527"
                    ]
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Recent Accounting Pronouncements",
                            "label":  "New Accounting Pronouncements, Policy [Policy Text Block]",
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_NonoperatingIncomeExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NonoperatingIncomeExpense",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Nonoperating Income (Expense)",
                            "totalLabel":  "Total Other Income",
                            "documentation":  "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r101"
                    ]
                },
            "us-gaap_NonoperatingIncomeExpenseAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "NonoperatingIncomeExpenseAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Nonoperating Income (Expense) [Abstract]",
                            "terseLabel":  "Other Income (Expense)"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_NonrefundableUpfrontFeePaid":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "NonrefundableUpfrontFeePaid",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Nonrefundable upfront fee paid.",
                            "label":  "Nonrefundable Upfront Fee Paid",
                            "terseLabel":  "Nonrefundable upfront fee paid"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_NumberOfAdditionalIPRProceedingsFiled":  {
                "xbrltype":  "integerItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "NumberOfAdditionalIPRProceedingsFiled",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of additional IPR proceedings filed.",
                            "label":  "Number Of Additional I P R Proceedings Filed",
                            "terseLabel":  "Number of additional IPR proceedings filed"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_NumberOfClinicallyTestedCompounds":  {
                "xbrltype":  "integerItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "NumberOfClinicallyTestedCompounds",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Number of clinically tested compounds",
                            "documentation":  "Number of clinically tested compounds.",
                            "label":  "Number of clinically tested compounds"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_NumberOfDiscoveryOrPreclinicalCompounds":  {
                "xbrltype":  "integerItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "NumberOfDiscoveryOrPreclinicalCompounds",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Number of discovery or preclinical compounds",
                            "documentation":  "Number of discovery or preclinical compounds.",
                            "label":  "Number of discovery or preclinical compounds"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_NumberOfLeaseAgreement":  {
                "xbrltype":  "integerItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "NumberOfLeaseAgreement",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of lease agreement.",
                            "label":  "Number Of Lease Agreement",
                            "terseLabel":  "Number of lease agreement"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_NumberOfParticipantsEnrolledInEmployeeStockPurchasePlan":  {
                "xbrltype":  "integerItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "NumberOfParticipantsEnrolledInEmployeeStockPurchasePlan",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockPurchasePlanParentheticalDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of participants enrolled in employee stock purchase plan.",
                            "label":  "Number Of Participants Enrolled In Employee Stock Purchase Plan",
                            "terseLabel":  "Participants enrolled into the employee stock purchase plan"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OperatingIncomeLoss":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingIncomeLoss",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Income (Loss)",
                            "totalLabel":  "Loss from Operations",
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues."
                            }
                        }
                    },
                "auth_ref":  [
                    "r225",
                    "r232",
                    "r236",
                    "r238",
                    "r622"
                    ]
                },
            "us-gaap_OperatingLeaseCost":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseCost",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Lease, Cost",
                            "terseLabel":  "Rent expense",
                            "documentation":  "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term.  Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
                            }
                        }
                    },
                "auth_ref":  [
                    "r444",
                    "r637"
                    ]
                },
            "us-gaap_OperatingLeaseExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseExpense",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Lease, Expense",
                            "terseLabel":  "Operating Lease, Expense",
                            "documentation":  "Amount of operating lease expense.  Excludes sublease income."
                            }
                        }
                    },
                "auth_ref":  [
                    "r758"
                    ]
                },
            "us-gaap_OperatingLeaseLiability":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseLiability",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails2":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  1.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails2":  {
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0,
                        "order":  1.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Lease, Liability",
                            "terseLabel":  "Operating lease, liability",
                            "totalLabel":  "Total lease liabilities",
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r442"
                    ]
                },
            "us-gaap_OperatingLeaseLiabilityCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseLiabilityCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails2":  {
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0,
                        "order":  0.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails2":  {
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0,
                        "order":  0.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails":  {
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0,
                        "order":  0.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Operating lease liability, current portion",
                            "label":  "Operating Lease, Liability, Current",
                            "negatedLabel":  "Less:  Current obligations",
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
                            }
                        }
                    },
                "auth_ref":  [
                    "r442"
                    ]
                },
            "us-gaap_OperatingLeaseLiabilityNoncurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseLiabilityNoncurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0,
                        "order":  1.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails2":  {
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0,
                        "order":  1.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails2":  {
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0,
                        "order":  1.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails":  {
                        "parentTag":  "us-gaap_OperatingLeaseLiability",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureLeasesScheduleOfFutureLeasePaymentsQuarterlyDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureLeasePaymentsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Lease, Liability, Noncurrent",
                            "terseLabel":  "Operating lease liability, net of current portion",
                            "verboseLabel":  "Noncurrent lease obligations",
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
                            }
                        }
                    },
                "auth_ref":  [
                    "r442"
                    ]
                },
            "onvo_OperatingLeaseLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "OperatingLeaseLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating lease.",
                            "label":  "Operating Lease [Line Items]",
                            "terseLabel":  "Operating Lease [Line Items]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OperatingLeasePayments":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeasePayments",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Lease, Payments",
                            "terseLabel":  "Operating cash flows from operating leases",
                            "documentation":  "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
                            }
                        }
                    },
                "auth_ref":  [
                    "r443",
                    "r447"
                    ]
                },
            "us-gaap_OperatingLeaseRightOfUseAsset":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseRightOfUseAsset",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  3.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Lease, Right-of-Use Asset",
                            "terseLabel":  "Operating lease right-of-use assets",
                            "totalLabel":  "Total lease right-of-use assets",
                            "documentation":  "Amount of lessee's right to use underlying asset under operating lease."
                            }
                        }
                    },
                "auth_ref":  [
                    "r441"
                    ]
                },
            "onvo_OperatingLeaseRightOfUseAssetNonCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "OperatingLeaseRightOfUseAssetNonCurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails":  {
                        "parentTag":  "us-gaap_OperatingLeaseRightOfUseAsset",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating lease right of use asset non current.",
                            "label":  "Operating Lease Right Of Use Asset Non Current",
                            "terseLabel":  "Operating lease right-of-use assets"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_OperatingLeaseTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "OperatingLeaseTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating lease disclosure.",
                            "label":  "Operating Lease [Table]",
                            "terseLabel":  "Operating Lease [Table]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseWeightedAverageDiscountRatePercent",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Lease, Weighted Average Discount Rate, Percent",
                            "terseLabel":  "Weighted average discount rate:",
                            "documentation":  "Weighted average discount rate for operating lease calculated at point in time."
                            }
                        }
                    },
                "auth_ref":  [
                    "r450",
                    "r637"
                    ]
                },
            "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesScheduleOfLeaseLiabilitiesAndCorrespondingRightOfUseAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Lease, Weighted Average Remaining Lease Term",
                            "terseLabel":  "Weighted average remaining lease term:",
                            "documentation":  "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
                            }
                        }
                    },
                "auth_ref":  [
                    "r449",
                    "r637"
                    ]
                },
            "onvo_OperatingLeasesMonthlyRentExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "OperatingLeasesMonthlyRentExpense",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Operating leases monthly rent expense.",
                            "label":  "Operating Leases Monthly Rent Expense",
                            "terseLabel":  "Monthly rental payments"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OperatingLossCarryforwards":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLossCarryforwards",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Loss Carryforwards",
                            "terseLabel":  "Operating loss carry forwards",
                            "documentation":  "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
                            }
                        }
                    },
                "auth_ref":  [
                    "r75"
                    ]
                },
            "us-gaap_OperatingLossCarryforwardsLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLossCarryforwardsLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Loss Carryforwards [Line Items]",
                            "terseLabel":  "Operating Loss Carryforwards [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OperatingLossCarryforwardsTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OperatingLossCarryforwardsTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Loss Carryforwards [Table]",
                            "terseLabel":  "Operating Loss Carryforwards [Table]",
                            "documentation":  "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
                            }
                        }
                    },
                "auth_ref":  [
                    "r74"
                    ]
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
                            "terseLabel":  "Description of Business and Summary of Significant Accounting Policies",
                            "documentation":  "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles."
                            }
                        }
                    },
                "auth_ref":  [
                    "r107",
                    "r108",
                    "r109",
                    "r129"
                    ]
                },
            "us-gaap_OtherCommitmentsAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OtherCommitmentsAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Commitments [Axis]",
                            "terseLabel":  "Other Commitments",
                            "documentation":  "Information by type of other commitment."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OtherCommitmentsDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OtherCommitmentsDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Commitments [Domain]",
                            "terseLabel":  "Other Commitments",
                            "documentation":  "Other future obligation."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Other Comprehensive Income (Loss):",
                            "label":  "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_ComprehensiveIncomeNetOfTax",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Unrealized gain (loss) on available-for-sale debt securities",
                            "label":  "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
                            "documentation":  "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).  Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
                            }
                        }
                    },
                "auth_ref":  [
                    "r173",
                    "r174",
                    "r256"
                    ]
                },
            "us-gaap_OtherLiabilitiesCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OtherLiabilitiesCurrent",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails":  {
                        "parentTag":  "us-gaap_AccruedLiabilitiesCurrent",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureAccruedExpensesSummaryOfAccruedExpensesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Liabilities, Current",
                            "terseLabel":  "Other accrued expenses",
                            "documentation":  "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r20",
                    "r638"
                    ]
                },
            "us-gaap_OtherNonoperatingIncomeExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "OtherNonoperatingIncomeExpense",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Nonoperating Income (Expense)",
                            "terseLabel":  "Other income",
                            "totalLabel":  "Other Nonoperating Income (Expense), Total",
                            "documentation":  "Amount of income (expense) related to nonoperating activities, classified as other."
                            }
                        }
                    },
                "auth_ref":  [
                    "r102"
                    ]
                },
            "us-gaap_PayablesAndAccrualsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PayablesAndAccrualsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payables and Accruals [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_PaymentsForRepurchaseOfCommonStock":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PaymentsForRepurchaseOfCommonStock",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payments for Repurchase of Common Stock",
                            "negatedLabel":  "Purchase of treasury stock",
                            "documentation":  "The cash outflow to reacquire common stock during the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r30"
                    ]
                },
            "us-gaap_PaymentsForRestructuring":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PaymentsForRestructuring",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfActivityAndBalancesOfRestructuringReserveDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payments for Restructuring",
                            "terseLabel":  "Payments for restructuring",
                            "negatedTerseLabel":  "Payments",
                            "documentation":  "Amount of cash payments made as the result of exit or disposal activities.  Excludes payments associated with a discontinued operation or an asset retirement obligation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r274",
                    "r680"
                    ]
                },
            "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payment, Tax Withholding, Share-Based Payment Arrangement",
                            "negatedLabel":  "Employee taxes paid related to net share settlement of equity awards",
                            "documentation":  "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r185"
                    ]
                },
            "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PaymentsToAcquireEquitySecuritiesFvNi",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payments to Acquire Equity Securities, FV-NI",
                            "negatedLabel":  "Purchases of equity securities",
                            "verboseLabel":  "Purchases at cost",
                            "terseLabel":  "Purchase of equity securities",
                            "documentation":  "Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r136",
                    "r186"
                    ]
                },
            "onvo_PaymentsToAcquireInvestment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "PaymentsToAcquireInvestment",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Payments to acquire investment.",
                            "label":  "Payments To Acquire Investment",
                            "negatedLabel":  "Purchases of investments"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PaymentsToAcquirePropertyPlantAndEquipment",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payments to Acquire Property, Plant, and Equipment",
                            "negatedLabel":  "Purchases of fixed assets",
                            "totalLabel":  "Payments to Acquire Property, Plant, and Equipment, Total",
                            "documentation":  "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r103"
                    ]
                },
            "onvo_PercentageOfFutureTaxableIncomeToBeOffset":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "PercentageOfFutureTaxableIncomeToBeOffset",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of future taxable income to be offset.",
                            "label":  "Percentage Of Future Taxable Income To Be Offset",
                            "terseLabel":  "Percentage of future taxable income to be offset"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_PercentageOfRoyaltyRevenueFromSublicensee":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "PercentageOfRoyaltyRevenueFromSublicensee",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of royalty revenue from sublicensee.",
                            "label":  "Percentage Of Royalty Revenue From Sublicensee",
                            "terseLabel":  "Percentage of royalty revenue from sublicensee"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_PercentageOfSublicensingRevenue":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "PercentageOfSublicensingRevenue",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of sublicensing revenue.",
                            "label":  "Percentage of sublicensing revenue"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_PerformanceBasedRestrictedStockUnitsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "PerformanceBasedRestrictedStockUnitsMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Performance based restricted stock units.",
                            "label":  "Performance Based Restricted Stock Units [Member]",
                            "terseLabel":  "Performance-Based Restricted Stock Units [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_PlanNameAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PlanNameAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockPurchasePlanParentheticalDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Plan Name [Axis]",
                            "terseLabel":  "Plan Name",
                            "documentation":  "Information by plan name for share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r722",
                    "r723",
                    "r724",
                    "r725",
                    "r726",
                    "r727",
                    "r728",
                    "r729",
                    "r730",
                    "r731",
                    "r732",
                    "r733",
                    "r734",
                    "r735",
                    "r736",
                    "r737",
                    "r738",
                    "r739",
                    "r740",
                    "r741",
                    "r742",
                    "r743",
                    "r744",
                    "r745",
                    "r746",
                    "r747"
                    ]
                },
            "us-gaap_PlanNameDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PlanNameDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockPurchasePlanParentheticalDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Plan Name [Domain]",
                            "terseLabel":  "Plan Name",
                            "documentation":  "Plan name for share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r722",
                    "r723",
                    "r724",
                    "r725",
                    "r726",
                    "r727",
                    "r728",
                    "r729",
                    "r730",
                    "r731",
                    "r732",
                    "r733",
                    "r734",
                    "r735",
                    "r736",
                    "r737",
                    "r738",
                    "r739",
                    "r740",
                    "r741",
                    "r742",
                    "r743",
                    "r744",
                    "r745",
                    "r746",
                    "r747"
                    ]
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PreferredStockSharesAuthorized",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityPreferredStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Preferred Stock, Shares Authorized",
                            "terseLabel":  "Preferred stock, shares authorized",
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
                            }
                        }
                    },
                "auth_ref":  [
                    "r88",
                    "r557"
                    ]
                },
            "us-gaap_PreferredStockSharesOutstanding":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PreferredStockSharesOutstanding",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityPreferredStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Preferred Stock, Shares Outstanding",
                            "terseLabel":  "Preferred stock, shares outstanding",
                            "periodStartLabel":  "Preferred Stock, Shares Outstanding, Beginning Balance",
                            "periodEndLabel":  "Preferred Stock, Shares Outstanding, Ending Balance",
                            "documentation":  "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders.  Does not include preferred shares that have been repurchased."
                            }
                        }
                    },
                "auth_ref":  [
                    "r88",
                    "r557",
                    "r575",
                    "r777",
                    "r778"
                    ]
                },
            "us-gaap_PrepaidExpenseAndOtherAssetsCurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PrepaidExpenseAndOtherAssetsCurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0,
                        "order":  3.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Prepaid Expense and Other Assets, Current",
                            "terseLabel":  "Prepaid expenses and other current assets",
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r674"
                    ]
                },
            "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PrepaidExpenseAndOtherAssetsNoncurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Prepaid Expense and Other Assets, Noncurrent",
                            "terseLabel":  "Prepaid expenses and other assets, net",
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r131",
                    "r673"
                    ]
                },
            "us-gaap_ProceedsFromIssuanceOfCommonStock":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ProceedsFromIssuanceOfCommonStock",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Proceeds from Issuance of Common Stock",
                            "terseLabel":  "Proceeds from issuance of common stock, net",
                            "verboseLabel":  "Proceeds from sale of common stock shares",
                            "documentation":  "The cash inflow from the additional capital contribution to the entity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r3"
                    ]
                },
            "onvo_ProceedsFromMaturitiesPrepaymentsAndCallsOfInvestments":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ProceedsFromMaturitiesPrepaymentsAndCallsOfInvestments",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Proceeds from maturities prepayments and calls of investments.",
                            "label":  "Proceeds From Maturities Prepayments And Calls Of Investments",
                            "terseLabel":  "Maturities of investments"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ProceedsFromSaleOfEquitySecuritiesFvNi":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ProceedsFromSaleOfEquitySecuritiesFvNi",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0,
                        "order":  5.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Liquidation of equity securities",
                            "label":  "Proceeds from Sale of Equity Securities, FV-NI",
                            "negatedLabel":  "Sales",
                            "terseLabel":  "Sale of equity securities",
                            "documentation":  "Amount of cash inflow from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r136",
                    "r186"
                    ]
                },
            "us-gaap_ProceedsFromStockOptionsExercised":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ProceedsFromStockOptionsExercised",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Proceeds from Stock Options Exercised",
                            "terseLabel":  "Proceeds from exercise of stock options",
                            "documentation":  "Amount of cash inflow from exercise of option under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r3",
                    "r15"
                    ]
                },
            "srt_ProductOrServiceAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "ProductOrServiceAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product and Service [Axis]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r239",
                    "r469",
                    "r511",
                    "r512",
                    "r513",
                    "r514",
                    "r515",
                    "r516",
                    "r617",
                    "r627",
                    "r639",
                    "r666",
                    "r716",
                    "r717",
                    "r721",
                    "r775"
                    ]
                },
            "srt_ProductsAndServicesDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "ProductsAndServicesDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Product and Service [Domain]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r239",
                    "r469",
                    "r511",
                    "r512",
                    "r513",
                    "r514",
                    "r515",
                    "r516",
                    "r617",
                    "r627",
                    "r639",
                    "r666",
                    "r716",
                    "r717",
                    "r721",
                    "r775"
                    ]
                },
            "us-gaap_ProfitLoss":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ProfitLoss",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
                            "terseLabel":  "Net loss",
                            "verboseLabel":  "Net loss",
                            "totalLabel":  "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total",
                            "documentation":  "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
                            }
                        }
                    },
                "auth_ref":  [
                    "r159",
                    "r175",
                    "r177",
                    "r187",
                    "r191",
                    "r198",
                    "r210",
                    "r211",
                    "r225",
                    "r232",
                    "r236",
                    "r238",
                    "r258",
                    "r288",
                    "r289",
                    "r290",
                    "r291",
                    "r292",
                    "r293",
                    "r294",
                    "r295",
                    "r296",
                    "r402",
                    "r405",
                    "r406",
                    "r420",
                    "r426",
                    "r490",
                    "r503",
                    "r544",
                    "r577",
                    "r597",
                    "r598",
                    "r622",
                    "r634",
                    "r635",
                    "r650",
                    "r677",
                    "r718"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentByTypeAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentByTypeAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Long-Lived Tangible Asset [Axis]",
                            "terseLabel":  "Long-Lived Tangible Asset",
                            "documentation":  "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
                            }
                        }
                    },
                "auth_ref":  [
                    "r6"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentDisclosureTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureFixedAssets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment Disclosure [Text Block]",
                            "terseLabel":  "Fixed Assets",
                            "documentation":  "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale.  Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
                            }
                        }
                    },
                "auth_ref":  [
                    "r112",
                    "r144",
                    "r147",
                    "r148"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentGross":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentGross",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails":  {
                        "parentTag":  "us-gaap_PropertyPlantAndEquipmentNet",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment, Gross",
                            "totalLabel":  "Fixed Assets, gross",
                            "periodStartLabel":  "Property, Plant and Equipment, Gross, Beginning Balance",
                            "periodEndLabel":  "Property, Plant and Equipment, Gross, Ending Balance",
                            "documentation":  "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
                            }
                        }
                    },
                "auth_ref":  [
                    "r113",
                    "r163",
                    "r502"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentNet",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  1.0
                        },
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureFixedAssetsScheduleOfFixedAssetsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment, Net",
                            "terseLabel":  "Fixed assets, net",
                            "totalLabel":  "Fixed Assets, net",
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
                            }
                        }
                    },
                "auth_ref":  [
                    "r6",
                    "r491",
                    "r502",
                    "r638"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentPolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment, Policy [Policy Text Block]",
                            "terseLabel":  "Fixed assets and depreciation",
                            "documentation":  "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale.  Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
                            }
                        }
                    },
                "auth_ref":  [
                    "r6",
                    "r144",
                    "r147",
                    "r500"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureFixedAssetsTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment [Table Text Block]",
                            "terseLabel":  "Schedule of Fixed Assets",
                            "documentation":  "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r6"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentTypeDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentTypeDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Long-Lived Tangible Asset [Domain]",
                            "terseLabel":  "Long-Lived Tangible Asset",
                            "documentation":  "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
                            }
                        }
                    },
                "auth_ref":  [
                    "r113"
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentUsefulLife":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentUsefulLife",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment, Useful Life",
                            "terseLabel":  "Useful life of fixed assets, range",
                            "documentation":  "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.  Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration":  {
                "xbrltype":  "enumerationSetItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]",
                            "label":  "Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]",
                            "documentation":  "Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value."
                            }
                        }
                    },
                "auth_ref":  [
                    "r709"
                    ]
                },
            "onvo_ProspectusTo2021ShelfMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ProspectusTo2021ShelfMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Prospectus to the 2021 Shelf.",
                            "label":  "Prospectus To2021 Shelf [Member]",
                            "terseLabel":  "Prospectus to 2021 Shelf [Member]",
                            "verboseLabel":  "ATM Prospectus Supplement [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_ProspectusToTwoThousandAndTwentyFourShelfMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ProspectusToTwoThousandAndTwentyFourShelfMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "2024 ATM Prospectus [Member]",
                            "label":  "Prospectus To Two Thousand and Twenty Four Shelf [Member]",
                            "documentation":  "Prospectus to 2024 shelf."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_ProvisionBenefitForIncomeTaxes":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ProvisionBenefitForIncomeTaxes",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfStatutoryFederalRateAndEffectiveRateForOperationsDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Provision (benefit) for income taxes.",
                            "label":  "Provision Benefit For Income Taxes",
                            "totalLabel":  "Provision (benefit) for income taxes"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_QuarterlyRestructuringPayment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "QuarterlyRestructuringPayment",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Quarterly restructuring payment.",
                            "label":  "Quarterly Restructuring Payment",
                            "terseLabel":  "Quarterly restructuring payment"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_QuarterlyRestructuringPaymentDescription":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "QuarterlyRestructuringPaymentDescription",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Quarterly restructuring payment description.",
                            "label":  "Quarterly Restructuring Payment Description",
                            "terseLabel":  "Quarterly restructuring payment, description"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "srt_RangeAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "RangeAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Axis]",
                            "terseLabel":  "Statistical Measurement"
                            }
                        }
                    },
                "auth_ref":  [
                    "r284",
                    "r285",
                    "r286",
                    "r287",
                    "r316",
                    "r324",
                    "r354",
                    "r355",
                    "r356",
                    "r467",
                    "r468",
                    "r517",
                    "r547",
                    "r548",
                    "r605",
                    "r608",
                    "r609",
                    "r610",
                    "r611",
                    "r614",
                    "r615",
                    "r623",
                    "r626",
                    "r631",
                    "r640",
                    "r643",
                    "r712",
                    "r720",
                    "r769",
                    "r770",
                    "r771",
                    "r772",
                    "r773"
                    ]
                },
            "srt_RangeMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "RangeMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Domain]",
                            "terseLabel":  "Statistical Measurement"
                            }
                        }
                    },
                "auth_ref":  [
                    "r284",
                    "r285",
                    "r286",
                    "r287",
                    "r316",
                    "r324",
                    "r354",
                    "r355",
                    "r356",
                    "r467",
                    "r468",
                    "r517",
                    "r547",
                    "r548",
                    "r605",
                    "r608",
                    "r609",
                    "r610",
                    "r611",
                    "r614",
                    "r615",
                    "r623",
                    "r626",
                    "r631",
                    "r640",
                    "r643",
                    "r712",
                    "r720",
                    "r769",
                    "r770",
                    "r771",
                    "r772",
                    "r773"
                    ]
                },
            "us-gaap_RelatedPartyDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RelatedPartyDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party, Type [Domain]",
                            "terseLabel":  "Related Party",
                            "documentation":  "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
                            }
                        }
                    },
                "auth_ref":  [
                    "r323",
                    "r458",
                    "r459",
                    "r550",
                    "r551",
                    "r552",
                    "r553",
                    "r554",
                    "r574",
                    "r576",
                    "r604"
                    ]
                },
            "us-gaap_RelatedPartyTransactionAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RelatedPartyTransactionAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transaction [Axis]",
                            "documentation":  "Information by type of related party transaction."
                            }
                        }
                    },
                "auth_ref":  [
                    "r458",
                    "r459",
                    "r765"
                    ]
                },
            "us-gaap_RelatedPartyTransactionDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RelatedPartyTransactionDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transaction [Domain]",
                            "documentation":  "Transaction between related party."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_RelatedPartyTransactionLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RelatedPartyTransactionLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transaction [Line Items]",
                            "terseLabel":  "Related Party Transaction [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    "r580",
                    "r581",
                    "r584"
                    ]
                },
            "us-gaap_RelatedPartyTransactionsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RelatedPartyTransactionsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RelatedPartyTransactionsByRelatedPartyAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party, Type [Axis]",
                            "terseLabel":  "Related Party",
                            "documentation":  "Information by type of related party.  Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
                            }
                        }
                    },
                "auth_ref":  [
                    "r323",
                    "r458",
                    "r459",
                    "r475",
                    "r476",
                    "r477",
                    "r478",
                    "r479",
                    "r480",
                    "r481",
                    "r482",
                    "r483",
                    "r484",
                    "r485",
                    "r486",
                    "r550",
                    "r551",
                    "r552",
                    "r553",
                    "r554",
                    "r574",
                    "r576",
                    "r604",
                    "r765"
                    ]
                },
            "us-gaap_RelatedPartyTransactionsDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RelatedPartyTransactionsDisclosureTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRelatedParties"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions Disclosure [Text Block]",
                            "terseLabel":  "Related Parties",
                            "documentation":  "The entire disclosure for related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
                            }
                        }
                    },
                "auth_ref":  [
                    "r455",
                    "r456",
                    "r457",
                    "r459",
                    "r460",
                    "r540",
                    "r541",
                    "r542",
                    "r582",
                    "r583",
                    "r584",
                    "r602",
                    "r603"
                    ]
                },
            "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
                            "terseLabel":  "Research and Development Arrangement, Contract to Perform for Others, Type",
                            "documentation":  "Information by form of arrangement related to research and development."
                            }
                        }
                    },
                "auth_ref":  [
                    "r370",
                    "r749"
                    ]
                },
            "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
                            "terseLabel":  "Research and Development Arrangement, Contract to Perform for Others, Type",
                            "documentation":  "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others."
                            }
                        }
                    },
                "auth_ref":  [
                    "r370",
                    "r749"
                    ]
                },
            "us-gaap_ResearchAndDevelopmentExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ResearchAndDevelopmentExpense",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Research and Development Expense",
                            "terseLabel":  "Research and development expenses",
                            "totalLabel":  "Research and Development Expense, Total",
                            "documentation":  "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
                            }
                        }
                    },
                "auth_ref":  [
                    "r84",
                    "r369",
                    "r774"
                    ]
                },
            "us-gaap_ResearchAndDevelopmentExpenseMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ResearchAndDevelopmentExpenseMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockbasedCompensationExpenseDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Research and Development Expense [Member]",
                            "verboseLabel":  "Research and development",
                            "documentation":  "Primary financial statement caption in which the reported facts about research and development expense have been included."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ResearchAndDevelopmentExpensePolicy":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ResearchAndDevelopmentExpensePolicy",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Research and Development Expense, Policy [Policy Text Block]",
                            "terseLabel":  "Research and development",
                            "documentation":  "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
                            }
                        }
                    },
                "auth_ref":  [
                    "r368"
                    ]
                },
            "srt_RestatementAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "RestatementAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revision of Prior Period [Axis]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r157",
                    "r193",
                    "r194",
                    "r195",
                    "r198",
                    "r199",
                    "r202",
                    "r203",
                    "r204",
                    "r205",
                    "r207",
                    "r208",
                    "r209",
                    "r210",
                    "r211",
                    "r212",
                    "r222",
                    "r262",
                    "r263",
                    "r391",
                    "r416",
                    "r418",
                    "r419",
                    "r420",
                    "r437",
                    "r452",
                    "r453",
                    "r518",
                    "r519",
                    "r520",
                    "r521",
                    "r522",
                    "r523",
                    "r524",
                    "r525",
                    "r526",
                    "r527",
                    "r528"
                    ]
                },
            "srt_RestatementDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "RestatementDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revision of Prior Period [Domain]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r157",
                    "r193",
                    "r194",
                    "r195",
                    "r198",
                    "r199",
                    "r202",
                    "r203",
                    "r204",
                    "r205",
                    "r207",
                    "r208",
                    "r209",
                    "r210",
                    "r211",
                    "r212",
                    "r222",
                    "r262",
                    "r263",
                    "r391",
                    "r416",
                    "r418",
                    "r419",
                    "r420",
                    "r437",
                    "r452",
                    "r453",
                    "r518",
                    "r519",
                    "r520",
                    "r521",
                    "r522",
                    "r523",
                    "r524",
                    "r525",
                    "r526",
                    "r527",
                    "r528"
                    ]
                },
            "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestrictedCashAndCashEquivalentsNoncurrent",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restricted Cash and Cash Equivalents, Noncurrent",
                            "terseLabel":  "Restricted cash",
                            "totalLabel":  "Restricted Cash and Cash Equivalents, Noncurrent, Total",
                            "documentation":  "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
                            }
                        }
                    },
                "auth_ref":  [
                    "r32",
                    "r138",
                    "r189"
                    ]
                },
            "us-gaap_RestrictedCashNoncurrent":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestrictedCashNoncurrent",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restricted Cash, Noncurrent",
                            "periodEndLabel":  "Restricted cash",
                            "terseLabel":  "Restricted cash",
                            "documentation":  "Amount of cash restricted as to withdrawal or usage, classified as noncurrent.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
                            }
                        }
                    },
                "auth_ref":  [
                    "r138",
                    "r672",
                    "r683"
                    ]
                },
            "us-gaap_RestrictedStockUnitsRSUMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestrictedStockUnitsRSUMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restricted Stock Units (RSUs) [Member]",
                            "terseLabel":  "Restricted stock units (RSUs) [Member]",
                            "documentation":  "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_RestructuringAndRelatedActivitiesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestructuringAndRelatedActivitiesAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restructuring and Related Activities [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestructuringAndRelatedActivitiesDisclosureTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuring"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restructuring and Related Activities Disclosure [Text Block]",
                            "terseLabel":  "Restructuring",
                            "documentation":  "The entire disclosure for restructuring and related activities.  Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled."
                            }
                        }
                    },
                "auth_ref":  [
                    "r271",
                    "r272",
                    "r274",
                    "r277",
                    "r283"
                    ]
                },
            "us-gaap_RestructuringAndRelatedActivitiesInitiationDate":  {
                "xbrltype":  "dateItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestructuringAndRelatedActivitiesInitiationDate",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Restructuring activities, initiated date",
                            "label":  "Restructuring and Related Activities, Initiation Date",
                            "documentation":  "Date the restructuring activities were initiated or are expected to be initiated, in YYYY-MM-DD format."
                            }
                        }
                    },
                "auth_ref":  [
                    "r714",
                    "r715"
                    ]
                },
            "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated":  {
                "xbrltype":  "integerItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestructuringAndRelatedCostNumberOfPositionsEliminated",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Restructuring, number of positions eliminated",
                            "label":  "Restructuring and Related Cost, Number of Positions Eliminated",
                            "documentation":  "The number of positions eliminated during the period as a result of restructuring activities."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Restructuring, number of positions eliminated, percent",
                            "label":  "Restructuring and Related Cost, Number of Positions Eliminated, Period Percent",
                            "documentation":  "The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s)."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_RestructuringAnnualCostSavings":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "RestructuringAnnualCostSavings",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Restructuring, annual cost savings",
                            "label":  "Restructuring, annual cost savings",
                            "documentation":  "Restructuring annual cost savings."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_RestructuringCharges":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestructuringCharges",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfRestructuringChargesRecordedInSellingGeneralAndAdministrativeExpensesDetails":  {
                        "parentTag":  null,
                        "weight":  null,
                        "order":  null,
                        "root":  true
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfRestructuringChargesRecordedInSellingGeneralAndAdministrativeExpensesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restructuring Charges",
                            "terseLabel":  "Restructuring charges",
                            "totalLabel":  "Total Restructuring Expense",
                            "documentation":  "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan.  Excludes expenses related to a discontinued operation or an asset retirement obligation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5",
                    "r278",
                    "r280",
                    "r713"
                    ]
                },
            "us-gaap_RestructuringCostAndReserveAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestructuringCostAndReserveAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfActivityAndBalancesOfRestructuringReserveDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restructuring Type [Axis]",
                            "terseLabel":  "Restructuring Type",
                            "documentation":  "Information by type of restructuring cost."
                            }
                        }
                    },
                "auth_ref":  [
                    "r273",
                    "r274",
                    "r280",
                    "r281"
                    ]
                },
            "us-gaap_RestructuringCostAndReserveLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestructuringCostAndReserveLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfActivityAndBalancesOfRestructuringReserveDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfRestructuringChargesRecordedInSellingGeneralAndAdministrativeExpensesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restructuring Cost and Reserve [Line Items]",
                            "terseLabel":  "Restructuring Cost And Reserve [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    "r273",
                    "r274",
                    "r275",
                    "r276",
                    "r280",
                    "r281",
                    "r282"
                    ]
                },
            "us-gaap_RestructuringReserve":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestructuringReserve",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfActivityAndBalancesOfRestructuringReserveDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "periodEndLabel":  "Balance at December 31, 2023",
                            "periodStartLabel":  "Balance at March 31, 2023",
                            "label":  "Restructuring Reserve",
                            "totalLabel":  "Restructuring Reserve, Total",
                            "documentation":  "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan."
                            }
                        }
                    },
                "auth_ref":  [
                    "r274",
                    "r279"
                    ]
                },
            "us-gaap_RestructuringReserveAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RestructuringReserveAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfActivityAndBalancesOfRestructuringReserveDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restructuring Reserve [Abstract]",
                            "terseLabel":  "Utilization of reserve:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Retained Earnings (Accumulated Deficit)",
                            "terseLabel":  "Accumulated deficit",
                            "totalLabel":  "Retained Earnings (Accumulated Deficit), Total",
                            "documentation":  "Amount of accumulated undistributed earnings (deficit)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r91",
                    "r120",
                    "r498",
                    "r522",
                    "r527",
                    "r538",
                    "r558",
                    "r638"
                    ]
                },
            "us-gaap_RetainedEarningsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RetainedEarningsMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Retained Earnings [Member]",
                            "terseLabel":  "Accumulated Deficit [Member]",
                            "documentation":  "Accumulated undistributed earnings (deficit)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r156",
                    "r193",
                    "r194",
                    "r195",
                    "r199",
                    "r209",
                    "r211",
                    "r259",
                    "r264",
                    "r360",
                    "r361",
                    "r362",
                    "r390",
                    "r391",
                    "r409",
                    "r411",
                    "r412",
                    "r415",
                    "r418",
                    "r518",
                    "r520",
                    "r545",
                    "r777"
                    ]
                },
            "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RevenueFromContractWithCustomerExcludingAssessedTax",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue from Contract with Customer, Excluding Assessed Tax",
                            "terseLabel":  "Total Revenues",
                            "verboseLabel":  "Revenue recognized",
                            "documentation":  "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.  Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
                            }
                        }
                    },
                "auth_ref":  [
                    "r226",
                    "r227",
                    "r231",
                    "r234",
                    "r235",
                    "r239",
                    "r240",
                    "r241",
                    "r314",
                    "r315",
                    "r469"
                    ]
                },
            "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RevenueFromContractWithCustomerPolicyTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue from Contract with Customer [Policy Text Block]",
                            "terseLabel":  "Revenue recognition",
                            "documentation":  "Disclosure of accounting policy for revenue from contract with customer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r154",
                    "r306",
                    "r307",
                    "r308",
                    "r309",
                    "r310",
                    "r311",
                    "r312",
                    "r313",
                    "r616"
                    ]
                },
            "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList":  {
                "xbrltype":  "enumerationSetItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
                            "terseLabel":  "Revenue From Contract With Customer Product And Service [Extensible List]",
                            "documentation":  "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer."
                            }
                        }
                    },
                "auth_ref":  [
                    "r627"
                    ]
                },
            "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
                            "terseLabel":  "Operating lease liabilities arising from obtaining right-of-use assets",
                            "documentation":  "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
                            }
                        }
                    },
                "auth_ref":  [
                    "r448",
                    "r637"
                    ]
                },
            "us-gaap_RisksAndUncertaintiesAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "RisksAndUncertaintiesAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Risks and Uncertainties [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_RoyaltyFeesPercentageMaximum":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "RoyaltyFeesPercentageMaximum",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Royalty fees percentage maximum.",
                            "label":  "Royalty Fees Percentage Maximum",
                            "terseLabel":  "Royalty fees percentage maximum"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_RoyaltyFeesPercentageMinimum":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "RoyaltyFeesPercentageMinimum",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Royalty fees percentage minimum.",
                            "label":  "Royalty Fees Percentage Minimum",
                            "terseLabel":  "Royalty fees percentage minimum"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_RoyaltyPaymentsUnderLicenseAgreementDueYearTwo":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "RoyaltyPaymentsUnderLicenseAgreementDueYearTwo",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Royalty payments under license agreement due year two.",
                            "label":  "Royalty Payments Under License Agreement Due Year Two",
                            "terseLabel":  "Minimum annual royalty payment due"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SaleOfStockNameOfTransactionDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SaleOfStockNameOfTransactionDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale of Stock [Domain]",
                            "terseLabel":  "Sale of Stock",
                            "documentation":  "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_SalesBasedRoyaltiesMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "SalesBasedRoyaltiesMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Sales Based Royalties Member",
                            "label":  "Sales Based Royalties [Member]",
                            "documentation":  "Sales based royalties member."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_SalesOfEquitySecurities":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "SalesOfEquitySecurities",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows":  {
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Sales of equity securities",
                            "label":  "Sales Of Equity Securities",
                            "documentation":  "Sales of equity securities."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_SalkInstituteForBiologicalStudiesMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "SalkInstituteForBiologicalStudiesMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Salk Institute for Biological Studies Member",
                            "documentation":  "Salk institute for biological studies.",
                            "label":  "Salk Institute for Biological Studies [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_SanDiegoPermanentLeaseMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "SanDiegoPermanentLeaseMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "San Diego permanent lease.",
                            "label":  "San Diego Permanent Lease [Member]",
                            "terseLabel":  "San Diego Permanent Lease [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_SanDiegoTemporaryLeaseMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "SanDiegoTemporaryLeaseMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "San Diego temporary lease.",
                            "label":  "San Diego Temporary Lease [Member]",
                            "terseLabel":  "San Diego Temporary Lease [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "srt_ScenarioPreviouslyReportedMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "ScenarioPreviouslyReportedMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Previously Reported [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    "r157",
                    "r193",
                    "r195",
                    "r198",
                    "r199",
                    "r202",
                    "r203",
                    "r211",
                    "r222",
                    "r391",
                    "r416",
                    "r418",
                    "r419",
                    "r437",
                    "r518",
                    "r519",
                    "r520",
                    "r521",
                    "r522",
                    "r523",
                    "r524",
                    "r525",
                    "r526",
                    "r527",
                    "r528",
                    "r665",
                    "r667",
                    "r668",
                    "r669",
                    "r689",
                    "r707",
                    "r708",
                    "r756",
                    "r762",
                    "r763"
                    ]
                },
            "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfAccruedLiabilitiesTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureAccruedExpensesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Accrued Liabilities [Table Text Block]",
                            "terseLabel":  "Summary of Accrued Expenses",
                            "documentation":  "Tabular disclosure of the components of accrued liabilities."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfAvailableForSaleSecuritiesLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementSummaryOfInvestmentsInDebtSecuritiesThatAreMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Securities, Available-for-Sale [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    "r244",
                    "r245",
                    "r246",
                    "r247",
                    "r248",
                    "r249",
                    "r250",
                    "r251",
                    "r252",
                    "r253",
                    "r254",
                    "r255"
                    ]
                },
            "onvo_ScheduleOfCapitalizedLicenseFeesTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ScheduleOfCapitalizedLicenseFeesTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of capitalized license fees.",
                            "label":  "Schedule Of Capitalized License Fees Table [Text Block]",
                            "terseLabel":  "Schedule of Capitalized License Fees"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
                            "terseLabel":  "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]",
                            "documentation":  "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
                            }
                        }
                    },
                "auth_ref":  [
                    "r401"
                    ]
                },
            "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureIncomeTaxesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
                            "terseLabel":  "Summary of Net Deferred Tax Assets",
                            "documentation":  "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r128"
                    ]
                },
            "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureIncomeTaxesTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
                            "terseLabel":  "Summary of Reconciliation of Statutory Federal Rate and Effective Rate for Operations",
                            "documentation":  "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
                            }
                        }
                    },
                "auth_ref":  [
                    "r127"
                    ]
                },
            "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityScheduleOfStockbasedCompensationExpenseDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
                            "terseLabel":  "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
                            "documentation":  "Disclosure of information about amount recognized for award under share-based payment arrangement.  Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
                            }
                        }
                    },
                "auth_ref":  [
                    "r69"
                    ]
                },
            "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
                            "terseLabel":  "Schedule of Stock-based Compensation Expense",
                            "documentation":  "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position.  Includes, but is not limited to, corresponding line item in financial statement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r69"
                    ]
                },
            "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfFiniteLivedIntangibleAssetsTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsScheduleOfCapitalizedLicenseFeesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Finite-Lived Intangible Assets [Table]",
                            "terseLabel":  "Schedule Of Finite Lived Intangible Assets [Table]",
                            "documentation":  "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
                            }
                        }
                    },
                "auth_ref":  [
                    "r45",
                    "r46",
                    "r470"
                    ]
                },
            "onvo_ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Schedule of Investments in Equity Securities Measured at Fair Value [Line Items)",
                            "label":  "Schedule Of Investments In Equity Securities Measured At Fair Value [Line Items]",
                            "documentation":  "Schedule of investments in equity securities measured at fair value."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ScheduleOfInvestmentsInEquitySecuritiesMeasuredAtFairValueTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Schedule of Activity for Investments in Equity Securities Measured at Fair Value",
                            "label":  "Schedule Of Investments In Equity Securities Measured At Fair Value Table [Text Block]",
                            "documentation":  "Schedule of investments in equity securities measured at fair value."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Related Party Transactions, by Related Party [Table]",
                            "terseLabel":  "Schedule Of Related Party Transactions By Related Party [Table]",
                            "documentation":  "Schedule of quantitative and qualitative information pertaining to related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
                            }
                        }
                    },
                "auth_ref":  [
                    "r81",
                    "r82",
                    "r580",
                    "r581",
                    "r584"
                    ]
                },
            "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfRestructuringAndRelatedCostsTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfActivityAndBalancesOfRestructuringReserveDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfRestructuringChargesRecordedInSellingGeneralAndAdministrativeExpensesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Restructuring and Related Costs [Table]",
                            "terseLabel":  "Schedule Of Restructuring And Related Costs [Table]",
                            "documentation":  "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
                            }
                        }
                    },
                "auth_ref":  [
                    "r273",
                    "r274",
                    "r275",
                    "r276",
                    "r280",
                    "r281",
                    "r282"
                    ]
                },
            "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfRestructuringAndRelatedCostsTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restructuring and Related Costs [Table Text Block]",
                            "terseLabel":  "Summary of Restructuring Charges Recorded in Selling, General and Administrative Expenses",
                            "documentation":  "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets."
                            }
                        }
                    },
                "auth_ref":  [
                    "r51",
                    "r53",
                    "r54"
                    ]
                },
            "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
                            "terseLabel":  "Summary of Activity and Balances of Restructuring Reserve",
                            "documentation":  "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost.  This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities.  This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r52",
                    "r55"
                    ]
                },
            "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockPurchasePlanParentheticalDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
                            "terseLabel":  "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
                            "documentation":  "Disclosure of information about share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r326",
                    "r328",
                    "r329",
                    "r330",
                    "r331",
                    "r333",
                    "r334",
                    "r335",
                    "r336",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r342",
                    "r343",
                    "r344",
                    "r345",
                    "r346",
                    "r347",
                    "r348",
                    "r349",
                    "r350",
                    "r353",
                    "r354",
                    "r355",
                    "r356",
                    "r357"
                    ]
                },
            "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
                            "terseLabel":  "Summary of Stock Option Activity",
                            "documentation":  "Tabular disclosure for stock option plans.  Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
                            }
                        }
                    },
                "auth_ref":  [
                    "r12",
                    "r14",
                    "r68"
                    ]
                },
            "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
                            "terseLabel":  "Fair Value of Employee Stock Options",
                            "documentation":  "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
                            }
                        }
                    },
                "auth_ref":  [
                    "r126"
                    ]
                },
            "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
                            "terseLabel":  "Summary of Company's RSUs Activity",
                            "documentation":  "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ScheduleOfStockByClassTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ScheduleOfStockByClassTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Stock by Class [Table]",
                            "terseLabel":  "Schedule Of Stock By Class [Table]",
                            "documentation":  "Schedule detailing information related to equity by class of stock.  Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r56",
                    "r57",
                    "r58",
                    "r59",
                    "r60",
                    "r61",
                    "r62",
                    "r118",
                    "r119",
                    "r120",
                    "r168",
                    "r169",
                    "r170",
                    "r224",
                    "r298",
                    "r299",
                    "r300",
                    "r301",
                    "r302",
                    "r303",
                    "r304",
                    "r534",
                    "r535",
                    "r536",
                    "r537",
                    "r626",
                    "r663",
                    "r684"
                    ]
                },
            "onvo_ScheduleOfSummaryOfSignificantAccountingPolicyTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ScheduleOfSummaryOfSignificantAccountingPolicyTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureInvestmentsAndFairValueMeasurementScheduleOfActivityForInvestmentsInEquitySecuritiesMeasuredAtFairValueDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Schedule Of Summary Of Significant Accounting Policy [Table]",
                            "label":  "Schedule Of Summary Of Significant Accounting Policy [Table]",
                            "documentation":  "Schedule of summary of significant accounting policy."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_Security12bTitle":  {
                "xbrltype":  "securityTitleItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "Security12bTitle",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of 12(b) Security",
                            "terseLabel":  "Title of 12(b) Security",
                            "documentation":  "Title of a 12(b) registered security."
                            }
                        }
                    },
                "auth_ref":  [
                    "r652"
                    ]
                },
            "dei_SecurityExchangeName":  {
                "xbrltype":  "edgarExchangeCodeItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "SecurityExchangeName",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Security Exchange Name",
                            "terseLabel":  "Security Exchange Name",
                            "documentation":  "Name of the Exchange on which a security is registered."
                            }
                        }
                    },
                "auth_ref":  [
                    "r655"
                    ]
                },
            "us-gaap_SellingGeneralAndAdministrativeExpense":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SellingGeneralAndAdministrativeExpense",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss":  {
                        "parentTag":  "us-gaap_CostsAndExpenses",
                        "weight":  1.0,
                        "order":  1.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Selling, General and Administrative Expense",
                            "terseLabel":  "Selling, general, and administrative expenses",
                            "totalLabel":  "Selling, General and Administrative Expense, Total",
                            "documentation":  "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses.  Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products.  Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges.  General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
                            }
                        }
                    },
                "auth_ref":  [
                    "r99"
                    ]
                },
            "us-gaap_SellingGeneralAndAdministrativeExpensesMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SellingGeneralAndAdministrativeExpensesMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfRestructuringChargesRecordedInSellingGeneralAndAdministrativeExpensesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Selling, General and Administrative Expenses [Member]",
                            "terseLabel":  "Selling, General and Administrative Expenses [Member]",
                            "documentation":  "Primary financial statement caption encompassing selling, general and administrative expense."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SeveranceCosts1":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SeveranceCosts1",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfRestructuringChargesRecordedInSellingGeneralAndAdministrativeExpensesDetails":  {
                        "parentTag":  "us-gaap_RestructuringCharges",
                        "weight":  1.0,
                        "order":  0.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfRestructuringChargesRecordedInSellingGeneralAndAdministrativeExpensesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Severance costs",
                            "label":  "Severance Costs",
                            "verboseLabel":  "Severance for Involuntary Employee Terminations",
                            "documentation":  "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan.  Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
                            }
                        }
                    },
                "auth_ref":  [
                    "r5"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement, Accelerated Cost",
                            "terseLabel":  "Expense recorded",
                            "documentation":  "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Description",
                            "terseLabel":  "Description of plan",
                            "documentation":  "Description of terms of share-based payment arrangement.  Includes, but is not limited to, type of award or grantee and reason for issuance."
                            }
                        }
                    },
                "auth_ref":  [
                    "r65",
                    "r67"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date",
                            "terseLabel":  "Fair market value at discount",
                            "documentation":  "Discount rate from fair value on purchase date that participants pay for shares."
                            }
                        }
                    },
                "auth_ref":  [
                    "r66"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Cancelled / forfeited, Weighted Average Price",
                            "documentation":  "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
                            }
                        }
                    },
                "auth_ref":  [
                    "r346"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
                            "verboseLabel":  "Granted, Number of Shares",
                            "documentation":  "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r344"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Granted, Weighted Average Price",
                            "documentation":  "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r344"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
                            "periodEndLabel":  "Ending balance, Unvested, Number of Shares",
                            "periodStartLabel":  "Beginning balance, Unvested, Number of Shares",
                            "terseLabel":  "Number of shares allocated",
                            "documentation":  "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
                            }
                        }
                    },
                "auth_ref":  [
                    "r341",
                    "r342"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
                            "periodEndLabel":  "Ending balance, Unvested, Weighted Average Price",
                            "periodStartLabel":  "Beginning balance, Unvested, Weighted Average Price",
                            "documentation":  "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement.  Excludes share and unit options."
                            }
                        }
                    },
                "auth_ref":  [
                    "r341",
                    "r342"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
                            "negatedLabel":  "Vested, Number of Shares",
                            "documentation":  "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r345"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Vested, Weighted Average Price",
                            "documentation":  "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r345"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
                            "terseLabel":  "Dividend yield",
                            "documentation":  "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
                            }
                        }
                    },
                "auth_ref":  [
                    "r355"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
                            "terseLabel":  "Volatility",
                            "documentation":  "The estimated measure of the percentage by which a share price is expected to fluctuate during a period.  Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean.  The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period.  That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r354"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
                            "terseLabel":  "Risk-free interest rate",
                            "documentation":  "The risk-free interest rate assumption that is used in valuing an option on its own shares."
                            }
                        }
                    },
                "auth_ref":  [
                    "r356"
                    ]
                },
            "onvo_ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialOfferingPeriod":  {
                "xbrltype":  "gYearMonthItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardInitialOfferingPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share based compensation arrangement by share based payment award initial offering period.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Initial Offering Period",
                            "terseLabel":  "Initial offering period"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockPurchasePlanParentheticalDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
                            "terseLabel":  "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    "r326",
                    "r328",
                    "r329",
                    "r330",
                    "r331",
                    "r333",
                    "r334",
                    "r335",
                    "r336",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r342",
                    "r343",
                    "r344",
                    "r345",
                    "r346",
                    "r347",
                    "r348",
                    "r349",
                    "r350",
                    "r353",
                    "r354",
                    "r355",
                    "r356",
                    "r357"
                    ]
                },
            "onvo_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumAmountPerEmployee",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share based compensation arrangement by share based payment award maximum amount per employee.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Maximum Amount Per Employee",
                            "terseLabel":  "Compensation amount per employee"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
                            "terseLabel":  "Employee subscription rate",
                            "documentation":  "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan."
                            }
                        }
                    },
                "auth_ref":  [
                    "r66"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
                            "terseLabel":  "Number of shares per employee",
                            "documentation":  "The highest quantity of shares an employee can purchase under the plan per period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r66"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations",
                            "negatedLabel":  "Cancelled / forfeited, Number of Shares",
                            "totalLabel":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations, Total",
                            "documentation":  "Number of shares under non-option equity instrument agreements that were either cancelled or expired."
                            }
                        }
                    },
                "auth_ref":  [
                    "r11"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
                            "terseLabel":  "Common shares authorized to be issued",
                            "documentation":  "Number of shares authorized for issuance under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r633"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
                            "terseLabel":  "Shares available for issuance",
                            "verboseLabel":  "Shares remaining available for purchase under ESPP",
                            "documentation":  "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
                            }
                        }
                    },
                "auth_ref":  [
                    "r66"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
                            "terseLabel":  "Vested and Exercisable, Options Outstanding",
                            "documentation":  "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
                            }
                        }
                    },
                "auth_ref":  [
                    "r335"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
                            "terseLabel":  "Vested and Exercisable, Weighted-Average Exercise Price",
                            "documentation":  "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
                            }
                        }
                    },
                "auth_ref":  [
                    "r335"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
                            "terseLabel":  "Options Exercised, Aggregate Intrinsic Value",
                            "documentation":  "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
                            }
                        }
                    },
                "auth_ref":  [
                    "r348"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Expired, Options Outstanding",
                            "terseLabel":  "Expired, Options Outstanding",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
                            "documentation":  "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
                            }
                        }
                    },
                "auth_ref":  [
                    "r340"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
                            "negatedLabel":  "Canceled, Options Outstanding",
                            "totalLabel":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total",
                            "documentation":  "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
                            }
                        }
                    },
                "auth_ref":  [
                    "r728"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Options canceled, Weighted-Average Exercise Price",
                            "documentation":  "Weighted average price of options that were either forfeited or expired."
                            }
                        }
                    },
                "auth_ref":  [
                    "r728"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "negatedLabel":  "Cancelled / forfeited, Options Outstanding",
                            "terseLabel":  "Voluntarily forfeited outstanding stock options",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
                            "documentation":  "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
                            }
                        }
                    },
                "auth_ref":  [
                    "r339"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
                            "terseLabel":  "Stock options granted",
                            "totalLabel":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total",
                            "documentation":  "Net number of share options (or share units) granted during the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r729"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
                            "verboseLabel":  "Granted, Options Outstanding",
                            "documentation":  "Gross number of share options (or share units) granted during the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r337"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
                            "terseLabel":  "Weighted average grant date fair value",
                            "documentation":  "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
                            }
                        }
                    },
                "auth_ref":  [
                    "r347"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
                            "periodEndLabel":  "Aggregate Intrinsic Value, Options Ending balance",
                            "periodStartLabel":  "Aggregate Intrinsic Value, Options Beginning balance",
                            "documentation":  "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
                            }
                        }
                    },
                "auth_ref":  [
                    "r66"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
                            "periodEndLabel":  "Options Outstanding, Ending balance",
                            "periodStartLabel":  "Options Outstanding, Beginning balance",
                            "documentation":  "Number of options outstanding, including both vested and non-vested options."
                            }
                        }
                    },
                "auth_ref":  [
                    "r333",
                    "r334"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
                            "periodEndLabel":  "Weighted-Average Exercise Price, Options Ending balance",
                            "periodStartLabel":  "Weighted-Average Exercise Price, Options Beginning balance",
                            "documentation":  "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
                            }
                        }
                    },
                "auth_ref":  [
                    "r333",
                    "r334"
                    ]
                },
            "onvo_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share based compensation arrangement by share based payment award purchase period.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Purchase Period",
                            "terseLabel":  "Purchase period"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
                            "terseLabel":  "Common stock shares issued",
                            "documentation":  "Number of shares issued under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r66"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockbasedCompensationExpenseAndValuationInformationAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfCompanysRsusActivityDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquityTables"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Award Type [Domain]",
                            "terseLabel":  "Award Type",
                            "documentation":  "Award under share-based payment arrangement."
                            }
                        }
                    },
                "auth_ref":  [
                    "r329",
                    "r330",
                    "r331",
                    "r333",
                    "r334",
                    "r335",
                    "r336",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r342",
                    "r343",
                    "r344",
                    "r345",
                    "r346",
                    "r347",
                    "r348",
                    "r349",
                    "r350",
                    "r353",
                    "r354",
                    "r355",
                    "r356",
                    "r357"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
                            "verboseLabel":  "Options exercised, Weighted-Average Exercise Price",
                            "documentation":  "Weighted average price at which option holders acquired shares when converting their stock options into shares."
                            }
                        }
                    },
                "auth_ref":  [
                    "r338"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Options expired, Weighted-Average Exercise Price",
                            "label":  "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
                            "documentation":  "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
                            }
                        }
                    },
                "auth_ref":  [
                    "r340"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Options cancelled / forfeited, Weighted-Average Exercise Price",
                            "label":  "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
                            "documentation":  "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
                            }
                        }
                    },
                "auth_ref":  [
                    "r339"
                    ]
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
                            "verboseLabel":  "Options granted, Weighted-Average Exercise Price",
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
                            }
                        }
                    },
                "auth_ref":  [
                    "r337"
                    ]
                },
            "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareBasedCompensationOptionAndIncentivePlansPolicy",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Payment Arrangement [Policy Text Block]",
                            "terseLabel":  "Stock-based compensation",
                            "documentation":  "Disclosure of accounting policy for award under share-based payment arrangement.  Includes, but is not limited to, methodology and assumption used in measuring cost."
                            }
                        }
                    },
                "auth_ref":  [
                    "r325",
                    "r332",
                    "r351",
                    "r352",
                    "r353",
                    "r354",
                    "r357",
                    "r363",
                    "r364",
                    "r365",
                    "r366"
                    ]
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
                            "terseLabel":  "Termination period of Equity Incentive Plan",
                            "documentation":  "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
                            }
                        }
                    },
                "auth_ref":  [
                    "r632"
                    ]
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEmployeeStockOptionsDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityFairValueOfEsppSharesDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
                            "terseLabel":  "Expected life of options",
                            "documentation":  "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
                            }
                        }
                    },
                "auth_ref":  [
                    "r353"
                    ]
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
                            "terseLabel":  "Vested and Exercisable, Aggregate Intrinsic Value",
                            "documentation":  "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
                            }
                        }
                    },
                "auth_ref":  [
                    "r66"
                    ]
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Weighted-average remaining contractual term of stock options exercisable",
                            "documentation":  "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
                            }
                        }
                    },
                "auth_ref":  [
                    "r66"
                    ]
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Unvested, cancelled shares",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
                            "documentation":  "Number of non-vested options forfeited."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2":  {
                "xbrltype":  "durationItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Weighted-average remaining contractual term of stock options outstanding",
                            "documentation":  "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
                            }
                        }
                    },
                "auth_ref":  [
                    "r125"
                    ]
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares",
                            "terseLabel":  "Number of stock options vested",
                            "documentation":  "Number of options vested."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShareholdersEquityAndShareBasedPaymentsTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Shareholders' Equity and Share-Based Payments [Text Block]",
                            "terseLabel":  "Stockholders' Equity",
                            "documentation":  "The entire disclosure for shareholders' equity and share-based payment arrangement.  Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
                            }
                        }
                    },
                "auth_ref":  [
                    "r117",
                    "r124"
                    ]
                },
            "us-gaap_SharesIssuedPricePerShare":  {
                "xbrltype":  "perShareItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharesIssuedPricePerShare",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Shares Issued, Price Per Share",
                            "terseLabel":  "Excercise price per share",
                            "documentation":  "Per share or per unit amount of equity securities issued."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SharesOutstanding":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SharesOutstanding",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Shares, Outstanding",
                            "periodEndLabel":  "Ending balance, Shares",
                            "periodStartLabel":  "Beginning balance, Shares",
                            "documentation":  "Number of shares issued which are neither cancelled nor held in the treasury."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_ShortTermLeaseCost":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ShortTermLeaseCost",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Short-Term Lease, Cost",
                            "terseLabel":  "Short term lease cost",
                            "documentation":  "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
                            }
                        }
                    },
                "auth_ref":  [
                    "r445",
                    "r637"
                    ]
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Summary of Significant Accounting Policies",
                            "label":  "Significant Accounting Policies [Text Block]",
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r107",
                    "r190"
                    ]
                },
            "us-gaap_StateAndLocalJurisdictionMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StateAndLocalJurisdictionMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "State and Local Jurisdiction [Member]",
                            "terseLabel":  "State [Member]",
                            "documentation":  "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_StateNetOperatingLossCarryForwardsExpirationYearStart":  {
                "xbrltype":  "gYearItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "StateNetOperatingLossCarryForwardsExpirationYearStart",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "State net operating loss carry forwards expiration year start.",
                            "label":  "State Net Operating Loss Carry Forwards Expiration Year Start",
                            "verboseLabel":  "State net operating loss carryforwards (\u201cNOLs\u201d) expiring year"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementEquityComponentsAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity Components [Axis]",
                            "terseLabel":  "Equity Components",
                            "documentation":  "Information by component of equity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r25",
                    "r156",
                    "r180",
                    "r181",
                    "r182",
                    "r193",
                    "r194",
                    "r195",
                    "r199",
                    "r209",
                    "r211",
                    "r223",
                    "r259",
                    "r264",
                    "r305",
                    "r360",
                    "r361",
                    "r362",
                    "r390",
                    "r391",
                    "r409",
                    "r410",
                    "r411",
                    "r412",
                    "r413",
                    "r415",
                    "r418",
                    "r430",
                    "r431",
                    "r432",
                    "r433",
                    "r434",
                    "r435",
                    "r453",
                    "r518",
                    "r519",
                    "r520",
                    "r545",
                    "r599"
                    ]
                },
            "us-gaap_StatementLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement [Line Items]",
                            "terseLabel":  "Statement [Line Items]",
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "auth_ref":  [
                    "r193",
                    "r194",
                    "r195",
                    "r223",
                    "r469",
                    "r529",
                    "r546",
                    "r549",
                    "r550",
                    "r551",
                    "r552",
                    "r553",
                    "r554",
                    "r557",
                    "r560",
                    "r561",
                    "r562",
                    "r563",
                    "r564",
                    "r565",
                    "r566",
                    "r567",
                    "r568",
                    "r570",
                    "r571",
                    "r572",
                    "r573",
                    "r574",
                    "r576",
                    "r578",
                    "r579",
                    "r585",
                    "r586",
                    "r587",
                    "r588",
                    "r589",
                    "r590",
                    "r591",
                    "r592",
                    "r593",
                    "r594",
                    "r595",
                    "r596",
                    "r599",
                    "r644"
                    ]
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementOfCashFlowsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementOfFinancialPositionAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Financial Position [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementOfStockholdersEquityAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Stockholders' Equity [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_StatementTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StatementTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement [Table]",
                            "terseLabel":  "Statement [Table]",
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
                            }
                        }
                    },
                "auth_ref":  [
                    "r193",
                    "r194",
                    "r195",
                    "r223",
                    "r469",
                    "r529",
                    "r546",
                    "r549",
                    "r550",
                    "r551",
                    "r552",
                    "r553",
                    "r554",
                    "r557",
                    "r560",
                    "r561",
                    "r562",
                    "r563",
                    "r564",
                    "r565",
                    "r566",
                    "r567",
                    "r568",
                    "r570",
                    "r571",
                    "r572",
                    "r573",
                    "r574",
                    "r576",
                    "r578",
                    "r579",
                    "r585",
                    "r586",
                    "r587",
                    "r588",
                    "r589",
                    "r590",
                    "r591",
                    "r592",
                    "r593",
                    "r594",
                    "r595",
                    "r596",
                    "r599",
                    "r644"
                    ]
                },
            "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
                            "verboseLabel":  "Shares issued under ESPP",
                            "documentation":  "Number of shares issued during the period as a result of an employee stock purchase plan."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r88",
                    "r89",
                    "r120"
                    ]
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "verboseLabel":  "Common stock, shares issued",
                            "label":  "Stock Issued During Period, Shares, New Issues",
                            "terseLabel":  "Issuance of common stock from stock options exercises, net, Shares",
                            "documentation":  "Number of new stock issued during the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r88",
                    "r89",
                    "r120",
                    "r534",
                    "r599",
                    "r612"
                    ]
                },
            "onvo_StockIssuedDuringPeriodSharesPublicOffering":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "StockIssuedDuringPeriodSharesPublicOffering",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period shares public offering.",
                            "label":  "Stock Issued During Period Shares Public Offering",
                            "terseLabel":  "Issuance of common stock from public offering, Shares"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
                            "terseLabel":  "Stock option exercises, Shares",
                            "verboseLabel":  "Exercised, Options Outstanding",
                            "documentation":  "Number of share options (or share units) exercised during the current period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r88",
                    "r89",
                    "r120",
                    "r338"
                    ]
                },
            "onvo_StockIssuedDuringPeriodSharesUnderEmployeeAndDirectorStockOptionRSUAndPurchasePlans":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "StockIssuedDuringPeriodSharesUnderEmployeeAndDirectorStockOptionRSUAndPurchasePlans",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period shares under employee and director stock option RSU and purchase plans.",
                            "label":  "Stock Issued During Period Shares Under Employee And Director Stock Option R S U And Purchase Plans",
                            "terseLabel":  "Issuance of common stock under employee and director stock option, RSU and purchase plans, Shares"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stock Issued During Period, Value, New Issues",
                            "terseLabel":  "Value of shares sold under equity distribution agreement",
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r88",
                    "r89",
                    "r120",
                    "r545",
                    "r599",
                    "r612",
                    "r650"
                    ]
                },
            "onvo_StockIssuedDuringPeriodValuePublicOffering":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "StockIssuedDuringPeriodValuePublicOffering",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period value public offering.",
                            "label":  "Stock Issued During Period Value Public Offering",
                            "terseLabel":  "Issuance of common stock from public offering, net"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_StockIssuedDuringPeriodValueUnderEmployeeAndDirectorStockOptionRSUAndPurchasePlans":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "StockIssuedDuringPeriodValueUnderEmployeeAndDirectorStockOptionRSUAndPurchasePlans",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock issued during period value under employee and director stock option RSU and purchase plans.",
                            "label":  "Stock Issued During Period Value Under Employee And Director Stock Option R S U And Purchase Plans",
                            "terseLabel":  "Issuance of common stock under employee and director stock option, RSU and purchase plans"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_StockholdersEquity":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockholdersEquity",
                "crdr":  "credit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0,
                        "order":  2.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity, Attributable to Parent",
                            "totalLabel":  "Total stockholders' equity",
                            "periodStartLabel":  "Stockholders' Equity Attributable to Parent, Beginning Balance",
                            "periodEndLabel":  "Stockholders' Equity Attributable to Parent, Ending Balance",
                            "documentation":  "Amount of equity (deficit) attributable to parent.  Excludes temporary equity and equity attributable to noncontrolling interest."
                            }
                        }
                    },
                "auth_ref":  [
                    "r89",
                    "r92",
                    "r93",
                    "r110",
                    "r559",
                    "r575",
                    "r600",
                    "r601",
                    "r638",
                    "r651",
                    "r685",
                    "r706",
                    "r757",
                    "r777"
                    ]
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockholdersEquityAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity, Attributable to Parent [Abstract]",
                            "terseLabel":  "Stockholders' Equity"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity, Including Portion Attributable to Noncontrolling Interest",
                            "periodEndLabel":  "Ending balance",
                            "periodStartLabel":  "Beginning balance",
                            "totalLabel":  "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Total",
                            "documentation":  "Amount of equity (deficit) attributable to parent and noncontrolling interest.  Excludes temporary equity."
                            }
                        }
                    },
                "auth_ref":  [
                    "r78",
                    "r79",
                    "r80",
                    "r156",
                    "r157",
                    "r181",
                    "r193",
                    "r194",
                    "r195",
                    "r199",
                    "r209",
                    "r259",
                    "r264",
                    "r305",
                    "r360",
                    "r361",
                    "r362",
                    "r390",
                    "r391",
                    "r409",
                    "r410",
                    "r411",
                    "r412",
                    "r413",
                    "r415",
                    "r418",
                    "r430",
                    "r431",
                    "r435",
                    "r453",
                    "r519",
                    "r520",
                    "r543",
                    "r559",
                    "r575",
                    "r600",
                    "r601",
                    "r613",
                    "r650",
                    "r685",
                    "r706",
                    "r757",
                    "r777"
                    ]
                },
            "onvo_SublicenseAgreementsMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "SublicenseAgreementsMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Sublicense Agreements Member",
                            "documentation":  "Sublicense agreements.",
                            "label":  "Sublicense Agreements [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SubsequentEventLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsequentEventLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Event [Line Items]",
                            "documentation":  "Detail information of subsequent event by type.  User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
                            }
                        }
                    },
                "auth_ref":  [
                    "r436",
                    "r462"
                    ]
                },
            "us-gaap_SubsequentEventMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsequentEventMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Subsequent Event [Member]",
                            "label":  "Subsequent Event [Member]",
                            "documentation":  "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
                            }
                        }
                    },
                "auth_ref":  [
                    "r436",
                    "r462"
                    ]
                },
            "us-gaap_SubsequentEventTable":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsequentEventTable",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Event [Table]",
                            "documentation":  "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
                            }
                        }
                    },
                "auth_ref":  [
                    "r436",
                    "r462"
                    ]
                },
            "us-gaap_SubsequentEventTypeAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsequentEventTypeAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Event Type [Axis]",
                            "documentation":  "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
                            }
                        }
                    },
                "auth_ref":  [
                    "r436",
                    "r462"
                    ]
                },
            "us-gaap_SubsequentEventTypeDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsequentEventTypeDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Event Type [Domain]",
                            "documentation":  "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
                            }
                        }
                    },
                "auth_ref":  [
                    "r436",
                    "r462"
                    ]
                },
            "us-gaap_SubsequentEventsAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsequentEventsAbstract",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events [Abstract]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SubsequentEventsTextBlock":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsequentEventsTextBlock",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureSubsequentEvents"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events [Text Block]",
                            "terseLabel":  "Subsequent Events",
                            "documentation":  "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.  Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
                            }
                        }
                    },
                "auth_ref":  [
                    "r461",
                    "r463"
                    ]
                },
            "us-gaap_SubsidiarySaleOfStockAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SubsidiarySaleOfStockAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale of Stock [Axis]",
                            "terseLabel":  "Sale of Stock",
                            "documentation":  "Information by type of sale of the entity's stock."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_SummaryOfSignificantAccountingPoliciesLineItems":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "SummaryOfSignificantAccountingPoliciesLineItems",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Summary of significant accounting policies.",
                            "label":  "Summary Of Significant Accounting Policies [Line Items]",
                            "terseLabel":  "Summary Of Significant Accounting Policies [Line Items]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_SupplementalCashFlowInformationAbstract":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "SupplementalCashFlowInformationAbstract",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Supplemental Cash Flow Information [Abstract]",
                            "terseLabel":  "Supplemental Disclosure of Cash Flow Information:"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "srt_TitleOfIndividualAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "TitleOfIndividualAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of Individual [Axis]",
                            "terseLabel":  "Title of Individual"
                            }
                        }
                    },
                "auth_ref":  [
                    "r690",
                    "r764"
                    ]
                },
            "srt_TitleOfIndividualWithRelationshipToEntityDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/srt/2023",
                "localname":  "TitleOfIndividualWithRelationshipToEntityDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of Individual [Domain]",
                            "terseLabel":  "Title of Individual"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "dei_TradingSymbol":  {
                "xbrltype":  "tradingSymbolItemType",
                "nsuri":  "http://xbrl.sec.gov/dei/2023",
                "localname":  "TradingSymbol",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Trading Symbol",
                            "terseLabel":  "Trading Symbol",
                            "documentation":  "Trading symbol of an instrument as listed on an exchange."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_TreasuryStockCommonMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "TreasuryStockCommonMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Treasury Stock Common [Member]",
                            "label":  "Treasury Stock, Common [Member]",
                            "documentation":  "Previously issued common shares repurchased by the issuing entity and held in treasury."
                            }
                        }
                    },
                "auth_ref":  [
                    "r63"
                    ]
                },
            "us-gaap_TreasuryStockCommonShares":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "TreasuryStockCommonShares",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Treasury Stock, Common, Shares",
                            "terseLabel":  "Treasury stock, shares",
                            "documentation":  "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
                            }
                        }
                    },
                "auth_ref":  [
                    "r63"
                    ]
                },
            "us-gaap_TreasuryStockCommonValue":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "TreasuryStockCommonValue",
                "crdr":  "debit",
                "calculation":  {
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets":  {
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  -1.0,
                        "order":  4.0
                        }
                    },
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedBalanceSheets"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Treasury Stock, Common, Value",
                            "negatedLabel":  "Treasury stock, 46 shares at cost",
                            "documentation":  "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
                            }
                        }
                    },
                "auth_ref":  [
                    "r26",
                    "r63",
                    "r64"
                    ]
                },
            "us-gaap_TreasuryStockSharesAcquired":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "TreasuryStockSharesAcquired",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Treasury Stock, Shares, Acquired",
                            "negatedLabel":  "Purchase of treasury stock, shares",
                            "documentation":  "Number of shares that have been repurchased during the period and are being held in treasury."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r89",
                    "r120"
                    ]
                },
            "us-gaap_TreasuryStockValueAcquiredCostMethod":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "TreasuryStockValueAcquiredCostMethod",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Treasury Stock, Value, Acquired, Cost Method",
                            "negatedLabel":  "Purchase of treasury stock",
                            "documentation":  "Equity impact of the cost of common and preferred stock that were repurchased during the period.  Recorded using the cost method."
                            }
                        }
                    },
                "auth_ref":  [
                    "r10",
                    "r63",
                    "r120"
                    ]
                },
            "onvo_TwoThousandAndTwentyFourShelfMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "TwoThousandAndTwentyFourShelfMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "2024 Shelf [Member]",
                            "label":  "Two Thousand and Twenty Four Shelf [Member]",
                            "documentation":  "2024 shelf."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_TwoThousandAndTwentyOneInducementEquityPlanMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "TwoThousandAndTwentyOneInducementEquityPlanMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two thousand and twenty one inducement equity plan.",
                            "label":  "Two Thousand And Twenty One Inducement Equity Plan [Member]",
                            "terseLabel":  "2021 Inducement Equity Plan [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_TwoThousandAndTwentyOneShelfMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "TwoThousandAndTwentyOneShelfMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two thousand and twenty one shelf.",
                            "label":  "Two Thousand And Twenty One Shelf [Member]",
                            "terseLabel":  "2021 Shelf [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_TwoThousandAndTwentyTwoInducementEquityPlanMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "TwoThousandAndTwentyTwoInducementEquityPlanMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two thousand and twenty two inducement equity plan.",
                            "label":  "Two Thousand And Twenty Two Inducement Equity Plan [Member]",
                            "terseLabel":  "2022 Inducement Equity Plan [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_TwoThousandEighteenSalesAgreementMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "TwoThousandEighteenSalesAgreementMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "2018 sales agreement.",
                            "label":  "Two Thousand Eighteen Sales Agreement [Member]",
                            "terseLabel":  "2018 Sales Agreement [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_TwoThousandTwelvePlanMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "TwoThousandTwelvePlanMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two thousand twelve plan.",
                            "label":  "Two Thousand Twelve Plan [Member]",
                            "terseLabel":  "2012 Plan [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_TwoThousandTwentyThreeEmployeeStockPurchasePlanMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "TwoThousandTwentyThreeEmployeeStockPurchasePlanMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityCommonStockReservedForFutureIssuanceDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "2023 Employee Stock Purchase Plan [Member]",
                            "label":  "Two Thousand Twenty Three Employee Stock Purchase Plan [Member]",
                            "documentation":  "2023 Employee Stock Purchase Plan."
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_TypeOfArrangementAxis":  {
                "xbrltype":  "stringItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "TypeOfArrangementAxis",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
                            "documentation":  "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
                            }
                        }
                    },
                "auth_ref":  [
                    "r401"
                    ]
                },
            "us-gaap_TypeOfRestructuringDomain":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "TypeOfRestructuringDomain",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringAdditionalInformationDetails",
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureRestructuringSummaryOfActivityAndBalancesOfRestructuringReserveDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Type of Restructuring [Domain]",
                            "terseLabel":  "Type of Restructuring",
                            "documentation":  "Identification of the types of restructuring costs."
                            }
                        }
                    },
                "auth_ref":  [
                    "r273",
                    "r274",
                    "r280",
                    "r281"
                    ]
                },
            "onvo_UniversityOfMissouriMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "UniversityOfMissouriMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "University of Missouri Member",
                            "documentation":  "University of Missouri.",
                            "label":  "University Of Missouri [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_UnrealizedGainLossOnSharesAvailableForSaleSecurities":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "UnrealizedGainLossOnSharesAvailableForSaleSecurities",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "terseLabel":  "Unrealized gain (loss) on available-for-sale debt securities, Shares",
                            "documentation":  "Unrealized gain (loss) on shares available-for-sale securities",
                            "label":  "Unrealized Gain (Loss) on Shares Available-for-Sale Securities"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_UnrecognizedTaxBenefits":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "UnrecognizedTaxBenefits",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Unrecognized Tax Benefits",
                            "terseLabel":  "Unrecognized tax benefits",
                            "periodStartLabel":  "Unrecognized Tax Benefits, Beginning Balance",
                            "periodEndLabel":  "Unrecognized Tax Benefits, Ending Balance",
                            "documentation":  "Amount of unrecognized tax benefits."
                            }
                        }
                    },
                "auth_ref":  [
                    "r372",
                    "r380"
                    ]
                },
            "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
                            "terseLabel":  "Accrued expense regarding interest or penalties",
                            "totalLabel":  "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total",
                            "documentation":  "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
                            }
                        }
                    },
                "auth_ref":  [
                    "r379"
                    ]
                },
            "onvo_UpfrontFeePayment":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "UpfrontFeePayment",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Upfront fee payment.",
                            "label":  "Upfront Fee Payment",
                            "terseLabel":  "Upfront payment"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_UpfrontPaymentPaid":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "UpfrontPaymentPaid",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Upfront payment paid.",
                            "label":  "Upfront payment paid"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_UseOfEstimates":  {
                "xbrltype":  "textBlockItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "UseOfEstimates",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Use of Estimates, Policy [Policy Text Block]",
                            "terseLabel":  "Use of estimates",
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
                            }
                        }
                    },
                "auth_ref":  [
                    "r41",
                    "r42",
                    "r43",
                    "r141",
                    "r143",
                    "r145",
                    "r146"
                    ]
                },
            "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "ValuationAllowanceDeferredTaxAssetChangeInAmount",
                "crdr":  "credit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
                            "terseLabel":  "Increase (decrease) in valuation allowance",
                            "documentation":  "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
                            }
                        }
                    },
                "auth_ref":  [
                    "r383"
                    ]
                },
            "us-gaap_VariableLeaseCost":  {
                "xbrltype":  "monetaryItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "VariableLeaseCost",
                "crdr":  "debit",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Variable Lease, Cost",
                            "terseLabel":  "Variable lease expense",
                            "documentation":  "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
                            }
                        }
                    },
                "auth_ref":  [
                    "r446",
                    "r637"
                    ]
                },
            "onvo_VestingCriteriaProbabilityOfAchievementPercentage":  {
                "xbrltype":  "percentItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "VestingCriteriaProbabilityOfAchievementPercentage",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureStockholdersEquityStockOptionsAndEmployeeStockPurchasePlanAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Vesting criteria probability of achievement percentage.",
                            "label":  "Vesting Criteria Probability Of Achievement Percentage",
                            "terseLabel":  "Vesting criteria probability of achievement percentage"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "onvo_ViscientBiosciencesMember":  {
                "xbrltype":  "domainItemType",
                "nsuri":  "http://www.organovo.com/20240412",
                "localname":  "ViscientBiosciencesMember",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Viscient Biosciences.",
                            "label":  "Viscient Biosciences [Member]",
                            "verboseLabel":  "Viscient [Member]",
                            "terseLabel":  "Viscient [Member]"
                            }
                        }
                    },
                "auth_ref":  [
                    ]
                },
            "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "WeightedAverageNumberOfDilutedSharesOutstanding",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Weighted Average Number of Shares Outstanding, Diluted, Total",
                            "label":  "Weighted Average Number of Shares Outstanding, Diluted",
                            "terseLabel":  "Weighted average shares used in computing net loss per common share diluted",
                            "documentation":  "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r215",
                    "r220"
                    ]
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic":  {
                "xbrltype":  "sharesItemType",
                "nsuri":  "http://fasb.org/us-gaap/2023",
                "localname":  "WeightedAverageNumberOfSharesOutstandingBasic",
                "presentation":  [
                    "http://www.organovo.com/20240412/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndOtherComprehensiveLoss"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "totalLabel":  "Weighted Average Number of Shares Outstanding, Basic, Total",
                            "label":  "Weighted Average Number of Shares Outstanding, Basic",
                            "terseLabel":  "Weighted average shares used in computing net loss per common share basic",
                            "documentation":  "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
                            }
                        }
                    },
                "auth_ref":  [
                    "r214",
                    "r220"
                    ]
                }
            }
        }
    },
"std_ref":  {
    "r0":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "05",
        "Paragraph":  "4",
        "SubTopic":  "10",
        "Topic":  "360",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
        },
    "r1":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "SubTopic":  "230",
        "Topic":  "830",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
        },
    "r2":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "10A",
        "SubTopic":  "10",
        "Topic":  "220",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
        },
    "r3":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "14",
        "Subparagraph":  "(a)",
        "SubTopic":  "10",
        "Topic":  "230",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
        },
    "r4":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Subparagraph":  "(a)",
        "SubTopic":  "10",
        "Topic":  "230",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
        },
    "r5":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Subparagraph":  "(b)",
        "SubTopic":  "10",
        "Topic":  "230",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
        },
    "r6":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "SubTopic":  "10",
        "Topic":  "360",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
        },
    "r7":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "SubTopic":  "10",
        "Topic":  "825",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
        },
    "r8":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "15",
        "Subparagraph":  "(e)",
        "SubTopic":  "10",
        "Topic":  "740",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
        },
    "r9":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1A",
        "Subparagraph":  "(c),(3)",
        "SubTopic":  "10",
        "Topic":  "810",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
        },
    "r10":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "SubTopic":  "10",
        "Topic":  "505",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
        },
    "r11":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(3)-(4)",
        "SubTopic":  "10",
        "Topic":  "718",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r12":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)",
        "SubTopic":  "10",
        "Topic":  "718",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r13":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)(2)",
        "SubTopic":  "30",
        "Topic":  "350",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r14":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(e)",
        "SubTopic":  "10",
        "Topic":  "718",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r15":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2A",
        "Subparagraph":  "(a)",
        "SubTopic":  "10",
        "Topic":  "718",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
        },
    "r16":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "60",
        "Paragraph":  "1",
        "SubTopic":  "10",
        "Topic":  "820",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
        },
    "r17":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r18":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.19(a),20,24)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r19":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.19-26)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r20":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r21":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r22":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.24)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r23":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r24":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.29)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r25":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r26":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "210",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02.30)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r27":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "220",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
        },
    "r28":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "220",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "14A",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
        },
    "r29":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "220",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
        },
    "r30":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "15",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
        },
    "r31":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "25",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
        },
    "r32":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
        },
    "r33":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
        },
    "r34":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
        },
    "r35":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
        },
    "r36":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
        },
    "r37":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "230",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
        },
    "r38":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "260",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
        },
    "r39":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "260",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
        },
    "r40":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "260",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
        },
    "r41":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "275",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
        },
    "r42":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "275",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
        },
    "r43":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "275",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
        },
    "r44":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "30",
        "Section":  "45",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
        },
    "r45":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "30",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
        },
    "r46":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "30",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r47":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "350",
        "SubTopic":  "30",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r48":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "360",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
        },
    "r49":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "360",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
        },
    "r50":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "360",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
        },
    "r51":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "420",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
        },
    "r52":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "420",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
        },
    "r53":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "420",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB TOPIC 5.P.3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
        },
    "r54":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "420",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB TOPIC 5.P.4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
        },
    "r55":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "420",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB Topic 5.P.4(b)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
        },
    "r56":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "480",
        "SubTopic":  "10",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(CFRR 211.02)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
        },
    "r57":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "505",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
        },
    "r58":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "505",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
        },
    "r59":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "505",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
        },
    "r60":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "505",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
        },
    "r61":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "505",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
        },
    "r62":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "505",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
        },
    "r63":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "505",
        "SubTopic":  "30",
        "Section":  "45",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
        },
    "r64":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "505",
        "SubTopic":  "30",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
        },
    "r65":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
        },
    "r66":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r67":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r68":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r69":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(h)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r70":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "20",
        "Section":  "55",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
        },
    "r71":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "20",
        "Section":  "55",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
        },
    "r72":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "40",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480489/718-40-50-1"
        },
    "r73":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "718",
        "SubTopic":  "40",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480489/718-40-50-1"
        },
    "r74":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "740",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
        },
    "r75":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "740",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
        },
    "r76":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "740",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
        },
    "r77":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "805",
        "SubTopic":  "20",
        "Section":  "55",
        "Paragraph":  "31",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479876/805-20-55-31"
        },
    "r78":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "810",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
        },
    "r79":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "810",
        "SubTopic":  "10",
        "Section":  "45",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
        },
    "r80":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "810",
        "SubTopic":  "10",
        "Section":  "55",
        "Paragraph":  "4I",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
        },
    "r81":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "850",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
        },
    "r82":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "850",
        "SubTopic":  "10",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
        },
    "r83":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "942",
        "SubTopic":  "210",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
        },
    "r84":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "985",
        "SubTopic":  "20",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
        },
    "r85":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "205",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//205/tableOfContent"
        },
    "r86":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(26)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r87":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(26)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r88":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r89":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r90":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r91":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r92":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r93":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r94":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r95":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
        },
    "r96":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r97":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(4))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r98":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r99":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r100":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03.7(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r101":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03.7)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r102":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03.9)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r103":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "13",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
        },
    "r104":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
        },
    "r105":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
        },
    "r106":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
        },
    "r107":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "235",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//235/tableOfContent"
        },
    "r108":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "250",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//250/tableOfContent"
        },
    "r109":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "275",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//275/tableOfContent"
        },
    "r110":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
        },
    "r111":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "350",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r112":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "360",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//360/tableOfContent"
        },
    "r113":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "360",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
        },
    "r114":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "360",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
        },
    "r115":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "360",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB Topic 5.CC)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
        },
    "r116":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "440",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//440/tableOfContent"
        },
    "r117":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "505",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//505/tableOfContent"
        },
    "r118":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
        },
    "r119":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
        },
    "r120":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.3-04)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
        },
    "r121":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "710",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//710/tableOfContent"
        },
    "r122":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "712",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//712/tableOfContent"
        },
    "r123":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "715",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//715/tableOfContent"
        },
    "r124":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "718",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//718/tableOfContent"
        },
    "r125":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Section":  "50",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r126":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Section":  "50",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r127":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Section":  "50",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
        },
    "r128":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Section":  "50",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
        },
    "r129":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "810",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//810/tableOfContent"
        },
    "r130":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-03(1)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
        },
    "r131":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-03(10))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
        },
    "r132":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
        },
    "r133":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-03(15)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
        },
    "r134":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
        },
    "r135":  {
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef",
        "Topic":  "942",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
        },
    "r136":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "SubTopic":  "10",
        "Topic":  "321",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479567/321-10-45-1"
        },
    "r137":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "SubTopic":  "20",
        "Topic":  "740",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
        },
    "r138":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "5",
        "SubTopic":  "210",
        "Topic":  "954",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480632/954-210-45-5"
        },
    "r139":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
        },
    "r140":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "SubTopic":  "10",
        "Topic":  "808",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
        },
    "r141":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
        },
    "r142":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "SubTopic":  "10",
        "Topic":  "808",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
        },
    "r143":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
        },
    "r144":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "SubTopic":  "360",
        "Topic":  "958",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
        },
    "r145":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "11",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
        },
    "r146":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "12",
        "SubTopic":  "10",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
        },
    "r147":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "SubTopic":  "360",
        "Topic":  "958",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
        },
    "r148":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "SubTopic":  "360",
        "Topic":  "958",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
        },
    "r149":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(d)(1)",
        "SubTopic":  "20",
        "Topic":  "310",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
        },
    "r150":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(d)(2)",
        "SubTopic":  "20",
        "Topic":  "310",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
        },
    "r151":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.4-08(h))",
        "SubTopic":  "10",
        "Topic":  "235",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
        },
    "r152":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "250",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//250/tableOfContent"
        },
    "r153":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "275",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//275/tableOfContent"
        },
    "r154":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "606",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//606/tableOfContent"
        },
    "r155":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "808",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//808/tableOfContent"
        },
    "r156":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "105",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
        },
    "r157":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "105",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
        },
    "r158":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "105",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
        },
    "r159":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "205",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
        },
    "r160":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
        },
    "r161":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
        },
    "r162":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r163":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(13))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r164":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(14))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r165":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(16))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r166":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(18))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r167":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r168":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r169":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r170":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r171":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(30)(a)(4))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r172":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(9))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r173":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "10A",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
        },
    "r174":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
        },
    "r175":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1A",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
        },
    "r176":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1A",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
        },
    "r177":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1B",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
        },
    "r178":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1B",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
        },
    "r179":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
        },
    "r180":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
        },
    "r181":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
        },
    "r182":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
        },
    "r183":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(24))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r184":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(25))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r185":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "15",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
        },
    "r186":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-19"
        },
    "r187":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
        },
    "r188":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
        },
    "r189":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
        },
    "r190":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
        },
    "r191":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
        },
    "r192":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.4-08(h)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
        },
    "r193":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "23",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
        },
    "r194":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
        },
    "r195":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "5",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
        },
    "r196":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
        },
    "r197":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
        },
    "r198":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
        },
    "r199":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
        },
    "r200":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
        },
    "r201":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
        },
    "r202":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "11",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
        },
    "r203":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "11",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
        },
    "r204":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
        },
    "r205":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
        },
    "r206":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
        },
    "r207":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
        },
    "r208":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
        },
    "r209":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
        },
    "r210":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
        },
    "r211":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
        },
    "r212":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "5",
        "Subparagraph":  "(SAB Topic 11.M.Q2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
        },
    "r213":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480530/250-10-S99-6"
        },
    "r214":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
        },
    "r215":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
        },
    "r216":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
        },
    "r217":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "60B",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
        },
    "r218":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "60B",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
        },
    "r219":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
        },
    "r220":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
        },
    "r221":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
        },
    "r222":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
        },
    "r223":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "272",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
        },
    "r224":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "272",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
        },
    "r225":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r226":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r227":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r228":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r229":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r230":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "22",
        "Subparagraph":  "(h)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
        },
    "r231":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "30",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
        },
    "r232":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "30",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
        },
    "r233":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "30",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
        },
    "r234":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r235":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r236":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r237":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r238":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "32",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
        },
    "r239":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
        },
    "r240":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "41",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
        },
    "r241":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "42",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
        },
    "r242":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
        },
    "r243":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
        },
    "r244":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r245":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r246":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(aa)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r247":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(aaa)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r248":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r249":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r250":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r251":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
        },
    "r252":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
        },
    "r253":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
        },
    "r254":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
        },
    "r255":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
        },
    "r256":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "9",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
        },
    "r257":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "321",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479536/321-10-50-4"
        },
    "r258":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "323",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
        },
    "r259":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "326",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "4",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
        },
    "r260":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "326",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "4",
        "Subparagraph":  "(e)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
        },
    "r261":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "326",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "4",
        "Subparagraph":  "(e)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
        },
    "r262":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "326",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "4",
        "Subparagraph":  "(e)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
        },
    "r263":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "326",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "4",
        "Subparagraph":  "(e)(4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
        },
    "r264":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "326",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "5",
        "Subparagraph":  "(c)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
        },
    "r265":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "326",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
        },
    "r266":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "350",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
        },
    "r267":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "350",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
        },
    "r268":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "350",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r269":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "350",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
        },
    "r270":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "360",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
        },
    "r271":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//420/tableOfContent"
        },
    "r272":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
        },
    "r273":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
        },
    "r274":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
        },
    "r275":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
        },
    "r276":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
        },
    "r277":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
        },
    "r278":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 5.P.3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479823/420-10-S99-1"
        },
    "r279":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB TOPIC 5.P.4(b)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
        },
    "r280":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB Topic 5.P.4(b)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
        },
    "r281":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB Topic 5.P.4(b)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
        },
    "r282":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB Topic 5.P.4(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
        },
    "r283":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB Topic 5.P.4(e))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
        },
    "r284":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
        },
    "r285":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "9",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
        },
    "r286":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 5.Y.Q2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
        },
    "r287":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 5.Y.Q4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
        },
    "r288":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(4)(i))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r289":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(A))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r290":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iv))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r291":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(5))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r292":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1B",
        "Subparagraph":  "(SX 210.13-02(a)(4)(i))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
        },
    "r293":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1B",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(A))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
        },
    "r294":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1B",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(B))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
        },
    "r295":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1B",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iv))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
        },
    "r296":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1B",
        "Subparagraph":  "(SX 210.13-02(a)(5))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
        },
    "r297":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "470",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1D",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
        },
    "r298":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r299":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r300":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r301":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(h)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r302":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "14",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
        },
    "r303":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "18",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
        },
    "r304":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
        },
    "r305":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.3-04)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
        },
    "r306":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
        },
    "r307":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "18",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
        },
    "r308":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "18",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
        },
    "r309":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
        },
    "r310":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "20",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
        },
    "r311":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "20",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
        },
    "r312":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "20",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
        },
    "r313":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "20",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
        },
    "r314":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
        },
    "r315":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
        },
    "r316":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r317":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)(iv)(01)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r318":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)(iv)(02)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r319":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)(iv)(02)(A)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r320":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)(iv)(02)(B)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r321":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)(iv)(02)(C)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r322":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)(iv)(03)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r323":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(n)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r324":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "715",
        "SubTopic":  "80",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
        },
    "r325":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//718/tableOfContent"
        },
    "r326":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "35",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
        },
    "r327":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "35",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
        },
    "r328":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "35",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
        },
    "r329":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r330":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r331":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r332":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r333":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r334":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r335":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r336":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r337":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(01)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r338":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(02)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r339":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(03)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r340":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(04)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r341":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r342":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r343":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(iii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r344":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(iii)(01)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r345":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(iii)(02)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r346":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(iii)(03)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r347":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r348":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r349":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(e)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r350":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(e)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r351":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r352":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r353":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r354":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r355":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(iii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r356":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(iv)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r357":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(v)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r358":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(h)(1)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r359":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r360":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "15",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
        },
    "r361":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "15",
        "Subparagraph":  "(f)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
        },
    "r362":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "15",
        "Subparagraph":  "(f)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
        },
    "r363":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 14.C.Q3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
        },
    "r364":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 14.D.1.Q5)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
        },
    "r365":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 14.D.2.Q6)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
        },
    "r366":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 14.D.3.Q2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
        },
    "r367":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 14.F)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
        },
    "r368":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "730",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "05",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
        },
    "r369":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "730",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
        },
    "r370":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "730",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483041/730-20-50-1"
        },
    "r371":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//740/tableOfContent"
        },
    "r372":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "10B",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
        },
    "r373":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482525/740-10-45-15"
        },
    "r374":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
        },
    "r375":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
        },
    "r376":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
        },
    "r377":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
        },
    "r378":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
        },
    "r379":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "15",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
        },
    "r380":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "15A",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
        },
    "r381":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "17",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
        },
    "r382":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
        },
    "r383":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
        },
    "r384":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
        },
    "r385":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
        },
    "r386":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
        },
    "r387":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
        },
    "r388":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
        },
    "r389":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
        },
    "r390":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "8",
        "Subparagraph":  "(d)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
        },
    "r391":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "8",
        "Subparagraph":  "(d)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
        },
    "r392":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "8",
        "Subparagraph":  "(e)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
        },
    "r393":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "8",
        "Subparagraph":  "(e)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
        },
    "r394":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "8",
        "Subparagraph":  "(e)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
        },
    "r395":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB TOPIC 6.I.5.Q1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
        },
    "r396":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB TOPIC 6.I.7)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
        },
    "r397":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 6.I.Fact.4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
        },
    "r398":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB Topic 11.C)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
        },
    "r399":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "270",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
        },
    "r400":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "740",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
        },
    "r401":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "808",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
        },
    "r402":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
        },
    "r403":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "25",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
        },
    "r404":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "25",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
        },
    "r405":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1A",
        "Subparagraph":  "(a)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
        },
    "r406":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1A",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
        },
    "r407":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(bb)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
        },
    "r408":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
        },
    "r409":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r410":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(h)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r411":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(h)(1)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r412":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(h)(1)(iii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r413":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(h)(1)(iv)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r414":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(i)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r415":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(i)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
        },
    "r416":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r417":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(e)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r418":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(e)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r419":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(e)(4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r420":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r421":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
        },
    "r422":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
        },
    "r423":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
        },
    "r424":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "820",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
        },
    "r425":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "825",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482736/825-10-45-1A"
        },
    "r426":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "825",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "28",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
        },
    "r427":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "825",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(e)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
        },
    "r428":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "825",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(e)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
        },
    "r429":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "825",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "6",
        "Subparagraph":  "(e)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
        },
    "r430":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
        },
    "r431":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "20",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
        },
    "r432":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "20",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
        },
    "r433":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "20",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
        },
    "r434":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "20",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
        },
    "r435":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
        },
    "r436":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "830",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
        },
    "r437":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "5",
        "Subparagraph":  "(d)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
        },
    "r438":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "5",
        "Subparagraph":  "(f)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
        },
    "r439":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "5",
        "Subparagraph":  "(f)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
        },
    "r440":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//842-20/tableOfContent"
        },
    "r441":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
        },
    "r442":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
        },
    "r443":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "5",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
        },
    "r444":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r445":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r446":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r447":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(g)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r448":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(g)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r449":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(g)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r450":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(g)(4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r451":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
        },
    "r452":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "848",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(3)(iii)(01)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
        },
    "r453":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "848",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(3)(iii)(03)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
        },
    "r454":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "848",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
        },
    "r455":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "850",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//850/tableOfContent"
        },
    "r456":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "850",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
        },
    "r457":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "850",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
        },
    "r458":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "850",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
        },
    "r459":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "850",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
        },
    "r460":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "850",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
        },
    "r461":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "855",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//855/tableOfContent"
        },
    "r462":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "855",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
        },
    "r463":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "855",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
        },
    "r464":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(bb)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r465":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(bb)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r466":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(bb)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r467":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r468":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "910",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
        },
    "r469":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "924",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
        },
    "r470":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "926",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
        },
    "r471":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "926",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
        },
    "r472":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "926",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
        },
    "r473":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "926",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
        },
    "r474":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "928",
        "SubTopic":  "340",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
        },
    "r475":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "15",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
        },
    "r476":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "15",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
        },
    "r477":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "20",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
        },
    "r478":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "20",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
        },
    "r479":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "28",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
        },
    "r480":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "28",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
        },
    "r481":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "33",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
        },
    "r482":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "33",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
        },
    "r483":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "35A",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
        },
    "r484":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "35A",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
        },
    "r485":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
        },
    "r486":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "932",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "Subparagraph":  "(c)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
        },
    "r487":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "942",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-03(6))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
        },
    "r488":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "942",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-04(26))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
        },
    "r489":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "942",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-04(27))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
        },
    "r490":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "942",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.9-05(b)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
        },
    "r491":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "942",
        "SubTopic":  "360",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
        },
    "r492":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(1)(h))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r493":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r494":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r495":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(19))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r496":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(22))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r497":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r498":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r499":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r500":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(8)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r501":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(8)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r502":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
        },
    "r503":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(16))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r504":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r505":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(22))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r506":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(23))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r507":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(3)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r508":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(3)(d)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r509":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(3)(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r510":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.7-04(9))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
        },
    "r511":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column A))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r512":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column B))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r513":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column C))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r514":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column D))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r515":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column E))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r516":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-17(Column F))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
        },
    "r517":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7A",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
        },
    "r518":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r519":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r520":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r521":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(g)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r522":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(g)(2)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r523":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(g)(2)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r524":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(g)(2)(iii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r525":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(g)(2)(iv)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r526":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(h)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r527":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(h)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
        },
    "r528":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
        },
    "r529":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r530":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(f)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r531":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(f)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r532":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(f)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r533":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(h)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r534":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(i)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r535":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(i)(2)(i))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r536":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(i)(2)(ii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r537":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-03(i)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
        },
    "r538":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
        },
    "r539":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
        },
    "r540":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
        },
    "r541":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
        },
    "r542":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
        },
    "r543":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
        },
    "r544":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "3",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
        },
    "r545":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "4",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
        },
    "r546":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
        },
    "r547":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
        },
    "r548":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
        },
    "r549":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r550":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(12)(b)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r551":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(12)(b)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r552":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(12)(b)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r553":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(13)(a)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r554":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(13)(a)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r555":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(14))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r556":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(15))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r557":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(16)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r558":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(17))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r559":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(19))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r560":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(2)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r561":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(2)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r562":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(3)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r563":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(3)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r564":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(3)(c))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r565":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(6)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r566":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(6)(c))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r567":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(6)(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r568":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(6)(e))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r569":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(8))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r570":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(9)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r571":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(9)(c))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r572":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(9)(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r573":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-04(9)(e))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
        },
    "r574":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.6-05(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
        },
    "r575":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.6-05(4))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
        },
    "r576":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "3",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
        },
    "r577":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
        },
    "r578":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r579":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(2)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r580":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(2)(c)(2)(i))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r581":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(2)(c)(2)(ii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r582":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(2)(c))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r583":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(2)(e))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r584":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(2)(g)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r585":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r586":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r587":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r588":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(5))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r589":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(6))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r590":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(a)(7))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r591":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(1))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r592":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r593":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(3))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r594":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(5))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r595":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(6))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r596":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(7)(c)(7))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r597":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.6-07(9))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
        },
    "r598":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(1)(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r599":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(4)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r600":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(6))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r601":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(7))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r602":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
        },
    "r603":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "235",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(e)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
        },
    "r604":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
        },
    "r605":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-12(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
        },
    "r606":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "12",
        "Subparagraph":  "(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-12"
        },
    "r607":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "19",
        "Subparagraph":  "(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
        },
    "r608":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-12A(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
        },
    "r609":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.12-12B(Column A)(Footnote 4)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
        },
    "r610":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.12-12B(Column A)(Footnote 4)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
        },
    "r611":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "6",
        "Subparagraph":  "(SX 210.12-14(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
        },
    "r612":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "505",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
        },
    "r613":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "946",
        "SubTopic":  "505",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
        },
    "r614":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "976",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
        },
    "r615":  {
        "role":  "http://www.xbrl.org/2003/role/disclosureRef",
        "Topic":  "978",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
        },
    "r616":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(e)",
        "SubTopic":  "10",
        "Topic":  "235",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
        },
    "r617":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "13H",
        "Subparagraph":  "(a)",
        "SubTopic":  "40",
        "Topic":  "944",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
        },
    "r618":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
        },
    "r619":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
        },
    "r620":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "260",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "52",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
        },
    "r621":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "30",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
        },
    "r622":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "280",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
        },
    "r623":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "12A",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
        },
    "r624":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "470",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "69B",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
        },
    "r625":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "470",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "69C",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
        },
    "r626":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "505",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "13",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
        },
    "r627":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "91",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
        },
    "r628":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r629":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(d)(iv)(01)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
        },
    "r630":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "715",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
        },
    "r631":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "715",
        "SubTopic":  "80",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
        },
    "r632":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r633":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r634":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "4J",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
        },
    "r635":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "810",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "4K",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
        },
    "r636":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
        },
    "r637":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "53",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
        },
    "r638":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "852",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
        },
    "r639":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "944",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
        },
    "r640":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "944",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "29F",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
        },
    "r641":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
        },
    "r642":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Subparagraph":  "(a)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
        },
    "r643":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "210",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
        },
    "r644":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "310",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
        },
    "r645":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.12-12(Column A)(Footnote 2)(i))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
        },
    "r646":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.12-12A(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
        },
    "r647":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.12-12B(Column A)(Footnote 1)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
        },
    "r648":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "320",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "6",
        "Subparagraph":  "(SX 210.12-14(Column A)(Footnote 2))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
        },
    "r649":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "830",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
        },
    "r650":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "830",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
        },
    "r651":  {
        "role":  "http://www.xbrl.org/2003/role/exampleRef",
        "Topic":  "946",
        "SubTopic":  "830",
        "Name":  "Accounting Standards Codification",
        "Section":  "55",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
        },
    "r652":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r653":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r654":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12",
        "Subsection":  "b-23"
        },
    "r655":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Exchange Act",
        "Number":  "240",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r656":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Form 10-K",
        "Number":  "249",
        "Section":  "310"
        },
    "r657":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Form 20-F",
        "Number":  "249",
        "Section":  "220",
        "Subsection":  "f"
        },
    "r658":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Form 40-F",
        "Number":  "249",
        "Section":  "240",
        "Subsection":  "f"
        },
    "r659":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Section":  "13",
        "Subsection":  "a-1"
        },
    "r660":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Section":  "405"
        },
    "r661":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Securities Act",
        "Number":  "230",
        "Section":  "405"
        },
    "r662":  {
        "role":  "http://www.xbrl.org/2003/role/presentationRef",
        "Publisher":  "SEC",
        "Name":  "Securities Act",
        "Number":  "7A",
        "Section":  "B",
        "Subsection":  "2"
        },
    "r663":  {
        "role":  "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
        "Topic":  "272",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
        },
    "r664":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "35",
        "Paragraph":  "2",
        "SubTopic":  "740",
        "Topic":  "718",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480887/718-740-35-2"
        },
    "r665":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "SubTopic":  "10",
        "Topic":  "250",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
        },
    "r666":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4H",
        "SubTopic":  "40",
        "Topic":  "944",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
        },
    "r667":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(a)",
        "SubTopic":  "10",
        "Topic":  "250",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
        },
    "r668":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(b)",
        "SubTopic":  "10",
        "Topic":  "250",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
        },
    "r669":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "SubTopic":  "10",
        "Topic":  "250",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
        },
    "r670":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "321",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//321/tableOfContent"
        },
    "r671":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Name":  "Accounting Standards Codification",
        "Topic":  "325",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//325/tableOfContent"
        },
    "r672":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(17))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r673":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(18))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r674":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "210",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.5-02(9))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
        },
    "r675":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
        },
    "r676":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
        },
    "r677":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
        },
    "r678":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(7)(c))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r679":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "220",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SX 210.5-03(9)(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
        },
    "r680":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "17",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
        },
    "r681":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
        },
    "r682":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "28",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
        },
    "r683":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "230",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
        },
    "r684":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
        },
    "r685":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "235",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
        },
    "r686":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "23",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
        },
    "r687":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
        },
    "r688":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "5",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
        },
    "r689":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "250",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
        },
    "r690":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "310",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
        },
    "r691":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//320/tableOfContent"
        },
    "r692":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
        },
    "r693":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r694":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(aa)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r695":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(aaa)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r696":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r697":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r698":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
        },
    "r699":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
        },
    "r700":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
        },
    "r701":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
        },
    "r702":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
        },
    "r703":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
        },
    "r704":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "320",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "9",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
        },
    "r705":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "321",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479536/321-10-50-4"
        },
    "r706":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "323",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
        },
    "r707":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "326",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "4",
        "Subparagraph":  "(e)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
        },
    "r708":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "326",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "4",
        "Subparagraph":  "(e)(4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
        },
    "r709":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "360",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "35",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482190/360-10-35-3"
        },
    "r710":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "360",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482130/360-10-45-5"
        },
    "r711":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "360",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
        },
    "r712":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "410",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "10",
        "Subparagraph":  "(c)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
        },
    "r713":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482047/420-10-45-3"
        },
    "r714":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
        },
    "r715":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "420",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "2",
        "Subparagraph":  "(SAB Topic 5.P.4(a))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
        },
    "r716":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "9",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
        },
    "r717":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "450",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 5.Y.Q2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
        },
    "r718":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(4)(ii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r719":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "470",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1A",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
        },
    "r720":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "470",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1B",
        "Subparagraph":  "(d)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
        },
    "r721":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "606",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
        },
    "r722":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r723":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r724":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r725":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r726":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r727":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r728":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r729":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(01)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r730":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(02)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r731":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(03)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r732":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(1)(iv)(04)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r733":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r734":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r735":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(iii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r736":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(iii)(01)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r737":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(iii)(02)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r738":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(c)(2)(iii)(03)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r739":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r740":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(d)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r741":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(e)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r742":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(e)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r743":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r744":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(ii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r745":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(iii)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r746":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(iv)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r747":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(f)(2)(v)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r748":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "718",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Subparagraph":  "(i)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
        },
    "r749":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "730",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483041/730-20-50-1"
        },
    "r750":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
        },
    "r751":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
        },
    "r752":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
        },
    "r753":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "740",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "1",
        "Subparagraph":  "(SAB Topic 6.I.Fact.4)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
        },
    "r754":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "805",
        "SubTopic":  "50",
        "Name":  "Accounting Standards Codification",
        "Section":  "15",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480123/805-50-15-3"
        },
    "r755":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(e)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r756":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "815",
        "SubTopic":  "40",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "1",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
        },
    "r757":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "825",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "28",
        "Subparagraph":  "(f)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
        },
    "r758":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "4",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
        },
    "r759":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(a)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
        },
    "r760":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
        },
    "r761":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "842",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
        },
    "r762":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "848",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(3)(iii)(01)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
        },
    "r763":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "848",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "65",
        "Paragraph":  "2",
        "Subparagraph":  "(a)(3)(iii)(03)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
        },
    "r764":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "850",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
        },
    "r765":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "850",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
        },
    "r766":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "852",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
        },
    "r767":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "852",
        "SubTopic":  "10",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "7",
        "Subparagraph":  "(b)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
        },
    "r768":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r769":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r770":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "3",
        "Subparagraph":  "(c)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
        },
    "r771":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(b)(1)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
        },
    "r772":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(b)(2)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
        },
    "r773":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "860",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "4",
        "Subparagraph":  "(b)(3)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
        },
    "r774":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "912",
        "SubTopic":  "730",
        "Name":  "Accounting Standards Codification",
        "Section":  "25",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
        },
    "r775":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "944",
        "SubTopic":  "30",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "2B",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
        },
    "r776":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "205",
        "Name":  "Accounting Standards Codification",
        "Section":  "45",
        "Paragraph":  "4",
        "Subparagraph":  "(a)",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
        },
    "r777":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(4)(b))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r778":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "946",
        "SubTopic":  "220",
        "Name":  "Accounting Standards Codification",
        "Section":  "S99",
        "Paragraph":  "3",
        "Subparagraph":  "(SX 210.6-09(7))",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
        },
    "r779":  {
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef",
        "Topic":  "985",
        "SubTopic":  "20",
        "Name":  "Accounting Standards Codification",
        "Section":  "50",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "URI":  "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
        }
    }
}

30 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/03/23  Organovo Holdings, Inc.           8-K:5,9    10/31/23   11:374K                                   Donnelley … Solutions/FA
 9/22/23  Organovo Holdings, Inc.           8-K/A:2,5,9 8/16/23   11:242K                                   Donnelley … Solutions/FA
 9/12/23  Organovo Holdings, Inc.           8-K:5,9     9/07/23   11:218K                                   Donnelley … Solutions/FA
 7/14/23  Organovo Holdings, Inc.           10-K        3/31/23   75:12M                                    Donnelley … Solutions/FA
10/25/22  Organovo Holdings, Inc.           S-8        10/25/22    6:283K                                   Donnelley … Solutions/FA
10/14/22  Organovo Holdings, Inc.           8-K:5,9    10/12/22   11:546K                                   ActiveDisclosure/FA
 6/10/22  Organovo Holdings, Inc.           10-K        3/31/22   76:8.3M                                   ActiveDisclosure/FA
11/19/21  Organovo Holdings, Inc.           8-K:1,9    11/17/21   11:2M                                     ActiveDisclosure/FA
10/06/21  Organovo Holdings, Inc.           8-K:5,9    10/05/21   12:553K                                   ActiveDisclosure/FA
 3/25/21  Organovo Holdings, Inc.           S-8         3/25/21    5:169K                                   Donnelley … Solutions/FA
 3/10/21  Organovo Holdings, Inc.           8-K:5,9     3/05/21    3:193K                                   Donnelley … Solutions/FA
 2/08/21  Organovo Holdings, Inc.           10-Q       12/31/20   54:5.4M                                   ActiveDisclosure/FA
12/31/20  Organovo Holdings, Inc.           8-K:1,9    12/28/20    2:182K                                   ActiveDisclosure/FA
11/25/20  Organovo Holdings, Inc.           8-K:1,9    11/23/20    3:3.2M                                   ActiveDisclosure/FA
11/05/20  Organovo Holdings, Inc.           10-Q        9/30/20   56:5.5M                                   ActiveDisclosure/FA
 8/17/20  Organovo Holdings, Inc.           8-K:3,5,8,9 8/17/20    3:67K                                    ActiveDisclosure/FA
 5/20/20  Organovo Holdings, Inc.           8-K:5,9     5/19/20    2:56K                                    ActiveDisclosure/FA
 1/29/20  Organovo Holdings, Inc.           8-K:1,9     1/26/20    2:43K                                    Donnelley … Solutions/FA
12/16/19  Organovo Holdings, Inc.           8-K:1,5,8,912/13/19    7:797K                                   Donnelley … Solutions/FA
 8/14/18  Organovo Holdings, Inc.           S-8         8/14/18    5:145K                                   Donnelley … Solutions/FA
 7/27/18  Organovo Holdings, Inc.           8-K:5,9     7/26/18    3:185K                                   ActiveDisclosure/FA
 3/16/18  Organovo Holdings, Inc.           8-K:1,9     3/16/18    3:211K                                   Donnelley … Solutions/FA
 4/24/17  Organovo Holdings, Inc.           S-8         4/24/17    5:156K                                   Donnelley … Solutions/FA
 8/18/16  Organovo Holdings, Inc.           8-K:5,7,9   8/17/16    3:104K                                   Donnelley … Solutions/FA
 8/04/16  Organovo Holdings, Inc.           10-Q        6/30/16   51:4.1M                                   ActiveDisclosure/FA
11/09/15  Organovo Holdings, Inc.           10-Q        9/30/15   48:4.4M                                   ActiveDisclosure/FA
 6/09/15  Organovo Holdings, Inc.           10-K        3/31/15   72:11M                                    ActiveDisclosure/FA
 5/11/12  Organovo Holdings, Inc.           8-K/A:1,2,3 2/08/12    4:1.5M                                   Donnelley … Solutions/FA
 2/13/12  Organovo Holdings, Inc.           8-K:1,2,3,4 2/08/12   30:6M                                     EdgarAgents LLC/FA
 2/03/12  Organovo Holdings, Inc.           8-K:3,5,8,9 1/30/12    7:686K                                   EdgarAgents LLC/FA

↑Top

Filing Submission 0000950170-24-044137 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Organovo Holdings, Inc. – ‘S-1’ on 4/12/24 – ‘JSON’

On: Friday, 4/12/24, at 5:16pm ET · Accession #: 950170-24-44137 · File #: 333-278668

Registration Statement (General Form) — Form S-1 — SA’33Filing Table of Contents

‘JSON’ — XBRL Instance as JSON Data — MetaLinks

This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.

30 Previous Filings that this Filing References

Registration Statement (General Form) — Form S-1 — SA’33

Filing Table of Contents